The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS.
Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation.
Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.
The process whereby PLATELETS adhere to something other than platelets, e.g., COLLAGEN; BASEMENT MEMBRANE; MICROFIBRILS; or other "foreign" surfaces.
The number of PLATELETS per unit volume in a sample of venous BLOOD.
Surface glycoproteins on platelets which have a key role in hemostasis and thrombosis such as platelet adhesion and aggregation. Many of these are receptors.
Adenosine 5'-(trihydrogen diphosphate). An adenine nucleotide containing two phosphate groups esterified to the sugar moiety at the 5'-position.
Laboratory examination used to monitor and evaluate platelet function in a patient's blood.
Platelet membrane glycoprotein complex important for platelet adhesion and aggregation. It is an integrin complex containing INTEGRIN ALPHAIIB and INTEGRIN BETA3 which recognizes the arginine-glycine-aspartic acid (RGD) sequence present on several adhesive proteins. As such, it is a receptor for FIBRINOGEN; VON WILLEBRAND FACTOR; FIBRONECTIN; VITRONECTIN; and THROMBOSPONDINS. A deficiency of GPIIb-IIIa results in GLANZMANN THROMBASTHENIA.
Duration of blood flow after skin puncture. This test is used as a measure of capillary and platelet function.
An enzyme formed from PROTHROMBIN that converts FIBRINOGEN to FIBRIN.
The phenomenon by which dissociated cells intermixed in vitro tend to group themselves with cells of their own type.
Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products.
An unstable intermediate between the prostaglandin endoperoxides and thromboxane B2. The compound has a bicyclic oxaneoxetane structure. It is a potent inducer of platelet aggregation and causes vasoconstriction. It is the principal component of rabbit aorta contracting substance (RCS).
A series of progressive, overlapping events, triggered by exposure of the PLATELETS to subendothelial tissue. These events include shape change, adhesiveness, aggregation, and release reactions. When carried through to completion, these events lead to the formation of a stable hemostatic plug.
A CXC chemokine that is found in the alpha granules of PLATELETS. The protein has a molecular size of 7800 kDa and can occur as a monomer, a dimer or a tetramer depending upon its concentration in solution. Platelet factor 4 has a high affinity for HEPARIN and is often found complexed with GLYCOPROTEINS such as PROTEIN C.
A phospholipid derivative formed by PLATELETS; BASOPHILS; NEUTROPHILS; MONOCYTES; and MACROPHAGES. It is a potent platelet aggregating agent and inducer of systemic anaphylactic symptoms, including HYPOTENSION; THROMBOCYTOPENIA; NEUTROPENIA; and BRONCHOCONSTRICTION.
Platelet membrane glycoprotein complex essential for normal platelet adhesion and clot formation at sites of vascular injury. It is composed of three polypeptides, GPIb alpha, GPIb beta, and GPIX. Glycoprotein Ib functions as a receptor for von Willebrand factor and for thrombin. Congenital deficiency of the GPIb-IX complex results in Bernard-Soulier syndrome. The platelet glycoprotein GPV associates with GPIb-IX and is also absent in Bernard-Soulier syndrome.
The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH).
Formation and development of a thrombus or blood clot in the blood vessel.
A subclass of purinergic P2Y receptors that have a preference for ADP binding and are coupled to GTP-BINDING PROTEIN ALPHA SUBUNIT, GI. The P2Y12 purinergic receptors are found in PLATELETS where they play an important role regulating PLATELET ACTIVATION.
A stable, physiologically active compound formed in vivo from the prostaglandin endoperoxides. It is important in the platelet-release reaction (release of ADP and serotonin).
The transfer of blood platelets from a donor to a recipient or reinfusion to the donor.
An antibiotic mixture of two components, A and B, obtained from Nocardia lurida (or the same substance produced by any other means). It is no longer used clinically because of its toxicity. It causes platelet agglutination and blood coagulation and is used to assay those functions in vitro.
A calcium-activated enzyme that catalyzes the hydrolysis of ATP to yield AMP and orthophosphate. It can also act on ADP and other nucleoside triphosphates and diphosphates. EC 3.6.1.5.
A high-molecular-weight plasma protein, produced by endothelial cells and megakaryocytes, that is part of the factor VIII/von Willebrand factor complex. The von Willebrand factor has receptors for collagen, platelets, and ristocetin activity as well as the immunologically distinct antigenic determinants. It functions in adhesion of platelets to collagen and hemostatic plug formation. The prolonged bleeding time in VON WILLEBRAND DISEASES is due to the deficiency of this factor.
Venoms from snakes of the subfamily Crotalinae or pit vipers, found mostly in the Americas. They include the rattlesnake, cottonmouth, fer-de-lance, bushmaster, and American copperhead. Their venoms contain nontoxic proteins, cardio-, hemo-, cyto-, and neurotoxins, and many enzymes, especially phospholipases A. Many of the toxins have been characterized.
Cell adhesion molecule and CD antigen that mediates the adhesion of neutrophils and monocytes to activated platelets and endothelial cells.
A biochemical messenger and regulator, synthesized from the essential amino acid L-TRYPTOPHAN. In humans it is found primarily in the central nervous system, gastrointestinal tract, and blood platelets. Serotonin mediates several important physiological functions including neurotransmission, gastrointestinal motility, hemostasis, and cardiovascular integrity. Multiple receptor families (RECEPTORS, SEROTONIN) explain the broad physiological actions and distribution of this biochemical mediator.
The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot.
A prostaglandin that is a powerful vasodilator and inhibits platelet aggregation. It is biosynthesized enzymatically from PROSTAGLANDIN ENDOPEROXIDES in human vascular tissue. The sodium salt has been also used to treat primary pulmonary hypertension (HYPERTENSION, PULMONARY).
Physiologically active compounds found in many organs of the body. They are formed in vivo from the prostaglandin endoperoxides and cause platelet aggregation, contraction of arteries, and other biological effects. Thromboxanes are important mediators of the actions of polyunsaturated fatty acids transformed by cyclooxygenase.
Disorders caused by abnormalities in platelet count or function.
A subnormal level of BLOOD PLATELETS.
Human alloantigens expressed only on platelets, specifically on platelet membrane glycoproteins. These platelet-specific antigens are immunogenic and can result in pathological reactions to transfusion therapy.
A stable prostaglandin endoperoxide analog which serves as a thromboxane mimetic. Its actions include mimicking the hydro-osmotic effect of VASOPRESSIN and activation of TYPE C PHOSPHOLIPASES. (From J Pharmacol Exp Ther 1983;224(1): 108-117; Biochem J 1984;222(1):103-110)
The formation of clumps of RED BLOOD CELLS under low or non-flow conditions, resulting from the attraction forces between the red blood cells. The cells adhere to each other in rouleaux aggregates. Slight mechanical force, such as occurs in the circulation, is enough to disperse these aggregates. Stronger or weaker than normal aggregation may result from a variety of effects in the ERYTHROCYTE MEMBRANE or in BLOOD PLASMA. The degree of aggregation is affected by ERYTHROCYTE DEFORMABILITY, erythrocyte membrane sialylation, masking of negative surface charge by plasma proteins, etc. BLOOD VISCOSITY and the ERYTHROCYTE SEDIMENTATION RATE are affected by the amount of erythrocyte aggregation and are parameters used to measure the aggregation.
The process which spontaneously arrests the flow of BLOOD from vessels carrying blood under pressure. It is accomplished by contraction of the vessels, adhesion and aggregation of formed blood elements (eg. ERYTHROCYTE AGGREGATION), and the process of BLOOD COAGULATION.
Synthetic compounds that are analogs of the naturally occurring prostaglandin endoperoxides and that mimic their pharmacologic and physiologic activities. They are usually more stable than the naturally occurring compounds.
The active sympathomimetic hormone from the ADRENAL MEDULLA. It stimulates both the alpha- and beta- adrenergic systems, causes systemic VASOCONSTRICTION and gastrointestinal relaxation, stimulates the HEART, and dilates BRONCHI and cerebral vessels. It is used in ASTHMA and CARDIAC FAILURE and to delay absorption of local ANESTHETICS.
An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
A congenital bleeding disorder with prolonged bleeding time, absence of aggregation of platelets in response to most agents, especially ADP, and impaired or absent clot retraction. Platelet membranes are deficient in or have a defect in the glycoprotein IIb-IIIa complex (PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX).
A phospholipid from the platelet membrane that contributes to the blood clotting cascade by forming a phospholipid-protein complex (THROMBOPLASTIN) which serves as a cofactor with FACTOR VIIA to activate FACTOR X in the extrinsic pathway of BLOOD COAGULATION.
Platelet membrane glycoprotein IIb is an integrin alpha subunit that heterodimerizes with INTEGRIN BETA3 to form PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX. It is synthesized as a single polypeptide chain which is then postranslationally cleaved and processed into two disulfide-linked subunits of approximately 18 and 110 kDa in size.
Very large BONE MARROW CELLS which release mature BLOOD PLATELETS.
Univalent antigen-binding fragments composed of one entire IMMUNOGLOBULIN LIGHT CHAIN and the amino terminal end of one of the IMMUNOGLOBULIN HEAVY CHAINS from the hinge region, linked to each other by disulfide bonds. Fab contains the IMMUNOGLOBULIN VARIABLE REGIONS, which are part of the antigen-binding site, and the first IMMUNOGLOBULIN CONSTANT REGIONS. This fragment can be obtained by digestion of immunoglobulins with the proteolytic enzyme PAPAIN.
Cell surface proteins that bind THROMBOXANES with high affinity and trigger intracellular changes influencing the behavior of cells. Some thromboxane receptors act via the inositol phosphate and diacylglycerol second messenger systems.
An unsaturated, essential fatty acid. It is found in animal and human fat as well as in the liver, brain, and glandular organs, and is a constituent of animal phosphatides. It is formed by the synthesis from dietary linoleic acid and is a precursor in the biosynthesis of prostaglandins, thromboxanes, and leukotrienes.
The relationship between the dose of an administered drug and the response of the organism to the drug.
The species Oryctolagus cuniculus, in the family Leporidae, order LAGOMORPHA. Rabbits are born in burrows, furless, and with eyes and ears closed. In contrast with HARES, rabbits have 22 chromosome pairs.
A family of proteinase-activated receptors that are specific for THROMBIN. They are found primarily on PLATELETS and on ENDOTHELIAL CELLS. Activation of thrombin receptors occurs through the proteolytic action of THROMBIN, which cleaves the N-terminal peptide from the receptor to reveal a new N-terminal peptide that is a cryptic ligand for the receptor. The receptors signal through HETEROTRIMERIC GTP-BINDING PROTEINS. Small synthetic peptides that contain the unmasked N-terminal peptide sequence can also activate the receptor in the absence of proteolytic activity.
Arachidonic acids are polyunsaturated fatty acids that play a role in various physiological processes and are commonly found in cell membranes.
A basic element found in nearly all organized tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes.
Antibodies produced by a single clone of cells.
Endogenous substances, usually proteins, that are involved in the blood coagulation process.
A subclass of eicosanoid receptors that have specificity for THROMBOXANE A2 and PROSTAGLANDIN H2.
The deformation and flow behavior of BLOOD and its elements i.e., PLASMA; ERYTHROCYTES; WHITE BLOOD CELLS; and BLOOD PLATELETS.
A subclass of purinergic P2Y receptors that have a preference for ATP and ADP. The activated P2Y1 receptor signals through the G-PROTEIN-coupled activation of PHOSPHOLIPASE C and mobilization of intracellular CALCIUM.
The rate dynamics in chemical or physical systems.
Laboratory tests for evaluating the individual's clotting mechanism.
Compounds that bind to and block the stimulation of PURINERGIC P2Y RECEPTORS. Included under this heading are antagonists for specific P2Y receptor subtypes.
Peptides composed of between two and twelve amino acids.
A dual specificity phosphatase subtype that plays a role in intracellular signal transduction by inactivating MITOGEN-ACTIVATED PROTEIN KINASES. It has specificity for EXTRACELLULAR SIGNAL-REGULATED MAP KINASES and is primarily localized to the CELL NUCLEUS.
The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments.
An enzyme found predominantly in platelet microsomes. It catalyzes the conversion of PGG(2) and PGH(2) (prostaglandin endoperoxides) to thromboxane A2. EC 5.3.99.5.
The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION.
A preparation consisting of PLATELETS concentrated in a limited volume of PLASMA. This is used in various surgical tissue regeneration procedures where the GROWTH FACTORS in the platelets enhance wound healing and regeneration.
Blood clot formation in any part of the CAROTID ARTERIES. This may produce CAROTID STENOSIS or occlusion of the vessel, leading to TRANSIENT ISCHEMIC ATTACK; CEREBRAL INFARCTION; or AMAUROSIS FUGAX.
Hydrazines are organic compounds containing a hydrazine group (-NH-NH2), which have been used in the medical field for various purposes such as as antifungals, anti-inflammatory agents, and as intermediates in the synthesis of other drugs.
A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts.
A genus of venomous snakes of the subfamily Crotalinae. Twelve species of this genus are found in North and Central America and Asia. Agkistrodon contortrix is the copperhead, A. piscivorus, the cottonmouth. The former is named for its russet or orange-brown color, the latter for the white interior of its mouth. (Goin, Goin, and Zug, Introduction to Herpetology, 3d ed, p336; Moore, Poisonous Snakes of the World, 1980, p75)
Retraction of a clot resulting from contraction of PLATELET pseudopods attached to FIBRIN strands. The retraction is dependent on the contractile protein thrombosthenin. Clot retraction is used as a measure of platelet function.
Condensed areas of cellular material that may be bounded by a membrane.
Elements of limited time intervals, contributing to particular results or situations.
Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.
Disorder characterized by a decrease or lack of platelet dense bodies in which the releasable pool of adenine nucleotides and 5HT are normally stored.
Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques.
Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are linear polypeptides that are normally synthesized on RIBOSOMES.
Single-chain polypeptides of about 65 amino acids (7 kDa) from LEECHES that have a neutral hydrophobic N terminus, an acidic hydrophilic C terminus, and a compact, hydrophobic core region. Recombinant hirudins lack tyr-63 sulfation and are referred to as 'desulfato-hirudins'. They form a stable non-covalent complex with ALPHA-THROMBIN, thereby abolishing its ability to cleave FIBRINOGEN.
A family of related, adhesive glycoproteins which are synthesized, secreted, and incorporated into the extracellular matrix of a variety of cells, including alpha granules of platelets following thrombin activation and endothelial cells. They interact with a number of BLOOD COAGULATION FACTORS and anticoagulant factors. Five distinct forms have been identified, thrombospondin 1, -2, -3, -4, and cartilage oligomeric matrix protein (COMP). They are involved in cell adhesion, platelet aggregation, cell proliferation, angiogenesis, tumor metastasis, VASCULAR SMOOTH MUSCLE growth, and tissue repair.
Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins.
Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN.
Any form of purpura in which the PLATELET COUNT is decreased. Many forms are thought to be caused by immunological mechanisms.
Compounds that bind to and block the stimulation of PURINERGIC P2 RECEPTORS.
Group of hemorrhagic disorders in which the VON WILLEBRAND FACTOR is either quantitatively or qualitatively abnormal. They are usually inherited as an autosomal dominant trait though rare kindreds are autosomal recessive. Symptoms vary depending on severity and disease type but may include prolonged bleeding time, deficiency of factor VIII, and impaired platelet adhesion.
A non-steroidal anti-inflammatory agent (NSAID) that inhibits the enzyme cyclooxygenase necessary for the formation of prostaglandins and other autacoids. It also inhibits the motility of polymorphonuclear leukocytes.
Hemorrhagic and thrombotic disorders that occur as a consequence of abnormalities in blood coagulation due to a variety of factors such as COAGULATION PROTEIN DISORDERS; BLOOD PLATELET DISORDERS; BLOOD PROTEIN DISORDERS or nutritional conditions.
A thrombin receptor subtype that couples to HETEROTRIMERIC GTP-BINDING PROTEINS resulting in the activation of a variety of signaling mechanisms including decreased intracellular CYCLIC AMP, increased TYPE C PHOSPHOLIPASES and increased PHOSPHOLIPASE A2.
Bleeding or escape of blood from a vessel.
Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake.
Cell surface receptors that bind prostaglandins with high affinity and trigger intracellular changes which influence the behavior of cells. Prostaglandin receptor subtypes have been tentatively named according to their relative affinities for the endogenous prostaglandins. They include those which prefer prostaglandin D2 (DP receptors), prostaglandin E2 (EP1, EP2, and EP3 receptors), prostaglandin F2-alpha (FP receptors), and prostacyclin (IP receptors).
Spontaneous or near spontaneous bleeding caused by a defect in clotting mechanisms (BLOOD COAGULATION DISORDERS) or another abnormality causing a structural flaw in the blood vessels (HEMOSTATIC DISORDERS).
The number of LEUKOCYTES and ERYTHROCYTES per unit volume in a sample of venous BLOOD. A complete blood count (CBC) also includes measurement of the HEMOGLOBIN; HEMATOCRIT; and ERYTHROCYTE INDICES.
A group of physiologically active prostaglandin endoperoxides. They are precursors in the biosynthesis of prostaglandins and thromboxanes. The most frequently encountered member of this group is the prostaglandin H2.
The physiologically active and stable hydrolysis product of EPOPROSTENOL. Found in nearly all mammalian tissue.
Adherence of cells to surfaces or to other cells.
A familial coagulation disorder characterized by a prolonged bleeding time, unusually large platelets, and impaired prothrombin consumption.
Precursors in the biosynthesis of prostaglandins and thromboxanes from arachidonic acid. They are physiologically active compounds, having effect on vascular and airway smooth muscles, platelet aggregation, etc.
Amidines substituted with a benzene group. Benzamidine and its derivatives are known as peptidase inhibitors.
Proteins prepared by recombinant DNA technology.
A potent vasodilator agent that increases peripheral blood flow.
Use of a thrombelastograph, which provides a continuous graphic record of the physical shape of a clot during fibrin formation and subsequent lysis.
Adenine nucleotides are molecules that contain the nitrogenous base adenine and are involved in various biological processes, including energy metabolism and DNA synthesis.
Venoms from SNAKES of the viperid family. They tend to be less toxic than elapid or hydrophid venoms and act mainly on the vascular system, interfering with coagulation and capillary membrane integrity and are highly cytotoxic. They contain large amounts of several enzymes, other factors, and some toxins.
The natural enzymatic dissolution of FIBRIN.
An ionophorous, polyether antibiotic from Streptomyces chartreusensis. It binds and transports CALCIUM and other divalent cations across membranes and uncouples oxidative phosphorylation while inhibiting ATPase of rat liver mitochondria. The substance is used mostly as a biochemical tool to study the role of divalent cations in various biological systems.
The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety.
An adenine nucleotide containing one phosphate group which is esterified to both the 3'- and 5'-positions of the sugar moiety. It is a second messenger and a key intracellular regulator, functioning as a mediator of activity for a number of hormones, including epinephrine, glucagon, and ACTH.
A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP.
A chelating agent that sequesters a variety of polyvalent cations such as CALCIUM. It is used in pharmaceutical manufacturing and as a food additive.
A platelet-specific protein which is released when platelets aggregate. Elevated plasma levels have been reported after deep venous thrombosis, pre-eclampsia, myocardial infarction with mural thrombosis, and myeloproliferative disorders. Measurement of beta-thromboglobulin in biological fluids by radioimmunoassay is used for the diagnosis and assessment of progress of thromboembolic disorders.
Collagen receptors are cell surface receptors that modulate signal transduction between cells and the EXTRACELLULAR MATRIX. They are found in many cell types and are involved in the maintenance and regulation of cell shape and behavior, including PLATELET ACTIVATION and aggregation, through many different signaling pathways and differences in their affinities for collagen isoforms. Collagen receptors include discoidin domain receptors, INTEGRINS, and glycoprotein VI.
A class of cell surface receptors for PURINES that prefer ATP or ADP over ADENOSINE. P2 purinergic receptors are widespread in the periphery and in the central and peripheral nervous system.
A sulfur-containing alkyl thionitrite that is one of the NITRIC OXIDE DONORS.
Microscopy using an electron beam, instead of light, to visualize the sample, thereby allowing much greater magnification. The interactions of ELECTRONS with specimens are used to provide information about the fine structure of that specimen. In TRANSMISSION ELECTRON MICROSCOPY the reactions of the electrons that are transmitted through the specimen are imaged. In SCANNING ELECTRON MICROSCOPY an electron beam falls at a non-normal angle on the specimen and the image is derived from the reactions occurring above the plane of the specimen.
A lipoxygenase metabolite of ARACHIDONIC ACID. It is a highly selective ligand used to label mu-opioid receptors in both membranes and tissue sections. The 12-S-HETE analog has been reported to augment tumor cell metastatic potential through activation of protein kinase C. (J Pharmacol Exp Ther 1995; 274(3):1545-51; J Natl Cancer Inst 1994; 86(15):1145-51)
A family of polypeptides purified from snake venoms, which contain the arginine-glycine-aspartic acid (RGD) sequence. The RGD tripeptide binds to integrin receptors and thus competitively inhibits normal integrin-ligand interactions. Disintegrins thus block adhesive functions and act as platelet aggregation inhibitors.
An adenine nucleotide containing three phosphate groups esterified to the sugar moiety. In addition to its crucial roles in metabolism adenosine triphosphate is a neurotransmitter.
The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway.
The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells.
Increased numbers of platelets in the peripheral blood. (Dorland, 27th ed)
A group of compounds derived from unsaturated 20-carbon fatty acids, primarily arachidonic acid, via the cyclooxygenase pathway. They are extremely potent mediators of a diverse group of physiological processes.
The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065)
A humoral factor that stimulates the production of thrombocytes (BLOOD PLATELETS). Thrombopoietin stimulates the proliferation of bone marrow MEGAKARYOCYTES and their release of blood platelets. The process is called THROMBOPOIESIS.
Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components.
A protein derived from FIBRINOGEN in the presence of THROMBIN, which forms part of the blood clot.
Guanosine cyclic 3',5'-(hydrogen phosphate). A guanine nucleotide containing one phosphate group which is esterified to the sugar moiety in both the 3'- and 5'-positions. It is a cellular regulatory agent and has been described as a second messenger. Its levels increase in response to a variety of hormones, including acetylcholine, insulin, and oxytocin and it has been found to activate specific protein kinases. (From Merck Index, 11th ed)
Chemically stimulated aggregation of cell surface receptors, which potentiates the action of the effector cell.
Coagulation of blood in any of the CORONARY VESSELS. The presence of a blood clot (THROMBUS) often leads to MYOCARDIAL INFARCTION.
An integrin beta subunit of approximately 85-kDa in size which has been found in INTEGRIN ALPHAIIB-containing and INTEGRIN ALPHAV-containing heterodimers. Integrin beta3 occurs as three alternatively spliced isoforms, designated beta3A-C.
Solutions or mixtures of toxic and nontoxic substances elaborated by snake (Ophidia) salivary glands for the purpose of killing prey or disabling predators and delivered by grooved or hollow fangs. They usually contain enzymes, toxins, and other factors.
DITERPENES with three LACTONES and a unique tert-butyl group, which are found in GINKGO plants along with BILOBALIDES.
Blood-coagulation factor VIII. Antihemophilic factor that is part of the factor VIII/von Willebrand factor complex. Factor VIII is produced in the liver and acts in the intrinsic pathway of blood coagulation. It serves as a cofactor in factor X activation and this action is markedly enhanced by small amounts of thrombin.
Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors.
Agents that prevent clotting.
The residual portion of BLOOD that is left after removal of BLOOD CELLS by CENTRIFUGATION without prior BLOOD COAGULATION.
Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others.
Proteins and peptides found in SALIVA and the SALIVARY GLANDS. Some salivary proteins such as ALPHA-AMYLASES are enzymes, but their composition varies in different individuals.
A purely physical condition which exists within any material because of strain or deformation by external forces or by non-uniform thermal expansion; expressed quantitatively in units of force per unit area.
Microscopy in which the object is examined directly by an electron beam scanning the specimen point-by-point. The image is constructed by detecting the products of specimen interactions that are projected above the plane of the sample, such as backscattered electrons. Although SCANNING TRANSMISSION ELECTRON MICROSCOPY also scans the specimen point by point with the electron beam, the image is constructed by detecting the electrons, or their interaction products that are transmitted through the sample plane, so that is a form of TRANSMISSION ELECTRON MICROSCOPY.
An integrin alpha subunit that primarily combines with INTEGRIN BETA1 to form the INTEGRIN ALPHA2BETA1 heterodimer. It contains a domain which has homology to collagen-binding domains found in von Willebrand factor.
The sum of the weight of all the atoms in a molecule.
A non-essential amino acid. In animals it is synthesized from PHENYLALANINE. It is also the precursor of EPINEPHRINE; THYROID HORMONES; and melanin.
Cell surface proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell (From Alberts, Molecular Biology of the Cell, 2nd ed, pp693-5). Cell surface receptors, unlike enzymes, do not chemically alter their ligands.
A layer of epithelium that lines the heart, blood vessels (ENDOTHELIUM, VASCULAR), lymph vessels (ENDOTHELIUM, LYMPHATIC), and the serous cavities of the body.
The internal resistance of the BLOOD to shear forces. The in vitro measure of whole blood viscosity is of limited clinical utility because it bears little relationship to the actual viscosity within the circulation, but an increase in the viscosity of circulating blood can contribute to morbidity in patients suffering from disorders such as SICKLE CELL ANEMIA and POLYCYTHEMIA.
Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
The parts of a macromolecule that directly participate in its specific combination with another molecule.
Clotting time of PLASMA recalcified in the presence of excess TISSUE THROMBOPLASTIN. Factors measured are FIBRINOGEN; PROTHROMBIN; FACTOR V; FACTOR VII; and FACTOR X. It is used for monitoring anticoagulant therapy with COUMARINS.
The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
A fibrous protein complex that consists of proteins folded into a specific cross beta-pleated sheet structure. This fibrillar structure has been found as an alternative folding pattern for a variety of functional proteins. Deposits of amyloid in the form of AMYLOID PLAQUES are associated with a variety of degenerative diseases. The amyloid structure has also been found in a number of functional proteins that are unrelated to disease.
Conjugated protein-carbohydrate compounds including mucins, mucoid, and amyloid glycoproteins.
Coagulant substances inhibiting the anticoagulant action of heparin.
The process of generating thrombocytes (BLOOD PLATELETS) from the pluripotent HEMATOPOIETIC STEM CELLS in the BONE MARROW via the MEGAKARYOCYTES. The humoral factor with thrombopoiesis-stimulating activity is designated THROMBOPOIETIN.
Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes.
Electrophoresis in which a polyacrylamide gel is used as the diffusion medium.
A deficiency or absence of FIBRINOGEN in the blood.
A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
An integrin found on fibroblasts, platelets, endothelial and epithelial cells, and lymphocytes where it functions as a receptor for COLLAGEN and LAMININ. Although originally referred to as the collagen receptor, it is one of several receptors for collagen. Ligand binding to integrin alpha2beta1 triggers a cascade of intracellular signaling, including activation of p38 MAP kinase.
Processes involved in the formation of TERTIARY PROTEIN STRUCTURE.
The time required for the appearance of FIBRIN strands following the mixing of PLASMA with phospholipid platelet substitute (e.g., crude cephalins, soybean phosphatides). It is a test of the intrinsic pathway (factors VIII, IX, XI, and XII) and the common pathway (fibrinogen, prothrombin, factors V and X) of BLOOD COAGULATION. It is used as a screening test and to monitor HEPARIN therapy.
A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
A family of snakes comprising three subfamilies: Azemiopinae (the mountain viper, the sole member of this subfamily), Viperinae (true vipers), and Crotalinae (pit vipers). They are widespread throughout the world, being found in the United States, Central and South America, Europe, Asia and Africa. Their venoms act on the blood (hemotoxic) as compared to the venom of elapids which act on the nervous system (neurotoxic). (Goin, Goin, and Zug, Introduction to Herpetology, 3d ed, pp333-36)
Adenine nucleotide containing one phosphate group esterified to the sugar moiety in the 2'-, 3'-, or 5'-position.
Domesticated bovine animals of the genus Bos, usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor.
The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain).
The diversion of RADIATION (thermal, electromagnetic, or nuclear) from its original path as a result of interactions or collisions with atoms, molecules, or larger particles in the atmosphere or other media. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
Physiologically active prostaglandins found in many tissues and organs. They show pressor activity, are mediators of inflammation, and have potential antithrombotic effects.
Compounds obtained by chemical synthesis that are analogs or derivatives of naturally occurring prostaglandins and that have similar activity.
Thiophenes are a class of heterocyclic compounds containing sulfur that are used in the medical field as anti-inflammatory and anti-cancer agents.
The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements.
The time required by whole blood to produce a visible clot.
2-Octylcyclopentaneheptanoic acids. The family of saturated carbon-20 cyclic fatty acids that represent the parent compounds of the prostaglandins.
(11 alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid (PGE(1)); (5Z,11 alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid (PGE(2)); and (5Z,11 alpha,13E,15S,17Z)-11,15-dihydroxy-9-oxoprosta-5,13,17-trien-1-oic acid (PGE(3)). Three of the six naturally occurring prostaglandins. They are considered primary in that no one is derived from another in living organisms. Originally isolated from sheep seminal fluid and vesicles, they are found in many organs and tissues and play a major role in mediating various physiological activities.
Surface ligands, usually glycoproteins, that mediate cell-to-cell adhesion. Their functions include the assembly and interconnection of various vertebrate systems, as well as maintenance of tissue integration, wound healing, morphogenic movements, cellular migrations, and metastasis.
The action of a drug in promoting or enhancing the effectiveness of another drug.
Disruption of the non-covalent bonds and/or disulfide bonds responsible for maintaining the three-dimensional shape and activity of the native protein.
A subclass of phospholipases that hydrolyze the phosphoester bond found in the third position of GLYCEROPHOSPHOLIPIDS. Although the singular term phospholipase C specifically refers to an enzyme that catalyzes the hydrolysis of PHOSPHATIDYLCHOLINE (EC 3.1.4.3), it is commonly used in the literature to refer to broad variety of enzymes that specifically catalyze the hydrolysis of PHOSPHATIDYLINOSITOLS.
Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme.
An eicosanoid, derived from the cyclooxygenase pathway of arachidonic acid metabolism. It is a stable and synthetic analog of EPOPROSTENOL, but with a longer half-life than the parent compound. Its actions are similar to prostacyclin. Iloprost produces vasodilation and inhibits platelet aggregation.
The network of filaments, tubules, and interconnecting filamentous bridges which give shape, structure, and organization to the cytoplasm.
The action of a drug that may affect the activity, metabolism, or toxicity of another drug.
Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment.
Two small peptide chains removed from the N-terminal segment of the alpha chains of fibrinogen by the action of thrombin during the blood coagulation process. Each peptide chain contains 18 amino acid residues. In vivo, fibrinopeptide A is used as a marker to determine the rate of conversion of fibrinogen to fibrin by thrombin.
C57BL mice are a commonly used strain of laboratory mice that are inbred to produce consistent and predictable results in scientific research.
A synuclein that is a major component of LEWY BODIES that plays a role in neurodegeneration and neuroprotection.
The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups.
Monomeric subunits of primarily globular ACTIN and found in the cytoplasmic matrix of almost all cells. They are often associated with microtubules and may play a role in cytoskeletal function and/or mediate movement of the cell or the organelles within the cell.
Strains of mice in which certain GENES of their GENOMES have been disrupted, or "knocked-out". To produce knockouts, using RECOMBINANT DNA technology, the normal DNA sequence of the gene being studied is altered to prevent synthesis of a normal gene product. Cloned cells in which this DNA alteration is successful are then injected into mouse EMBRYOS to produce chimeric mice. The chimeric mice are then bred to yield a strain in which all the cells of the mouse contain the disrupted gene. Knockout mice are used as EXPERIMENTAL ANIMAL MODELS for diseases (DISEASE MODELS, ANIMAL) and to clarify the functions of the genes.
Naturally occurring or experimentally induced animal diseases with pathological processes sufficiently similar to those of human diseases. They are used as study models for human diseases.
White blood cells. These include granular leukocytes (BASOPHILS; EOSINOPHILS; and NEUTROPHILS) as well as non-granular leukocytes (LYMPHOCYTES and MONOCYTES).
The volume of packed RED BLOOD CELLS in a blood specimen. The volume is measured by centrifugation in a tube with graduated markings, or with automated blood cell counters. It is an indicator of erythrocyte status in disease. For example, ANEMIA shows a low value; POLYCYTHEMIA, a high value.
An serine-threonine protein kinase that requires the presence of physiological concentrations of CALCIUM and membrane PHOSPHOLIPIDS. The additional presence of DIACYLGLYCEROLS markedly increases its sensitivity to both calcium and phospholipids. The sensitivity of the enzyme can also be increased by PHORBOL ESTERS and it is believed that protein kinase C is the receptor protein of tumor-promoting phorbol esters.
Compounds and molecular complexes that consist of very large numbers of atoms and are generally over 500 kDa in size. In biological systems macromolecular substances usually can be visualized using ELECTRON MICROSCOPY and are distinguished from ORGANELLES by the lack of a membrane structure.
Fatty acid derivatives of glycerophosphates. They are composed of glycerol bound in ester linkage with 1 mole of phosphoric acid at the terminal 3-hydroxyl group and with 2 moles of fatty acids at the other two hydroxyl groups.
A gram-positive organism found in dental plaque, in blood, on heart valves in subacute endocarditis, and infrequently in saliva and throat specimens. L-forms are associated with recurrent aphthous stomatitis.
Lipids containing one or more phosphate groups, particularly those derived from either glycerol (phosphoglycerides see GLYCEROPHOSPHOLIPIDS) or sphingosine (SPHINGOLIPIDS). They are polar lipids that are of great importance for the structure and function of cell membranes and are the most abundant of membrane lipids, although not stored in large amounts in the system.
An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes.
A family of transmembrane glycoproteins (MEMBRANE GLYCOPROTEINS) consisting of noncovalent heterodimers. They interact with a wide variety of ligands including EXTRACELLULAR MATRIX PROTEINS; COMPLEMENT, and other cells, while their intracellular domains interact with the CYTOSKELETON. The integrins consist of at least three identified families: the cytoadhesin receptors(RECEPTORS, CYTOADHESIN), the leukocyte adhesion receptors (RECEPTORS, LEUKOCYTE ADHESION), and the VERY LATE ANTIGEN RECEPTORS. Each family contains a common beta-subunit (INTEGRIN BETA CHAINS) combined with one or more distinct alpha-subunits (INTEGRIN ALPHA CHAINS). These receptors participate in cell-matrix and cell-cell adhesion in many physiologically important processes, including embryological development; HEMOSTASIS; THROMBOSIS; WOUND HEALING; immune and nonimmune defense mechanisms; and oncogenic transformation.
Clotting time of PLASMA mixed with a THROMBIN solution. It is a measure of the conversion of FIBRINOGEN to FIBRIN, which is prolonged by AFIBRINOGENEMIA, abnormal fibrinogen, or the presence of inhibitory substances, e.g., fibrin-fibrinogen degradation products, or HEPARIN. BATROXOBIN, a thrombin-like enzyme unaffected by the presence of heparin, may be used in place of thrombin.

Primary haemostasis: sticky fingers cement the relationship. (1/4463)

Platelet aggregation to form a haemostatic plug, or thrombus, plays a key role in preventing bleeding from a wound. Recent studies have provided new insights into how platelet receptors are deployed during the interactions with the vascular subendothelial matrix that lead to haemostatic plug formation.  (+info)

Nitric oxide in the endometrium. (2/4463)

Nitric oxide (NO) is an important mediator of paracrine interactions, especially within the vascular system. It is a powerful inhibitor of platelet aggregation and a potent vasodilator. NO is also a neurotransmitter and it plays a role in cell-mediated cytotoxicity. NO-generating enzymes (nitric oxide synthases, NOS) have been described in the endometrium of a number of species, suggesting that NO might be involved in endometrial function. In human endometrium, endothelial NOS and inducible NOS have been localized to glandular epithelium in the non-pregnant uterus. Weak inducible NOS immunoreactivity has been observed in decidualized stromal cells. NO might participate in the initiation and control of menstrual bleeding. Furthermore, it may play a part in the inhibition of platelet aggregation within the endometrium, where menstrual haemostasis is thought to occur primarily by vasoconstriction rather than clot organization. Endometrially derived NO could also suppress myometrial contractility. Recent attention has focused on the part that NO might play in maintaining myometrial quiescence during pregnancy. NO also appears to relax the non-pregnant myometrium, an action which could be exploited for the medical treatment of primary dysmenorrhoea.  (+info)

Labeling of the internal pool of GP IIb-IIIa in platelets by c7E3 Fab fragments (abciximab): flow and endocytic mechanisms contribute to the transport. (3/4463)

Abciximab is a new antiplatelet therapeutic in ischemic cardiovascular disease. The drug, chimeric Fab fragments of a murine monoclonal antibody (MoAb) (c7E3), blocks GP IIb-IIIa function. However, its capacity to reach all receptor pools in platelets is unknown. Electron microscopy and immunogold labeling were used to localize abciximab in platelets of patients receiving the drug for up to 24 hours. Studies on frozen-thin sections showed that c7E3 Fab, in addition to the surface pool, also labeled the surface-connected canalicular system (SCCS) and alpha-granules. Analysis of gold particle distribution showed that intraplatelet labeling was not accumulative and in equilibrium with the surface pool. After short-term incubations of platelets with c7E3 Fab in vitro, gold particles were often seen in lines within thin elements of the SCCS, some of which appeared in contact with alpha-granules. Little labeling was associated with Glanzmann's thrombasthenia platelets, confirming that the channels contained bound and not free c7E3 Fab. Endocytosis of abciximab in clathrin-containing vesicles was visualized by double staining and constitutes an alternative mechanism of transport. The remaining free pool of GP IIb-IIIa was evaluated with the MoAb AP-2; flow cytometry showed it to be about 9% on the surface of nonstimulated platelets but 33% on thrombin-activated platelets. The ability of drugs to block all pools of GP IIb-IIIa and then to be associated with secretion-dependent residual aggregation must be considered when evaluating their efficiency in a clinical context.  (+info)

Activation of G12/G13 results in shape change and Rho/Rho-kinase-mediated myosin light chain phosphorylation in mouse platelets. (4/4463)

Platelets respond to various stimuli with rapid changes in shape followed by aggregation and secretion of their granule contents. Platelets lacking the alpha-subunit of the heterotrimeric G protein Gq do not aggregate and degranulate but still undergo shape change after activation through thromboxane-A2 (TXA2) or thrombin receptors. In contrast to thrombin, the TXA2 mimetic U46619 led to the selective activation of G12 and G13 in Galphaq-deficient platelets indicating that these G proteins mediate TXA2 receptor-induced shape change. TXA2 receptor-mediated activation of G12/G13 resulted in tyrosine phosphorylation of pp72(syk) and stimulation of pp60(c-src) as well as in phosphorylation of myosin light chain (MLC) in Galphaq-deficient platelets. Both MLC phosphorylation and shape change induced through G12/G13 in the absence of Galphaq were inhibited by the C3 exoenzyme from Clostridium botulinum, by the Rho-kinase inhibitor Y-27632 and by cAMP-analogue Sp-5,6-DCl-cBIMPS. These data indicate that G12/G13 couple receptors to tyrosine kinases as well as to the Rho/Rho-kinase-mediated regulation of MLC phosphorylation. We provide evidence that G12/G13-mediated Rho/Rho-kinase-dependent regulation of MLC phosphorylation participates in receptor-induced platelet shape change.  (+info)

Carbohydrate on human factor VIII/von Willebrand factor. Impairment of function by removal of specific galactose residues. (5/4463)

Human factor VIII/von Willebrand factor protein containing 120 +/- 12 nmol of sialic acid and 135 +/- 13 nmol of galactose/mg of protein was digested with neuraminidase. The affinity of native factor VIII/von Willebrand factor and its asialo form for the hepatic lectin that specifically binds asialoglycoproteins was assessed from in vitro binding experiments. Native factor VIII/von Willebrand factor exhibited negligible affinity while binding of the asialo derivative was comparable to that observed for asialo-alpha1-acid glycoprotein. Incubation of asialo-factor VIII/von Willebrand factor with Streptococcus pneumoniae beta-galactosidase removed only 62% of the galactose but abolished binding to the purified hepatic lectin. When the asialo derivative was incubated with purified beta-D-galactoside alpha2 leads to 6 sialyltransferase and CMP-[14C]NeuAc, only 61% of the galactose incorporated [14C]NeuAc. From the known specificites of these enzymes, it is concluded that galactose residues important in lectin binding are present in a terminal Gal/beta1 leads to 4GlcNAc sequence on asialo-factor VIII/von Willebrand factor. The relative ristocetin-induced platelet aggregating activity of native, asialo-, and agalacto-factor VIII/von Willebrand factor was 100:38:12, respectively, while procoagulant activity was 100:100:103.  (+info)

Effects of docosahexaenoic and eicosapentaenoic acid on lipid metabolism, eicosanoid production, platelet aggregation and atherosclerosis in hypercholesterolemic rats. (6/4463)

Exogenously hypercholesterolemic (ExHC) rats were fed on an atherogenic diet supplemented with 1% each of either ethyl ester docosahexaenoic acid [EE-DHA, 22:6(n-3)], ethyl ester eicosapentaenoic acid [EE-EPA, 20:5(n-3)] or safflower oil (SO) for 6 months. The rats fed on the diets containing EE-EPA or EE-DHA, compared with those fed on SO, had lower serum cholesterol and triacylglycerol levels, less aggregation of platelets and slower progress of intimal thickening in the ascending aorta. Relative to the SO-fed rats, both of the (n-3) fatty acid-fed rats had a significantly reduced proportion of arachidonic acid in the platelet and aortic phospholipids, and lower production of thromboxane A2 by platelets and of prostacyclin by the aorta. These results suggest that EPA and DHA are similarly involved in preventing atherosclerosis development by reducing hypercholesterolemia and modifying the platelet functions.  (+info)

Platelet aggregation and incident ischaemic heart disease in the Caerphilly cohort. (7/4463)

BACKGROUND: Platelets are involved in myocardial infarction but evidence of prediction of infarction by measures of platelet function are sparce. METHODS: Platelet aggregation to thrombin and to ADP in platelet rich plasma was recorded for 2176 men aged 49-65 years in the Caerphilly cohort study. RESULTS: Results from 364 men were excluded, 80 of whom had not fasted before venepuncture; most of the others were excluded because antiplatelet medication had been taken shortly before the platelet tests. During the five years following the platelet tests 113 ischaemic heart disease (IHD) events which fulfilled the World Health Organisation criteria were identified--42 fatal and 71 non-fatal. No measure of platelet aggregation was found to be significantly predictive of incident IHD. The possibility that platelet function is predictive for only a limited time after it is characterised, and that prediction falls off with time, was tested. When IHD events are grouped by their time of occurrence after aggregation had been measured, the test results show a gradient suggestive of prediction of early IHD events. Thus, 24% of the men who had an event within 500 days of the test had had a high secondary response to ADP while only 12% of those whose IHD event had been 1000 or more days after the test had shown a high platelet response at baseline. The trend in these proportions is not significant. CONCLUSIONS: Platelet aggregation to thrombin and ADP in platelet rich plasma was recorded in the Caerphilly cohort study. No measure of aggregation was found to be predictive of IHD.  (+info)

Age-related changes in blood coagulation and fibrinolysis in mice fed on a high-cholesterol diet. (8/4463)

To investigate the pathogenesis of hyperlipidemia-induced atherosclerosis, we examined age-dependent changes in platelet activity, blood coagulation and fibrinolysis in susceptibility to a high cholesterol diet (HCD) feeding in male ICR mice. Pretreatment of platelet-rich-plasma from HCD feeding mice for 3 days with epinephrine (300 microM) resulted in a marked enhancement of adenosine 5'-diphosphate (ADP: 0.1 microM) or collagen (0.7 microgram/ml)-stimulated aggregation compared with the same in control mice. Yohimbine as alpha 2-adrenergic blocker antagonized these aggregations in a dose-dependent manner. A significant increase in plasma total cholesterol and VLDL (very low-density lipoprotein)-LDL (low-density lipoprotein)-cholesterol and the liver/body weight ratio was observed in mice fed on HCD for 3 months (3-month HCD mice). In the early phase of this experiment, a significant increase in fibrinogen was observed. In the middle phase, increases in the activity of antithrombin III (ATIII) and alpha 2-plasmin inhibitor (alpha 2-Pl) followed. Plasminogen content gradually decreased in both normal diet and HCD mice throughout the experiment. The activity of plasminogen activator inhibitor (PAI) decreased in 3-month HCD mice. Morphological observation of the aortic arch from 3-month HCD mice revealed apparent atheromatous plaques not seen in control mice. These results suggest that 3-month HCD mice can be a convenient hyperlipidemia-induced atherosclerotic model and the changes in platelet activity, coagulation and fibrinolysis in the early phase may be a cause of pathologic changes in this model.  (+info)

Blood platelets, also known as thrombocytes, are small, disc-shaped cells that play a crucial role in the blood clotting process. They are produced in the bone marrow and are essential for maintaining hemostasis, which is the body's ability to stop bleeding. Platelets are too small to be seen under a light microscope, but they are abundant in the blood, with an average of 150,000 to 450,000 platelets per microliter of blood. When a blood vessel is damaged, platelets are among the first cells to arrive at the site of injury. They adhere to the damaged vessel wall and release chemicals that attract more platelets and initiate the formation of a blood clot. Platelets also play a role in the immune response by releasing chemicals that attract immune cells to the site of infection or injury. They are involved in the formation of blood clots that prevent the spread of infection and help to repair damaged tissue. Abnormalities in platelet function or number can lead to bleeding disorders, such as thrombocytopenia (low platelet count) or thrombocytosis (high platelet count). Platelet disorders can be caused by a variety of factors, including genetic mutations, autoimmune disorders, and certain medications.

Platelet membrane glycoproteins are a group of proteins that are found on the surface of platelets, which are small blood cells that play a crucial role in blood clotting. These glycoproteins are made up of both a protein and a carbohydrate component, and they are involved in a variety of functions related to platelet activation, aggregation, and adhesion. There are several different types of platelet membrane glycoproteins, including glycoprotein IIb/IIIa (GP IIb/IIIa), glycoprotein Ib/IX (GP Ib/IX), and glycoprotein VI (GP VI). GP IIb/IIIa is a receptor that binds to fibrinogen, a protein that is essential for blood clotting. GP Ib/IX is a receptor that binds to von Willebrand factor, another protein that is involved in blood clotting. GP VI is a receptor that binds to collagen, a protein that is found in the walls of blood vessels. Platelet membrane glycoproteins play a critical role in the process of platelet aggregation, which is the process by which platelets clump together to form a plug that helps to stop bleeding. They also play a role in platelet adhesion, which is the process by which platelets stick to the walls of blood vessels. Dysregulation of platelet membrane glycoproteins can lead to a variety of bleeding disorders, including thrombocytopenia, von Willebrand disease, and platelet function defects.

Adenosine diphosphate (ADP) is a molecule that plays a crucial role in various metabolic processes in the body, particularly in the regulation of energy metabolism. It is a nucleotide that is composed of adenine, ribose, and two phosphate groups. In the medical field, ADP is often used as a diagnostic tool to assess the function of platelets, which are blood cells that play a critical role in blood clotting. ADP is a potent activator of platelets, and a decrease in platelet aggregation in response to ADP is often an indication of a bleeding disorder. ADP is also used in the treatment of various medical conditions, including heart disease, stroke, and migraines. For example, drugs that inhibit ADP receptors on platelets, such as clopidogrel and ticagrelor, are commonly used to prevent blood clots in patients with heart disease or stroke. Overall, ADP is a critical molecule in the regulation of energy metabolism and the function of platelets, and its role in the medical field is significant.

Platelet Glycoprotein GPIIb-IIIa Complex is a protein complex found on the surface of platelets, which are small blood cells that play a crucial role in blood clotting. The GPIIb-IIIa complex is also known as the alphaIIb beta3 integrin, and it is a receptor for fibrinogen, a protein that is essential for blood clotting. The GPIIb-IIIa complex is a transmembrane protein that consists of two subunits, alphaIIb and beta3. The alphaIIb subunit has a globular head domain that binds to fibrinogen, while the beta3 subunit has a cytoplasmic tail that interacts with other platelet proteins to regulate platelet activation and aggregation. The GPIIb-IIIa complex plays a critical role in platelet aggregation, which is the process by which platelets stick together to form a plug at the site of a blood vessel injury. When the complex binds to fibrinogen, it triggers a series of signaling events that activate platelets and promote their aggregation. In addition to its role in platelet aggregation, the GPIIb-IIIa complex is also involved in other platelet functions, such as adhesion to the blood vessel wall and the release of platelet granules that contain clotting factors. Disruptions in the function of the GPIIb-IIIa complex can lead to bleeding disorders, such as von Willebrand disease and Glanzmann thrombasthenia. These disorders are characterized by impaired platelet aggregation and bleeding episodes that can be severe and life-threatening.

Bleeding time is a medical test used to measure the time it takes for blood to clot and stop bleeding. During the test, a small amount of blood is drawn from a finger or earlobe and placed on a special piece of gauze or filter paper. The time it takes for the bleeding to stop is then recorded. Bleeding time is often used to diagnose bleeding disorders, such as hemophilia or von Willebrand disease, which affect the blood's ability to clot properly. It can also be used to monitor the effectiveness of blood-thinning medications, such as aspirin or warfarin, and to detect other conditions that may affect blood clotting, such as liver disease or vitamin K deficiency. The test is typically performed in a medical laboratory and is usually painless. However, it may cause some discomfort or minor bleeding at the site where the blood is drawn.

Thrombin is an enzyme that plays a crucial role in the blood clotting process. It is produced by the activation of the protein thromboplastin, which is present in the blood. Thrombin is responsible for converting fibrinogen, a soluble plasma protein, into insoluble fibrin fibers, which form the meshwork of a blood clot. Thrombin also activates platelets, which are small cell fragments that play a key role in blood clotting. It does this by cleaving a protein called von Willebrand factor, which binds platelets to the site of injury and helps them to aggregate and form a plug. In addition to its role in blood clotting, thrombin has other functions in the body, including the activation of certain types of cells and the regulation of inflammation. It is also used in medicine as a medication to stop bleeding, as well as in the treatment of certain blood disorders and cardiovascular diseases.

In the medical field, "cell aggregation" refers to the process by which cells clump together or aggregate to form a group or mass. This can occur naturally as cells grow and divide, or it can be induced by various factors such as chemical or mechanical stimuli. Cell aggregation is an important process in many areas of medicine, including tissue engineering, regenerative medicine, and cancer research. For example, in tissue engineering, cell aggregation is often used to create three-dimensional tissue constructs by culturing cells in a scaffold or matrix that promotes cell-cell interactions and aggregation. In cancer research, cell aggregation can be used to study the behavior of cancer cells and their interactions with other cells in the tumor microenvironment. For example, cancer cells can aggregate to form spheroids, which are three-dimensional structures that mimic the architecture of solid tumors. Studying cell aggregation in spheroids can provide insights into the mechanisms of cancer progression and the development of new treatments.

Fibrinogen is a plasma protein that plays a crucial role in the blood clotting process. It is synthesized in the liver and circulates in the bloodstream as a soluble protein. When the blood vessels are damaged, platelets aggregate at the site of injury and release various substances, including thrombin. Thrombin then converts fibrinogen into insoluble fibrin strands, which form a mesh-like structure that stabilizes the platelet plug and prevents further bleeding. This process is known as coagulation and is essential for stopping bleeding and healing wounds. Fibrinogen levels can be measured in the blood as a diagnostic tool for various medical conditions, including bleeding disorders, liver disease, and cardiovascular disease.

Thromboxane A2 is a potent vasoconstrictor and platelet aggregator that is produced by platelets and other cells in response to injury or inflammation. It plays a key role in the formation of blood clots and is involved in various cardiovascular diseases, such as atherosclerosis, myocardial infarction, and stroke. Thromboxane A2 is synthesized from arachidonic acid by the enzyme thromboxane synthase, which is activated by platelet activating factor and other inflammatory mediators. It acts on platelets to stimulate aggregation and on smooth muscle cells to constrict blood vessels, leading to increased blood pressure and reduced blood flow. Thromboxane A2 is also a potent stimulator of the release of other inflammatory mediators, such as prostaglandins and leukotrienes, which contribute to the inflammatory response and the progression of cardiovascular disease.

Platelet Factor 4 (PF4) is a protein that is produced by platelets, which are small blood cells that play a crucial role in blood clotting. PF4 is a member of a family of proteins called chemokines, which are involved in the recruitment of immune cells to sites of injury or infection. PF4 is primarily known for its role in the immune response to bacterial infections. When bacteria enter the bloodstream, they can trigger the release of PF4 from platelets, which then binds to the bacteria and helps to recruit immune cells to the site of infection. PF4 also has anticoagulant properties, meaning that it can help to prevent blood clots from forming. In addition to its role in the immune response and blood clotting, PF4 has been implicated in a number of other medical conditions. For example, high levels of PF4 have been associated with certain autoimmune disorders, such as lupus and rheumatoid arthritis. PF4 has also been linked to the development of certain types of cancer, including lung cancer and ovarian cancer. Overall, PF4 is an important protein that plays a role in a variety of physiological processes, including immune response, blood clotting, and cancer development.

Platelet Activating Factor (PAF) is a signaling molecule that plays a role in the immune response and inflammation. It is produced by various cells, including platelets, leukocytes, and endothelial cells, and acts on a specific receptor on the surface of these cells to trigger a variety of cellular responses. PAF is involved in the recruitment and activation of immune cells, such as neutrophils and monocytes, to sites of inflammation. It also promotes the release of other inflammatory mediators, such as prostaglandins and leukotrienes, and can cause vasodilation and increased permeability of blood vessels, leading to edema and tissue damage. In addition to its role in inflammation, PAF has been implicated in a variety of other conditions, including allergic reactions, asthma, and certain types of heart disease. It is also a potential therapeutic target for the treatment of these conditions.

The Platelet Glycoprotein GPIb-IX Complex is a protein complex found on the surface of platelets, which are small blood cells that play a crucial role in blood clotting. The complex is composed of two subunits, GPIb and GPIX, which together form a receptor for von Willebrand factor (VWF), a protein that helps to anchor platelets to the site of a blood vessel injury. The GPIb-IX Complex is essential for platelet function and is involved in the initiation of the platelet plug formation, which is the first step in the process of blood clotting. When a blood vessel is damaged, VWF is released from the vessel wall and binds to the GPIb-IX Complex on the platelet surface, triggering a series of events that lead to platelet activation and aggregation. Disruptions in the function of the GPIb-IX Complex can lead to bleeding disorders, such as von Willebrand disease, which is caused by a deficiency or abnormality in VWF or the GPIb-IX Complex.

Aspirin is a nonsteroidal anti-inflammatory drug (NSAID) that is commonly used to relieve pain, reduce inflammation, and lower fever. It is also used to prevent blood clots and reduce the risk of heart attack and stroke. Aspirin works by inhibiting the production of prostaglandins, which are chemicals that cause inflammation and pain. It is available over-the-counter in various strengths and is also used as a prescription medication for certain medical conditions. Aspirin is generally considered safe when taken as directed, but it can cause side effects such as stomach pain, nausea, and bleeding.

Collagen is a protein that is found in the extracellular matrix of connective tissues throughout the body. It is the most abundant protein in the human body and is responsible for providing strength and support to tissues such as skin, bones, tendons, ligaments, and cartilage. In the medical field, collagen is often used in various medical treatments and therapies. For example, it is used in dermal fillers to plump up wrinkles and improve skin texture, and it is also used in wound healing to promote tissue regeneration and reduce scarring. Collagen-based products are also used in orthopedic and dental applications, such as in the production of artificial joints and dental implants. In addition, collagen is an important biomarker for various medical conditions, including osteoporosis, rheumatoid arthritis, and liver disease. It is also used in research to study the mechanisms of tissue repair and regeneration, as well as to develop new treatments for various diseases and conditions.

Thrombosis is a medical condition in which a blood clot forms within a blood vessel. This can occur when the blood flow is slow or when the blood vessel is damaged, allowing the blood to clot. Thrombosis can occur in any blood vessel in the body, but it is most commonly seen in the veins of the legs, which can lead to a condition called deep vein thrombosis (DVT). Thrombosis can also occur in the arteries, which can lead to a condition called(arterial thrombosis). Arterial thrombosis can cause serious complications, such as heart attack or stroke, if the clot breaks off and travels to the lungs or brain. Thrombosis can be caused by a variety of factors, including injury to the blood vessel, prolonged immobility, certain medical conditions such as cancer or diabetes, and the use of certain medications such as birth control pills or hormone replacement therapy. Treatment for thrombosis depends on the severity of the condition and the location of the clot, but may include anticoagulant medications to prevent the clot from growing or breaking off, and in some cases, surgical removal of the clot.

Receptors, Purinergic P2Y12 are a type of protein receptors found on the surface of cells in the body, particularly blood cells. These receptors are activated by the neurotransmitter adenosine diphosphate (ADP), which is released by damaged or dying cells. Activation of P2Y12 receptors plays a role in platelet aggregation, which is the process by which platelets stick together to form a plug and stop bleeding at a site of injury. In the medical field, P2Y12 receptors are targeted by drugs used to prevent blood clots, such as clopidogrel and ticagrelor, which are commonly prescribed after heart attacks or stroke to reduce the risk of further cardiovascular events.

Thromboxane B2 is a potent vasoconstrictor and platelet aggregator that is produced by platelets and other cells in response to injury or inflammation. It plays a key role in the formation of blood clots and is involved in various cardiovascular diseases, such as atherosclerosis, myocardial infarction, and stroke. Thromboxane B2 is also a potent stimulator of uterine contractions during pregnancy and can contribute to the development of preterm labor.

Ristocetin is a medication that is used in the medical field to diagnose and treat certain blood disorders. It is a protein that is derived from the mold Claviceps purpurea and works by causing the blood to clot more easily. This can be useful in situations where the blood is not clotting properly, such as in cases of bleeding disorders or in surgery. Ristocetin is typically administered intravenously and is used in conjunction with other medications to treat certain types of blood clots. It is also sometimes used to diagnose von Willebrand disease, a bleeding disorder that affects the blood's ability to clot.

Apyrase is a protein that hydrolyzes (breaks down) a type of molecule called adenosine triphosphate (ATP) into adenosine diphosphate (ADP) and inorganic phosphate (Pi). ATP is a molecule that serves as a source of energy for many cellular processes, and its hydrolysis is an important step in energy metabolism. In the medical field, apyrase is sometimes used as a research tool to study cellular energy metabolism and to investigate the role of ATP in various physiological and pathological processes. For example, apyrase has been shown to have anti-inflammatory and anti-thrombotic effects, and it is being investigated as a potential therapeutic agent for conditions such as heart disease and stroke. Additionally, apyrase has been used as a tool to study the function of ATP-sensitive potassium channels, which are important regulators of cell membrane potential and ion transport.

Von Willebrand Factor (vWF) is a large glycoprotein that plays a crucial role in the blood clotting process. It is synthesized and secreted by endothelial cells and megakaryocytes, and is stored in the endothelial Weibel-Palade bodies. vWF is involved in the adhesion and aggregation of platelets at the site of injury, and also helps to stabilize and protect factor VIII, another protein involved in the clotting process. Deficiencies or defects in vWF can lead to von Willebrand disease (VWD), a bleeding disorder characterized by prolonged bleeding times and reduced platelet adhesion and aggregation. VWD can be inherited in an autosomal dominant or recessive manner, and can range from mild to severe. Treatment for VWD typically involves replacement therapy with vWF concentrate or desmopressin, a hormone that increases vWF release from endothelial cells.

Crotalid venoms are the toxic secretions produced by snakes of the family Viperidae, particularly those in the subfamily Crotalinae, which includes rattlesnakes, copperheads, and cottonmouths. These venoms are composed of a complex mixture of proteins, enzymes, and other molecules that can cause a range of physiological effects in humans and other animals. The effects of crotalid venom can vary depending on the species of snake, the size of the snake, and the amount of venom injected. Common symptoms of crotalid envenomation include pain, swelling, redness, and necrosis (tissue death) at the site of the bite. In severe cases, crotalid venom can cause systemic effects such as coagulopathy (disruption of the blood clotting process), cardiovascular collapse, and respiratory failure. Treatment for crotalid envenomation typically involves the administration of antivenom, which is a serum containing antibodies that neutralize the venom's toxic effects. In some cases, supportive care such as pain management, fluid replacement, and wound care may also be necessary. It is important to seek medical attention immediately if you suspect that you or someone else has been bitten by a venomous snake.

P-selectin is a type of adhesion molecule that plays a crucial role in the process of inflammation and thrombosis. It is expressed on the surface of activated platelets and endothelial cells, and it binds to a specific receptor on the surface of leukocytes, allowing them to adhere to the blood vessel wall and migrate into the site of inflammation or injury. P-selectin is also involved in the recruitment of neutrophils and monocytes to the site of inflammation, and it has been implicated in the development of various inflammatory diseases, including atherosclerosis, rheumatoid arthritis, and inflammatory bowel disease. In addition to its role in inflammation, P-selectin is also involved in the formation of blood clots. It plays a key role in the initial stages of platelet aggregation and the formation of the platelet plug, which is the first step in the process of hemostasis. Overall, P-selectin is an important molecule in the regulation of inflammation and thrombosis, and its dysfunction has been linked to a number of diseases and conditions.

Serotonin is a neurotransmitter, a chemical messenger that transmits signals between nerve cells in the brain and throughout the body. It plays a crucial role in regulating mood, appetite, sleep, and other bodily functions. In the medical field, serotonin is often studied in relation to mental health conditions such as depression, anxiety, and obsessive-compulsive disorder (OCD). Low levels of serotonin have been linked to these conditions, and medications such as selective serotonin reuptake inhibitors (SSRIs) are often prescribed to increase serotonin levels in the brain and improve symptoms. Serotonin is also involved in the regulation of pain perception, blood pressure, and other bodily functions. Imbalances in serotonin levels have been implicated in a variety of medical conditions, including migraines, fibromyalgia, and irritable bowel syndrome (IBS).

Blood coagulation is the process by which blood clots or solidifies to prevent excessive bleeding. It is a complex process that involves a series of chemical reactions that occur when blood vessels are damaged or injured. The process of blood coagulation is essential for the body to stop bleeding and promote healing. The process of blood coagulation involves three main stages: initiation, propagation, and termination. During the initiation stage, platelets are activated and release chemicals that attract more platelets to the site of injury. This forms a platelet plug that helps to stop bleeding. During the propagation stage, a series of enzymes are activated that convert fibrinogen, a soluble protein in the blood, into insoluble fibrin strands. These fibrin strands form a mesh-like structure that traps red and white blood cells and platelets, creating a blood clot. Finally, during the termination stage, the blood clot is dissolved by a group of enzymes called fibrinolytic enzymes. This process helps to prevent the formation of excessive blood clots that could block blood vessels and cause serious health problems. Overall, blood coagulation is a critical process that helps to prevent excessive bleeding and promote healing in the body.

Epoprostenol is a medication that is used to treat a variety of medical conditions, including pulmonary hypertension (high blood pressure in the lungs), heart failure, and Raynaud's disease (a condition that causes the blood vessels in the fingers and toes to constrict, leading to pain and discoloration). It is a synthetic form of a substance called prostacyclin, which is naturally produced by the body and helps to relax and widen blood vessels. Epoprostenol is typically administered through an infusion pump that is attached to a vein in the patient's arm or leg. It can also be administered through a nebulizer, which is a device that converts the medication into a fine mist that can be inhaled into the lungs. Epoprostenol is a powerful medication that can cause serious side effects, so it is typically only used in patients who have not responded to other treatments or who have severe medical conditions.

Thromboxanes are a group of lipid-derived signaling molecules that are produced by platelets and other cells in response to injury or inflammation. They are synthesized from arachidonic acid, which is an essential fatty acid that is found in cell membranes. There are two main types of thromboxanes: thromboxane A2 (TXA2) and thromboxane B2 (TXB2). TXA2 is a potent vasoconstrictor and platelet aggregator, which means that it causes blood vessels to narrow and platelets to stick together, respectively. It also promotes the formation of blood clots, which can help to stop bleeding after an injury. TXB2 is a breakdown product of TXA2 and is used as a marker of platelet activation. It is also a potent vasoconstrictor and platelet aggregator, but its effects are generally weaker than those of TXA2. Thromboxanes play an important role in the body's response to injury and inflammation, but they can also contribute to the development of certain medical conditions, such as cardiovascular disease and thrombosis. Medications that inhibit the production or action of thromboxanes are used to treat these conditions.

Blood platelet disorders refer to conditions that affect the production, function, or lifespan of platelets, which are small blood cells that play a crucial role in blood clotting. Platelets are produced in the bone marrow and are essential for preventing excessive bleeding and promoting wound healing. There are several types of blood platelet disorders, including: 1. Thrombocytopenia: This is a condition characterized by a low platelet count in the blood. It can be caused by various factors, including viral infections, autoimmune disorders, bone marrow disorders, and certain medications. 2. Thrombocytosis: This is a condition characterized by an abnormally high platelet count in the blood. It can be caused by various factors, including genetic disorders, bone marrow disorders, and certain medications. 3. Platelet function disorders: These are conditions that affect the ability of platelets to form clots. They can be caused by genetic disorders, autoimmune disorders, and certain medications. 4. Platelet shape disorders: These are conditions that affect the shape and size of platelets. They can be caused by genetic disorders and certain medications. 5. Platelet storage pool disorders: These are conditions that affect the ability of platelets to store and release clotting factors. They can be caused by genetic disorders and certain medications. Blood platelet disorders can lead to various complications, including easy bruising, excessive bleeding, and an increased risk of bleeding-related complications, such as internal bleeding and hemorrhage. Treatment for blood platelet disorders depends on the underlying cause and may include medications, blood transfusions, and in severe cases, surgery.

Thrombocytopenia is a medical condition characterized by a low number of platelets (thrombocytes) in the blood. Platelets are small, disc-shaped cells that play a crucial role in blood clotting and preventing excessive bleeding. In thrombocytopenia, the number of platelets in the blood is below the normal range, which can lead to an increased risk of bleeding and bruising. The severity of thrombocytopenia can vary widely, ranging from mild to severe, and can be caused by a variety of factors, including infections, autoimmune disorders, certain medications, and bone marrow disorders. Symptoms of thrombocytopenia may include easy bruising, nosebleeds, bleeding gums, and petechiae (small red or purple spots on the skin). Treatment for thrombocytopenia depends on the underlying cause and may include medications to increase platelet production, blood transfusions, or other therapies.

Antigens, Human Platelet are proteins or other molecules found on the surface of human platelets that can trigger an immune response in the body. These antigens can be recognized by the immune system as foreign substances and can cause an immune response that can lead to the destruction of platelets, a condition known as autoimmune thrombocytopenia. Platelets are small blood cells that play a crucial role in blood clotting, and a decrease in their number can lead to bleeding and bruising. Antigens, Human Platelet are important for the diagnosis and treatment of autoimmune thrombocytopenia and other platelet-related disorders.

Prostaglandin endoperoxides, synthetic, are a class of medications that are synthesized from prostaglandins, which are naturally occurring compounds that play a role in various physiological processes in the body. These synthetic prostaglandins are used to treat a variety of conditions, including inflammation, pain, and bleeding disorders. They are typically administered by injection or inhalation and are used to treat conditions such as asthma, chronic obstructive pulmonary disease (COPD), and rheumatoid arthritis. They are also used to prevent and treat bleeding in patients who are taking blood-thinning medications.

Epinephrine, also known as adrenaline, is a hormone and neurotransmitter that plays a crucial role in the body's "fight or flight" response. It is produced by the adrenal glands and is released into the bloodstream in response to stress or danger. In the medical field, epinephrine is used as a medication to treat a variety of conditions, including anaphylaxis (a severe allergic reaction), cardiac arrest, and asthma. It works by constricting blood vessels, increasing heart rate and contractility, and relaxing smooth muscles in the bronchial tubes, which can help to open airways and improve breathing. Epinephrine is typically administered via injection, either intravenously or subcutaneously (under the skin). It is a powerful medication and should only be used under the guidance of a healthcare professional.

Ticlopidine is a medication that is used to prevent blood clots in people who have had a heart attack or stroke. It works by inhibiting the formation of platelet clumps, which can lead to the formation of blood clots. Ticlopidine is typically prescribed to people who are unable to take aspirin or other antiplatelet medications due to an allergy or other medical condition. It is usually taken in combination with aspirin or another blood thinner to reduce the risk of blood clots. Ticlopidine can cause side effects such as bleeding, stomach pain, and an increased risk of infection. It is important to follow the instructions of your healthcare provider when taking ticlopidine and to report any side effects to your healthcare provider.

Thrombasthenia is a rare bleeding disorder that affects the platelets, which are small blood cells that play a crucial role in blood clotting. People with thrombasthenia have abnormal platelets that are unable to stick together properly, which can lead to excessive bleeding and bruising. There are two main types of thrombasthenia: quantitative and qualitative. Quantitative thrombasthenia is caused by a deficiency in platelet glycoprotein IIb/IIIa receptors, which are proteins that help platelets stick together. Qualitative thrombasthenia is caused by mutations in the genes that encode for these receptors, which can affect their structure and function. Symptoms of thrombasthenia can vary widely, but may include easy bruising, prolonged bleeding after injury or surgery, nosebleeds, and heavy menstrual bleeding. Treatment typically involves medications that help the blood to clot, such as platelet transfusions or desmopressin, a hormone that increases the production of von Willebrand factor, a protein that helps platelets stick together. In severe cases, surgery may be necessary to stop bleeding.

Platelet Factor 3 (PF3) is a protein that is produced by platelets, which are small blood cells that play a crucial role in blood clotting. PF3 is a glycoprotein that is found on the surface of platelets and is involved in the process of platelet aggregation, which is the process by which platelets stick together to form a plug at the site of a blood vessel injury. PF3 is also involved in the activation of the coagulation cascade, which is a series of chemical reactions that ultimately leads to the formation of a blood clot. PF3 binds to fibrinogen, a protein that is a key component of blood clots, and helps to stabilize the clot by promoting the formation of cross-links between fibrin molecules. In the medical field, PF3 is often used as a diagnostic tool to help diagnose and monitor a variety of conditions, including bleeding disorders, thrombocytopenia (a condition characterized by a low platelet count), and certain types of cancer. PF3 levels can be measured in a blood sample using a laboratory test called a platelet function test.

Platelet Membrane Glycoprotein IIb (also known as GPIIb or CD41) is a protein found on the surface of platelets, which are small blood cells that play a crucial role in blood clotting. GPIIb is a member of a family of proteins called integrins, which are involved in cell adhesion and signaling. GPIIb is a heterodimeric protein, meaning it is composed of two different subunits, GPIIbα and GPIIbβ. The α subunit is responsible for binding to von Willebrand factor (vWF), a protein found in the blood that helps platelets adhere to damaged blood vessels. The β subunit is responsible for binding to fibrinogen, another protein involved in blood clotting. Mutations in the GPIIb gene can lead to bleeding disorders, such as Glanzmann thrombasthenia, which is a rare inherited bleeding disorder characterized by an inability of platelets to form clots. In this disorder, the GPIIbα subunit is either absent or abnormal, preventing platelets from binding to vWF and forming clots.

Immunoglobulin Fab fragments, also known as Fab fragments or Fabs, are a type of protein that is derived from the variable regions of the heavy and light chains of an immunoglobulin (antibody). They are composed of two antigen-binding sites, which are responsible for recognizing and binding to specific antigens. Fab fragments are often used in medical research and diagnostic testing because they have a high specificity for their target antigens and can be easily produced and purified. They are also used in the development of therapeutic antibodies, as they can be engineered to have a variety of functions, such as delivering drugs to specific cells or tissues. In addition to their use in research and diagnostic testing, Fab fragments have also been used in the treatment of various diseases, including cancer, autoimmune disorders, and infectious diseases. They are typically administered intravenously or intramuscularly and can be used alone or in combination with other therapies.

Receptors, Thromboxane are a type of protein receptors found on the surface of cells in the body that bind to and respond to thromboxane, a hormone-like substance that plays a role in blood clotting and inflammation. These receptors are involved in a variety of physiological processes, including platelet aggregation, vasoconstriction, and smooth muscle contraction. In the medical field, the study of thromboxane receptors is important for understanding the pathophysiology of various diseases, including cardiovascular disease, asthma, and inflammatory disorders.

Arachidonic acid is a polyunsaturated omega-6 fatty acid that is found in the cell membranes of all living organisms. It is an essential fatty acid, meaning that it cannot be synthesized by the body and must be obtained through the diet. In the medical field, arachidonic acid plays a significant role in various physiological processes, including inflammation, immune function, and blood clotting. It is also a precursor to the production of eicosanoids, a group of biologically active compounds that have diverse effects on the body, including vasodilation, vasoconstriction, and pain perception. Arachidonic acid is commonly found in foods such as fish, nuts, and seeds, and is also available as a dietary supplement. However, excessive consumption of arachidonic acid has been linked to an increased risk of certain health conditions, such as heart disease and cancer. Therefore, it is important to consume arachidonic acid in moderation as part of a balanced diet.

Receptors, Thrombin are proteins found on the surface of cells in the blood vessels and platelets that bind to and respond to the hormone thrombin. Thrombin is a key enzyme in the blood clotting process, and its binding to these receptors triggers a series of events that lead to the formation of a blood clot. The receptors, Thrombin play an important role in regulating blood clotting and preventing excessive bleeding. They are also involved in the development of certain medical conditions, such as thrombosis and cardiovascular disease.

Arachidonic acid (AA) is a polyunsaturated omega-6 fatty acid that is found in the cell membranes of all living organisms. It is an essential fatty acid, meaning that it cannot be synthesized by the body and must be obtained through the diet. In the medical field, arachidonic acid is known for its role in the production of eicosanoids, a group of signaling molecules that play important roles in various physiological processes, including inflammation, blood clotting, and immune function. Eicosanoids are synthesized from arachidonic acid by enzymes called cyclooxygenases (COXs) and lipoxygenases (LOXs). Arachidonic acid is also a precursor to the synthesis of prostaglandins, which are another group of eicosanoids that have a wide range of effects on the body, including regulating blood pressure, controlling inflammation, and modulating pain and fever. In addition to its role in eicosanoid production, arachidonic acid is also important for maintaining the fluidity and integrity of cell membranes, and for regulating the activity of various enzymes and signaling molecules. Abnormal levels of arachidonic acid or disruptions in its metabolism have been linked to a number of medical conditions, including cardiovascular disease, inflammatory disorders, and neurological disorders. As a result, arachidonic acid is an important area of research in the medical field, with efforts focused on developing new treatments and therapies for these conditions.

Calcium is a chemical element with the symbol Ca and atomic number 20. It is a vital mineral for the human body and is essential for many bodily functions, including bone health, muscle function, nerve transmission, and blood clotting. In the medical field, calcium is often used to diagnose and treat conditions related to calcium deficiency or excess. For example, low levels of calcium in the blood (hypocalcemia) can cause muscle cramps, numbness, and tingling, while high levels (hypercalcemia) can lead to kidney stones, bone loss, and other complications. Calcium supplements are often prescribed to people who are at risk of developing calcium deficiency, such as older adults, vegetarians, and people with certain medical conditions. However, it is important to note that excessive calcium intake can also be harmful, and it is important to follow recommended dosages and consult with a healthcare provider before taking any supplements.

Monoclonal antibodies (mAbs) are laboratory-made proteins that can mimic the immune system's ability to fight off harmful pathogens, such as viruses and bacteria. They are produced by genetically engineering cells to produce large quantities of a single type of antibody, which is specific to a particular antigen (a molecule that triggers an immune response). In the medical field, monoclonal antibodies are used to treat a variety of conditions, including cancer, autoimmune diseases, and infectious diseases. They can be administered intravenously, intramuscularly, or subcutaneously, depending on the condition being treated. Monoclonal antibodies work by binding to specific antigens on the surface of cells or pathogens, marking them for destruction by the immune system. They can also block the activity of specific molecules involved in disease processes, such as enzymes or receptors. Overall, monoclonal antibodies have revolutionized the treatment of many diseases, offering targeted and effective therapies with fewer side effects than traditional treatments.

Blood coagulation factors are proteins that play a crucial role in the process of blood clotting, also known as coagulation. There are 13 different coagulation factors that work together in a complex cascade to form a blood clot and stop bleeding. The coagulation process begins when the blood vessel is damaged, and the platelets in the blood start to clump together to form a plug. The coagulation factors then activate a series of chemical reactions that ultimately lead to the formation of a fibrin clot, which stabilizes the plug and prevents further bleeding. Each coagulation factor has a specific role in the coagulation cascade, and deficiencies or abnormalities in any of these factors can lead to bleeding disorders. For example, hemophilia is a genetic disorder that affects the production of certain coagulation factors, leading to excessive bleeding. In the medical field, blood coagulation factors are often used as diagnostic tools to identify bleeding disorders or to monitor the effectiveness of treatments for these conditions. They may also be used in laboratory tests to assess the risk of blood clots forming in the body, which can be a serious health concern for people with certain medical conditions.

Receptors, Thromboxane A2, Prostaglandin H2 are a type of protein receptors found in the cells of the cardiovascular system that bind to and respond to signaling molecules called thromboxane A2 and prostaglandin H2. These receptors play a role in regulating blood vessel tone, platelet aggregation, and inflammation. Activation of these receptors can lead to vasoconstriction, platelet aggregation, and the release of inflammatory mediators, which can contribute to the development of cardiovascular diseases such as hypertension, atherosclerosis, and heart attack.

Receptors, Purinergic P2Y1 are a type of protein receptors found on the surface of cells in the body that bind to a specific type of signaling molecule called adenosine diphosphate (ADP). These receptors are part of the purinergic signaling system, which plays a role in many physiological processes, including inflammation, blood clotting, and neurotransmission. When ADP binds to P2Y1 receptors, it triggers a signaling cascade within the cell that can lead to a variety of cellular responses, such as the release of calcium ions, the activation of enzymes, or the production of signaling molecules like prostaglandins. P2Y1 receptors are found on many different types of cells, including platelets, immune cells, and neurons, and are thought to play a role in a variety of diseases, including cardiovascular disease, inflammation, and cancer.

Blood coagulation tests are a group of laboratory tests that measure the ability of blood to clot. These tests are used to diagnose and monitor a variety of medical conditions that affect blood clotting, including bleeding disorders, blood clots, and certain medications that affect clotting. There are several types of blood coagulation tests, including: 1. Prothrombin time (PT): This test measures the time it takes for blood to clot in a standardized test tube. It is used to diagnose and monitor bleeding disorders, liver disease, and the effectiveness of anticoagulant medications. 2. Activated partial thromboplastin time (aPTT): This test measures the time it takes for blood to clot in the presence of a specific activator. It is used to diagnose and monitor bleeding disorders, liver disease, and the effectiveness of anticoagulant medications. 3. Platelet count: This test measures the number of platelets in the blood. Platelets are important for blood clotting, and a low platelet count can increase the risk of bleeding. 4. Fibrinogen level: This test measures the amount of a protein called fibrinogen in the blood. Fibrinogen is important for blood clotting, and a low fibrinogen level can increase the risk of bleeding. 5. D-dimer test: This test measures the amount of a protein fragment called D-dimer in the blood. D-dimer is produced when blood clots break down, and a high level of D-dimer can indicate the presence of a blood clot. Overall, blood coagulation tests are an important part of the diagnostic and monitoring process for a variety of medical conditions that affect blood clotting.

In the medical field, oligopeptides are short chains of amino acids that typically contain between two and 50 amino acids. They are often used in various medical applications due to their unique properties and potential therapeutic effects. One of the main benefits of oligopeptides is their ability to penetrate the skin and reach underlying tissues, making them useful in the development of topical treatments for a variety of conditions. For example, oligopeptides have been shown to improve skin elasticity, reduce the appearance of wrinkles, and promote the growth of new skin cells. Oligopeptides are also used in the development of medications for a variety of conditions, including osteoporosis, diabetes, and hypertension. They work by interacting with specific receptors in the body, which can help to regulate various physiological processes and improve overall health. Overall, oligopeptides are a promising area of research in the medical field, with potential applications in a wide range of therapeutic areas.

Dual Specificity Phosphatase 2 (DUSP2) is a protein that belongs to the family of dual specificity phosphatases (DUSPs). DUSPs are a group of enzymes that can remove phosphate groups from both tyrosine and serine/threonine residues on proteins, thereby regulating their activity. DUSP2 is a widely expressed protein that is involved in various cellular processes, including cell proliferation, differentiation, and apoptosis. It has been implicated in the regulation of several signaling pathways, including the mitogen-activated protein kinase (MAPK) pathway, the phosphoinositide 3-kinase (PI3K) pathway, and the Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway. DUSP2 has been shown to play a role in the development and progression of several diseases, including cancer, cardiovascular disease, and neurodegenerative disorders. For example, DUSP2 has been shown to be downregulated in various types of cancer, including breast cancer, prostate cancer, and lung cancer, and its downregulation has been associated with poor prognosis. In addition, DUSP2 has been shown to be involved in the regulation of inflammation and immune responses, and its dysregulation has been implicated in the pathogenesis of autoimmune diseases and inflammatory disorders.

Thromboxane-A synthase (TXAS) is an enzyme that plays a crucial role in the production of thromboxane A2 (TXA2), a potent vasoconstrictor and platelet aggregator. TXA2 is synthesized from arachidonic acid, a polyunsaturated fatty acid that is released from membrane phospholipids in response to injury or inflammation. In the medical field, TXAS is primarily associated with the pathophysiology of cardiovascular diseases, such as hypertension, atherosclerosis, and thrombosis. Elevated levels of TXA2 have been linked to platelet aggregation, vasoconstriction, and increased blood pressure, all of which contribute to the development and progression of cardiovascular disease. In addition, TXAS has been implicated in other inflammatory and immune-related disorders, such as asthma, inflammatory bowel disease, and rheumatoid arthritis. Therefore, TXAS inhibitors have been developed as potential therapeutic agents for the treatment of these conditions.

In the medical field, an amino acid sequence refers to the linear order of amino acids in a protein molecule. Proteins are made up of chains of amino acids, and the specific sequence of these amino acids determines the protein's structure and function. The amino acid sequence is determined by the genetic code, which is a set of rules that specifies how the sequence of nucleotides in DNA is translated into the sequence of amino acids in a protein. Each amino acid is represented by a three-letter code, and the sequence of these codes is the amino acid sequence of the protein. The amino acid sequence is important because it determines the protein's three-dimensional structure, which in turn determines its function. Small changes in the amino acid sequence can have significant effects on the protein's structure and function, and this can lead to diseases or disorders. For example, mutations in the amino acid sequence of a protein involved in blood clotting can lead to bleeding disorders.

Carotid artery thrombosis refers to the formation of a blood clot (thrombus) in the carotid artery, which is one of the major arteries in the neck that supplies blood to the brain. This condition can lead to a stroke or other serious complications if not treated promptly. Carotid artery thrombosis can occur due to various factors, including blood clots that have traveled from other parts of the body, injury or damage to the artery, or underlying medical conditions such as heart disease, high blood pressure, or diabetes. Symptoms of carotid artery thrombosis may include sudden weakness or numbness on one side of the face or body, difficulty speaking or understanding speech, vision problems, dizziness or loss of balance, and severe headache. If left untreated, carotid artery thrombosis can lead to a stroke, which can cause permanent damage to the brain and other serious complications. Treatment for carotid artery thrombosis typically involves the use of blood-thinning medications to dissolve the clot or prevent it from growing larger, as well as surgery to remove the clot or repair the damaged artery. It is important to seek medical attention immediately if you suspect that you or someone else may have carotid artery thrombosis.

Hydrazines are a class of organic compounds that contain a nitrogen-nitrogen double bond (N-N) and are commonly used in various industrial and medical applications. In the medical field, hydrazines are used as intermediates in the synthesis of various drugs and as components in some diagnostic tests. One example of a hydrazine used in medicine is hydrazine sulfate, which is used as a treatment for Wilson's disease, a rare genetic disorder that causes the body to accumulate excess copper. Hydrazine sulfate works by binding to copper in the body and facilitating its excretion through the urine. Hydrazines are also used as intermediates in the synthesis of other drugs, such as antihistamines, antidepressants, and antipsychotics. Additionally, some hydrazines have been studied for their potential use in cancer treatment, as they can inhibit the growth of cancer cells and induce apoptosis (cell death). It is important to note that hydrazines can be toxic and can cause adverse effects if not used properly. Therefore, their use in medicine is typically closely monitored and regulated by healthcare professionals.

Heparin is a medication that is used to prevent and treat blood clots. It is a natural anticoagulant that works by inhibiting the activity of enzymes that are involved in the formation of blood clots. Heparin is typically administered intravenously, but it can also be given by injection or applied topically to the skin. It is commonly used to prevent blood clots in people who are at risk due to surgery, pregnancy, or other medical conditions. Heparin is also used to treat blood clots that have already formed, such as deep vein thrombosis (DVT) and pulmonary embolism (PE). It is important to note that heparin can have serious side effects, including bleeding, and should only be used under the supervision of a healthcare professional.

Agkistrodon is a genus of venomous snakes that are commonly known as copperheads. They are found in North and Central America, and are known for their distinctive copper-colored heads. Copperheads are pit vipers and are capable of delivering a venomous bite. The venom from a copperhead bite can cause a range of symptoms, including pain, swelling, and muscle weakness. In severe cases, it can lead to more serious complications such as respiratory failure or kidney failure. Treatment for a copperhead bite typically involves antivenom and supportive care in a hospital setting.

Clot retraction is a process that occurs when a blood clot in a blood vessel begins to shrink and become smaller in size. This process is a natural part of the healing process after an injury or surgery, as the body works to remove excess blood and repair damaged tissue. During clot retraction, the platelets in the clot begin to stick together and form a mesh-like structure. This mesh traps red blood cells and other blood components, causing the clot to become more solid and compact. As the clot shrinks, it also helps to prevent further bleeding from the site of the injury or surgery. Clot retraction is an important part of the healing process, as it helps to prevent the formation of large, potentially dangerous blood clots. However, in some cases, excessive clot retraction can lead to complications such as blood vessel blockages or the formation of blood clots that can travel to other parts of the body and cause serious health problems.

In the medical field, cytoplasmic granules refer to small, dense structures found within the cytoplasm of certain cells. These granules are often involved in various cellular processes, such as protein synthesis, metabolism, and signaling. There are many different types of cytoplasmic granules, each with its own unique function and composition. Some examples of cytoplasmic granules include: - Lysosomes: These are organelles that contain digestive enzymes and are involved in breaking down and recycling cellular waste. - Peroxisomes: These are organelles that contain enzymes involved in the breakdown of fatty acids and other molecules. - Endosomes: These are organelles that are involved in the internalization and processing of extracellular molecules. - Ribosomes: These are small structures that are involved in protein synthesis. Cytoplasmic granules can be visualized using various microscopy techniques, such as light microscopy, electron microscopy, and immunofluorescence microscopy. The presence and distribution of cytoplasmic granules can provide important information about the function and health of a cell.

Platelet Storage Pool Deficiency (PSPD) is a rare inherited disorder that affects the function of platelets, which are blood cells that play a crucial role in blood clotting. In PSPD, the platelets have an abnormality in their storage pools, which are compartments within the platelets that contain various substances that are important for their function. The storage pools in platelets contain substances such as adenosine diphosphate (ADP), serotonin, and calcium ions, which are released when a platelet is activated and helps it to stick to the site of injury and form a blood clot. In PSPD, the storage pools are either absent or reduced in size, which means that there are fewer of these substances available for release when a platelet is activated. This can lead to a reduced ability of platelets to form blood clots, which can result in bleeding episodes. PSPD can be inherited in an autosomal recessive pattern, which means that an individual must inherit two copies of the mutated gene (one from each parent) in order to develop the disorder. There are several different types of PSPD, which are classified based on the specific genetic mutation that is present. Treatment for PSPD typically involves managing bleeding episodes with medications such as desmopressin, which increases the levels of certain substances in the blood that help with clotting. In some cases, platelet transfusions may also be necessary to help manage bleeding.

In the medical field, a peptide fragment refers to a short chain of amino acids that are derived from a larger peptide or protein molecule. Peptide fragments can be generated through various techniques, such as enzymatic digestion or chemical cleavage, and are often used in diagnostic and therapeutic applications. Peptide fragments can be used as biomarkers for various diseases, as they may be present in the body at elevated levels in response to specific conditions. For example, certain peptide fragments have been identified as potential biomarkers for cancer, neurodegenerative diseases, and cardiovascular disease. In addition, peptide fragments can be used as therapeutic agents themselves. For example, some peptide fragments have been shown to have anti-inflammatory or anti-cancer properties, and are being investigated as potential treatments for various diseases. Overall, peptide fragments play an important role in the medical field, both as diagnostic tools and as potential therapeutic agents.

In the medical field, peptides are short chains of amino acids that are linked together by peptide bonds. They are typically composed of 2-50 amino acids and can be found in a variety of biological molecules, including hormones, neurotransmitters, and enzymes. Peptides play important roles in many physiological processes, including growth and development, immune function, and metabolism. They can also be used as therapeutic agents to treat a variety of medical conditions, such as diabetes, cancer, and cardiovascular disease. In the pharmaceutical industry, peptides are often synthesized using chemical methods and are used as drugs or as components of drugs. They can be administered orally, intravenously, or topically, depending on the specific peptide and the condition being treated.

Hirudins are a group of proteins found in leeches that are used to prevent blood clotting. They work by inhibiting the activity of thrombin, an enzyme that plays a key role in the formation of blood clots. Hirudins are often used in medicine as a medication to prevent blood clots and are particularly useful in patients who are at risk of developing deep vein thrombosis (DVT) or pulmonary embolism (PE). They are also used in some surgical procedures to prevent blood clots from forming in the veins of the legs.

Thrombospondins are a family of large, multidomain proteins that play important roles in various biological processes, including cell adhesion, migration, differentiation, and angiogenesis. They are also involved in the regulation of the immune response and the development of blood vessels. Thrombospondins are secreted proteins that are found in the extracellular matrix and in the circulation. They are composed of multiple domains, including a thrombospondin type 1 (TSR1) domain, a thrombospondin type 2 (TSR2) domain, and a thrombospondin type 3 (TSR3) domain. These domains are responsible for the various functions of thrombospondins, including their ability to bind to other proteins and to regulate cell signaling pathways. Thrombospondins are involved in a number of diseases, including cancer, cardiovascular disease, and autoimmune disorders. For example, some studies have suggested that thrombospondins may play a role in the development and progression of cancer by promoting the growth and survival of cancer cells. They may also be involved in the development of cardiovascular disease by promoting the formation of blood clots and by regulating the growth and differentiation of blood vessels. In autoimmune disorders, thrombospondins may play a role in the development of inflammation and tissue damage. Overall, thrombospondins are important proteins that play a variety of roles in the body and are involved in a number of diseases.

Blood proteins are proteins that are found in the blood plasma of humans and other animals. They play a variety of important roles in the body, including transporting oxygen and nutrients, regulating blood pressure, and fighting infections. There are several different types of blood proteins, including albumin, globulins, and fibrinogen. Each type of blood protein has a specific function and is produced by different cells in the body. For example, albumin is produced by the liver and helps to maintain the osmotic pressure of the blood, while globulins are produced by the immune system and help to fight infections. Fibrinogen, on the other hand, is produced by the liver and is involved in the clotting of blood.

Purpura, thrombocytopenic, is a medical condition characterized by the presence of purpura (purple or red spots on the skin or mucous membranes) and a low platelet count (thrombocytopenia) in the blood. Platelets are small blood cells that play a crucial role in blood clotting. When there are not enough platelets in the blood, the body is unable to form clots to stop bleeding, which can lead to serious complications such as internal bleeding and hemorrhage. Purpura, thrombocytopenic, can be caused by a variety of factors, including infections, autoimmune disorders, certain medications, and bone marrow disorders. It is often associated with other medical conditions such as Kawasaki disease, Henoch-Schönlein purpura, and thrombotic thrombocytopenic purpura. Treatment for purpura, thrombocytopenic, depends on the underlying cause and may include medications to increase platelet production, blood transfusions, and supportive care to manage bleeding and prevent complications. In severe cases, hospitalization may be necessary.

Von Willebrand disease (VWD) is a bleeding disorder that affects the blood's ability to clot properly. It is caused by a deficiency or dysfunction of von Willebrand factor (VWF), a protein that helps platelets stick together and form blood clots. VWD is the most common inherited bleeding disorder, affecting about 1% of the population. There are three main types of VWD: type 1, which is the most common and mild form; type 2, which is less common and can range from mild to severe; and type 3, which is the most severe and life-threatening form. Treatment for VWD typically involves replacement therapy with VWF concentrate or desmopressin, a hormone that increases the production of VWF.

Indomethacin is a nonsteroidal anti-inflammatory drug (NSAID) that is commonly used to relieve pain, reduce inflammation, and lower fever. It works by blocking the production of prostaglandins, which are chemicals that cause pain, inflammation, and fever. Indomethacin is available in various forms, including tablets, capsules, and suppositories. It is often prescribed for conditions such as arthritis, menstrual cramps, and headaches. It can also be used to treat gout, kidney stones, and other inflammatory conditions. However, indomethacin can have side effects, including stomach pain, nausea, vomiting, and diarrhea. It can also increase the risk of bleeding and ulcers in the stomach and intestines. Therefore, it is important to use indomethacin only as directed by a healthcare provider and to report any side effects immediately.

Blood coagulation disorders refer to a group of medical conditions that affect the blood's ability to clot properly. These disorders can either result in excessive bleeding (hemorrhage) or the formation of blood clots (thrombosis), which can lead to serious health complications such as stroke, heart attack, and pulmonary embolism. There are several types of blood coagulation disorders, including: 1. Hemophilia: A genetic disorder that affects the production of clotting factors in the blood, leading to excessive bleeding. 2. Von Willebrand disease: A genetic disorder that affects the production or function of von Willebrand factor, a protein that helps platelets stick together and form blood clots. 3. Thrombophilia: A condition that increases the risk of blood clots forming in the blood vessels, which can lead to stroke, heart attack, and pulmonary embolism. 4. Antiphospholipid syndrome: A condition in which the immune system mistakenly attacks phospholipids, which are important components of blood clots, leading to the formation of excessive blood clots. 5. Factor V Leiden mutation: A genetic mutation that increases the risk of blood clots forming in the blood vessels. Blood coagulation disorders can be diagnosed through blood tests and other medical procedures, and treatment options may include medications, blood transfusions, and surgery. It is important to seek medical attention if you suspect you may have a blood coagulation disorder, as prompt diagnosis and treatment can help prevent serious health complications.

Receptor, PAR-1 (Protease-Activated Receptor 1) is a type of G protein-coupled receptor that is expressed on the surface of various cells in the human body, including platelets, endothelial cells, and smooth muscle cells. PAR-1 is activated by proteases, such as thrombin, which cleave the extracellular domain of the receptor, exposing an intracellular domain that binds to and activates a G protein, leading to a cascade of intracellular signaling events. Activation of PAR-1 plays a critical role in the coagulation cascade and platelet aggregation, which are essential processes for hemostasis (the prevention of bleeding). However, excessive activation of PAR-1 has also been implicated in the pathogenesis of various cardiovascular diseases, such as atherosclerosis, thrombosis, and myocardial infarction. Therefore, PAR-1 is a target for the development of anti-thrombotic drugs, such as thrombin inhibitors, which block the activation of PAR-1 and reduce the risk of thrombotic events.

Hemorrhage is the medical term used to describe the loss of blood from a vessel or vessel system. It can occur due to a variety of reasons, including injury, disease, or abnormal blood vessel function. Hemorrhage can be classified based on the location of the bleeding, the amount of blood lost, and the severity of the condition. For example, internal hemorrhage occurs within the body's organs or tissues, while external hemorrhage occurs outside the body, such as through a wound or broken skin. The severity of hemorrhage can range from mild to life-threatening, depending on the amount of blood lost and the body's ability to compensate for the loss. In severe cases, hemorrhage can lead to shock, which is a life-threatening condition characterized by low blood pressure and inadequate blood flow to the body's organs and tissues. Treatment for hemorrhage depends on the cause and severity of the bleeding. In some cases, simple measures such as applying pressure to the wound or elevating the affected limb may be sufficient to stop the bleeding. In more severe cases, medical intervention such as surgery or blood transfusions may be necessary to control the bleeding and prevent further complications.

Receptors, Prostaglandin are a type of protein molecules that are found on the surface of cells in the body. They are responsible for binding to prostaglandins, which are hormone-like substances that are produced by the body in response to various stimuli, such as injury, inflammation, or stress. Prostaglandins play a variety of roles in the body, including regulating blood pressure, controlling inflammation, and modulating pain and fever. When prostaglandins bind to their receptors on cells, they trigger a series of chemical reactions that can have a wide range of effects on the body. There are several different types of prostaglandin receptors, each of which is specific to a particular type of prostaglandin. Some prostaglandin receptors are found on the surface of cells in the lining of blood vessels, where they help to regulate blood pressure and blood flow. Others are found on cells in the immune system, where they help to control inflammation and immune responses. In the medical field, understanding the role of prostaglandin receptors is important for developing treatments for a variety of conditions, including pain, inflammation, and cardiovascular disease. For example, drugs that block the action of prostaglandin receptors can be used to reduce inflammation and pain, while drugs that activate these receptors can be used to treat conditions such as high blood pressure and heart disease.

Hemorrhagic disorders are medical conditions that involve excessive bleeding or bleeding that does not stop easily. These disorders can be caused by a variety of factors, including genetic defects, vitamin deficiencies, hormonal imbalances, and certain medications. Hemorrhagic disorders can affect different parts of the body, including the skin, gastrointestinal tract, brain, and other organs. Some common types of hemorrhagic disorders include hemophilia, von Willebrand disease, and thrombocytopenia. Hemophilia is a genetic disorder that affects the blood's ability to clot properly. People with hemophilia have a deficiency in one of the clotting factors, which can lead to excessive bleeding after an injury or surgery. Von Willebrand disease is another genetic disorder that affects the blood's ability to clot properly. People with von Willebrand disease have a deficiency in von Willebrand factor, which is a protein that helps platelets stick together and form clots. Thrombocytopenia is a condition in which the body does not produce enough platelets, which are necessary for blood clotting. This can lead to excessive bleeding, especially after an injury or surgery. Treatment for hemorrhagic disorders typically involves replacing the missing clotting factors or increasing the number of platelets in the blood. In some cases, surgery may be necessary to stop bleeding.

Blood cell count is a medical test that measures the number and types of cells present in a sample of blood. It is a routine diagnostic test that is often performed to evaluate a person's overall health and to diagnose various medical conditions. The blood cell count typically includes measurements of red blood cells (RBCs), white blood cells (WBCs), and platelets. Red blood cells carry oxygen from the lungs to the body's tissues, while white blood cells help fight infections and other diseases. Platelets are responsible for blood clotting. A blood cell count can be performed using a variety of methods, including automated blood cell counters and manual methods. The results of a blood cell count can provide important information about a person's overall health, including their risk of anemia, infection, or bleeding disorders.

Prostaglandins H (PGH) are a group of lipid signaling molecules that are synthesized from arachidonic acid by the enzyme cyclooxygenase (COX). They are involved in a wide range of physiological processes, including inflammation, pain, fever, and blood clotting. PGH are further classified into different subtypes based on their structure and function. For example, prostaglandin H2 (PGH2) is a precursor for other prostaglandins, thromboxanes, and leukotrienes, which are involved in various inflammatory and immune responses. In the medical field, PGH and their derivatives are used as drugs to treat a variety of conditions, including pain, inflammation, and blood clotting disorders. For example, aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) work by inhibiting the production of PGH and other inflammatory mediators. Similarly, thromboxane inhibitors are used to prevent blood clots and reduce the risk of heart attack and stroke.

6-Ketoprostaglandin F1 alpha, also known as 6-keto-PGF1α, is a metabolite of prostaglandin F1 alpha (PGF1α) in the body. It is produced by the conversion of PGF1α by the enzyme 15-hydroxyprostaglandin dehydrogenase (15-PGDH) in various tissues, including platelets, endothelial cells, and monocytes. 6-Keto-PGF1α is a stable metabolite of PGF1α and is often used as a biomarker of platelet activation and inflammation in the body. It has been shown to have anti-inflammatory and anti-thrombotic effects, and has been studied for its potential therapeutic applications in various diseases, including cardiovascular disease, cancer, and inflammatory disorders. In the medical field, 6-keto-PGF1α is often measured in blood or urine samples using immunoassay techniques. It is also used as a research tool to study the biology of prostaglandins and their role in various physiological and pathological processes.

In the medical field, cell adhesion refers to the process by which cells stick to each other or to a surface. This is an essential process for the proper functioning of tissues and organs in the body. There are several types of cell adhesion, including: 1. Homophilic adhesion: This occurs when cells adhere to each other through the interaction of specific molecules on their surface. 2. Heterophilic adhesion: This occurs when cells adhere to each other through the interaction of different molecules on their surface. 3. Heterotypic adhesion: This occurs when cells adhere to each other through the interaction of different types of cells. 4. Intercellular adhesion: This occurs when cells adhere to each other through the interaction of molecules within the cell membrane. 5. Intracellular adhesion: This occurs when cells adhere to each other through the interaction of molecules within the cytoplasm. Cell adhesion is important for a variety of processes, including tissue development, wound healing, and the immune response. Disruptions in cell adhesion can lead to a variety of medical conditions, including cancer, autoimmune diseases, and inflammatory disorders.

Bernard-Soulier Syndrome (BSS) is a rare inherited bleeding disorder that affects the platelets, which are small blood cells that help the blood to clot. People with BSS have an abnormality in the platelets that causes them to be abnormally large and sticky, which can lead to bleeding and bruising. The condition is named after two French doctors, Jean Bernard and Jean-Louis Soulier, who first described it in 1951. BSS is caused by mutations in the genes that control the production of certain proteins on the surface of platelets. These proteins are important for the normal functioning of platelets, and mutations in these genes can lead to the abnormality seen in BSS. Symptoms of BSS can vary widely, but may include easy bruising, prolonged bleeding after injury or surgery, nosebleeds, bleeding gums, and heavy menstrual bleeding in women. In severe cases, BSS can also cause internal bleeding, which can be life-threatening. Treatment for BSS typically involves managing symptoms and preventing bleeding episodes. This may include medications to increase platelet production or to prevent platelets from sticking together, as well as blood transfusions in severe cases. In some cases, a bone marrow transplant may be necessary to replace damaged or abnormal blood cells.

Prostaglandin endoperoxides are a group of biologically active lipids that are derived from arachidonic acid. They are synthesized in the body by the enzyme cyclooxygenase (COX) and are involved in a wide range of physiological processes, including inflammation, pain, fever, and blood clotting. Prostaglandin endoperoxides are particularly important in the inflammatory response, where they are produced by cells in response to injury or infection. They can cause vasodilation (widening of blood vessels), increased blood flow, and increased mucus production, all of which contribute to the inflammatory response. Prostaglandin endoperoxides are also involved in the regulation of blood pressure, platelet aggregation, and smooth muscle contraction. They are synthesized in a variety of tissues throughout the body, including the lungs, kidneys, and gastrointestinal tract. In the medical field, prostaglandin endoperoxides are often used as drugs to treat a variety of conditions, including pain, inflammation, and blood clotting disorders. They are available in a variety of forms, including oral medications, topical creams, and injectable solutions.

Benzamidines are a class of chemical compounds that contain a benzene ring with an amide functional group. They are commonly used as inhibitors of serine proteases, which are enzymes that play important roles in various physiological processes, including blood clotting, inflammation, and digestion. In the medical field, benzamidines are used as anti-inflammatory agents and anticoagulants. They are also used to treat conditions such as peptic ulcers, pancreatitis, and inflammatory bowel disease. Some benzamidines are also used as antiviral agents to treat viral infections such as hepatitis B and C. Benzamidines work by binding to the active site of serine proteases, thereby inhibiting their activity. This inhibition can help to reduce inflammation, prevent blood clotting, and treat various conditions associated with excessive protease activity. However, benzamidines can also have side effects, including nausea, vomiting, and diarrhea, and they may interact with other medications.

Recombinant proteins are proteins that are produced by genetically engineering bacteria, yeast, or other organisms to express a specific gene. These proteins are typically used in medical research and drug development because they can be produced in large quantities and are often more pure and consistent than proteins that are extracted from natural sources. Recombinant proteins can be used for a variety of purposes in medicine, including as diagnostic tools, therapeutic agents, and research tools. For example, recombinant versions of human proteins such as insulin, growth hormones, and clotting factors are used to treat a variety of medical conditions. Recombinant proteins can also be used to study the function of specific genes and proteins, which can help researchers understand the underlying causes of diseases and develop new treatments.

Alprostadil is a medication that is used to treat a variety of medical conditions, including erectile dysfunction (ED), Raynaud's disease, and pulmonary hypertension. It is a synthetic version of a hormone called prostaglandin E1 (PGE1), which is naturally produced by the body and plays a role in regulating blood flow and maintaining normal blood pressure. Alprostadil is typically administered as a suppository, injection, or gel, and works by relaxing the smooth muscles in blood vessels, allowing blood to flow more freely and improving blood flow to the penis or other affected areas. It is often used in combination with other medications or treatments, such as phosphodiesterase type 5 inhibitors (PDE5 inhibitors) or vacuum therapy, to enhance their effectiveness. Alprostadil can cause side effects, including headache, flushing, nausea, and dizziness. It is important to follow the instructions provided by your healthcare provider and to report any side effects to them immediately.

Adenine nucleotides are a type of nucleotide that contains the nitrogenous base adenine (A) and a sugar-phosphate backbone. They are important molecules in the cell and play a crucial role in various biological processes, including energy metabolism and DNA synthesis. There are three types of adenine nucleotides: adenosine monophosphate (AMP), adenosine diphosphate (ADP), and adenosine triphosphate (ATP). AMP is the simplest form of adenine nucleotide, with only one phosphate group attached to the sugar. ADP has two phosphate groups attached to the sugar, while ATP has three phosphate groups. ATP is often referred to as the "energy currency" of the cell because it stores and releases energy through the transfer of phosphate groups. When ATP is broken down, one of its phosphate groups is released, releasing energy that can be used by the cell for various processes. When ATP is synthesized, energy is required to attach a new phosphate group to the molecule. Adenine nucleotides are involved in many cellular processes, including muscle contraction, nerve impulse transmission, and the synthesis of proteins and nucleic acids. They are also important in the regulation of gene expression and the maintenance of cellular homeostasis.

Viper venoms are the toxic secretions produced by venomous snakes of the Viperidae family, including rattlesnakes, copperheads, mambas, and cobras. These venoms contain a complex mixture of proteins, enzymes, and other molecules that can cause a range of physiological effects in humans and other animals. The effects of viper venom can vary depending on the species of snake, the amount of venom injected, and the location of the bite. Some common symptoms of viper venom poisoning include pain, swelling, redness, and blistering at the site of the bite, as well as nausea, vomiting, dizziness, weakness, and difficulty breathing. In severe cases, viper venom can cause systemic effects such as kidney failure, respiratory failure, and even death. Treatment for viper venom poisoning typically involves antivenom, which is a serum containing antibodies that can neutralize the venom and prevent its harmful effects. Other treatments may include supportive care, such as pain management, fluid replacement, and oxygen therapy.

Calcimycin, also known as FK506, is a medication that belongs to a class of drugs called immunosuppressants. It is primarily used to prevent organ rejection in people who have received a transplant, such as a kidney or liver transplant. Calcimycin works by inhibiting the activity of a protein called calcineurin, which plays a key role in the activation of T-cells, a type of white blood cell that is involved in the immune response. By inhibiting calcineurin, calcimycin helps to suppress the immune system and reduce the risk of organ rejection. Calcimycin is usually given as an oral tablet or as an injection. It can cause side effects such as headache, nausea, and diarrhea, and it may interact with other medications.

Cyclic AMP (cAMP) is a signaling molecule that plays a crucial role in many cellular processes, including metabolism, gene expression, and cell proliferation. It is synthesized from adenosine triphosphate (ATP) by the enzyme adenylyl cyclase, and its levels are regulated by various hormones and neurotransmitters. In the medical field, cAMP is often studied in the context of its role in regulating cellular signaling pathways. For example, cAMP is involved in the regulation of the immune system, where it helps to activate immune cells and promote inflammation. It is also involved in the regulation of the cardiovascular system, where it helps to regulate heart rate and blood pressure. In addition, cAMP is often used as a tool in research to study cellular signaling pathways. For example, it is commonly used to activate or inhibit specific signaling pathways in cells, allowing researchers to study the effects of these pathways on cellular function.

Nitric oxide (NO) is a colorless, odorless gas that is produced naturally in the body by various cells, including endothelial cells in the lining of blood vessels. It plays a crucial role in the regulation of blood flow and blood pressure, as well as in the immune response and neurotransmission. In the medical field, NO is often studied in relation to cardiovascular disease, as it is involved in the regulation of blood vessel dilation and constriction. It has also been implicated in the pathogenesis of various conditions, including hypertension, atherosclerosis, and heart failure. NO is also used in medical treatments, such as in the treatment of erectile dysfunction, where it is used to enhance blood flow to the penis. It is also used in the treatment of pulmonary hypertension, where it helps to relax blood vessels in the lungs and improve blood flow. Overall, NO is a critical molecule in the body that plays a vital role in many physiological processes, and its study and manipulation have important implications for the treatment of various medical conditions.

Edetic acid, also known as ethylenediaminetetraacetic acid (EDTA), is a synthetic organic acid that is commonly used in the medical field as a chelating agent. It is a colorless, water-soluble solid that is used to dissolve minerals and other metal ions in solution. In medicine, EDTA is often used to treat heavy metal poisoning, such as lead or mercury poisoning, by binding to the metal ions and facilitating their excretion from the body. It is also used as an anticoagulant in blood tests and as a component of certain contrast agents used in diagnostic imaging procedures. EDTA is available in various forms, including tablets, capsules, and intravenous solutions. It is generally considered safe when used as directed, but high doses or prolonged use can cause side effects such as nausea, vomiting, and allergic reactions.

Beta-thromboglobulin (β-TG) is a plasma protein that plays a role in the coagulation cascade, which is the series of chemical reactions that ultimately leads to the formation of a blood clot. It is produced by platelets, which are small blood cells that are involved in blood clotting. When platelets are activated, they release β-TG, which acts as a marker of platelet activation. It is also involved in the formation of platelet aggregates, which are clusters of platelets that stick together to form a plug at the site of a blood vessel injury. In the medical field, β-TG is often used as a diagnostic marker for platelet activation and thrombosis, which is the formation of a blood clot in a blood vessel. Elevated levels of β-TG in the blood can indicate a higher risk of thrombosis, while low levels may indicate a deficiency in platelet function. It is also used as a marker of inflammation and tissue damage.

Receptors, Collagen are proteins that are found on the surface of cells and are responsible for binding to collagen, a structural protein that is found in the extracellular matrix of tissues. These receptors play a role in regulating various cellular processes, including cell adhesion, migration, and proliferation. In the medical field, the study of receptors, collagen is important for understanding the function of collagen in various tissues and diseases, as well as for developing therapies for conditions that involve abnormal collagen metabolism or function.

Receptors, Purinergic P2 are a family of cell surface receptors that are activated by the neurotransmitter ATP (adenosine triphosphate) and other purine derivatives. These receptors are involved in a wide range of physiological processes, including neurotransmission, inflammation, and immune responses. There are several subtypes of P2 receptors, including P2X receptors, which are ligand-gated ion channels, and P2Y receptors, which are G protein-coupled receptors. P2 receptors are found in many different cell types and tissues throughout the body, and they play important roles in both normal physiology and disease.

S-Nitrosoglutathione (GSNO) is a naturally occurring molecule in the body that plays a role in the regulation of various physiological processes, including vasodilation, neurotransmission, and antioxidant defense. It is formed by the reaction of nitric oxide (NO) with glutathione (GSH), a tripeptide composed of glutamate, cysteine, and glycine. GSNO is a potent vasodilator, meaning it can cause blood vessels to widen, which can help to lower blood pressure and improve blood flow. It also plays a role in neurotransmission, as it can modulate the activity of certain neurotransmitters in the brain. Additionally, GSNO acts as an antioxidant, helping to protect cells from damage caused by reactive oxygen species. In the medical field, GSNO has been studied for its potential therapeutic applications in a variety of conditions, including cardiovascular disease, neurodegenerative disorders, and cancer. However, more research is needed to fully understand the role of GSNO in these conditions and to determine its safety and efficacy as a treatment.

12-Hydroxy-5,8,10,14-eicosatetraenoic acid (12-HETE) is a bioactive lipid molecule that is produced from arachidonic acid (AA) by the action of the enzyme 12-lipoxygenase (12-LOX). It is a member of the eicosanoid family of signaling molecules, which are derived from polyunsaturated fatty acids and play important roles in various physiological processes, including inflammation, blood pressure regulation, and cell proliferation. 12-HETE is synthesized in a variety of tissues, including platelets, endothelial cells, and immune cells, and has been implicated in a number of pathophysiological conditions, including cardiovascular disease, cancer, and inflammatory disorders. It exerts its effects by binding to specific receptors on target cells and activating intracellular signaling pathways that regulate gene expression and cellular function. In the medical field, 12-HETE is often studied as a potential therapeutic target for the treatment of various diseases, as modulating its production and activity may help to regulate inflammation and other pathological processes. However, more research is needed to fully understand the role of 12-HETE in health and disease and to develop effective therapies that target this molecule.

Disintegrins are a family of proteins that are found in various snake venoms and have been shown to have a number of biological activities, including the ability to bind to and activate integrins, a family of cell surface receptors that play a key role in cell adhesion and migration. Disintegrins have been shown to have potential therapeutic applications in a variety of fields, including cancer, cardiovascular disease, and infectious diseases. They are also being studied for their potential use in the development of new drugs for the treatment of these conditions.

Adenosine triphosphate (ATP) is a molecule that serves as the primary energy currency in living cells. It is composed of three phosphate groups attached to a ribose sugar and an adenine base. In the medical field, ATP is essential for many cellular processes, including muscle contraction, nerve impulse transmission, and the synthesis of macromolecules such as proteins and nucleic acids. ATP is produced through cellular respiration, which involves the breakdown of glucose and other molecules to release energy that is stored in the bonds of ATP. Disruptions in ATP production or utilization can lead to a variety of medical conditions, including muscle weakness, fatigue, and neurological disorders. In addition, ATP is often used as a diagnostic tool in medical testing, as levels of ATP can be measured in various bodily fluids and tissues to assess cellular health and function.

The cell membrane, also known as the plasma membrane, is a thin, flexible barrier that surrounds and encloses the cell. It is composed of a phospholipid bilayer, which consists of two layers of phospholipid molecules arranged tail-to-tail. The hydrophobic tails of the phospholipids face inward, while the hydrophilic heads face outward, forming a barrier that separates the inside of the cell from the outside environment. The cell membrane also contains various proteins, including channels, receptors, and transporters, which allow the cell to communicate with its environment and regulate the movement of substances in and out of the cell. In addition, the cell membrane is studded with cholesterol molecules, which help to maintain the fluidity and stability of the membrane. The cell membrane plays a crucial role in maintaining the integrity and function of the cell, and it is involved in a wide range of cellular processes, including cell signaling, cell adhesion, and cell division.

Thrombocytosis is a medical condition characterized by an abnormally high level of platelets in the blood. Platelets are small, disc-shaped cells that play a crucial role in blood clotting. When there are too many platelets in the blood, it can increase the risk of blood clots forming, which can lead to serious health problems such as stroke, heart attack, and pulmonary embolism. Thrombocytosis can be primary or secondary. Primary thrombocytosis is caused by a genetic disorder that affects the production of platelets in the bone marrow. Secondary thrombocytosis is caused by other medical conditions or medications that stimulate the production of platelets. The diagnosis of thrombocytosis typically involves a complete blood count (CBC) test, which measures the number of platelets in the blood. Treatment for thrombocytosis depends on the underlying cause and the severity of the condition. In some cases, no treatment may be necessary if the platelet count is not causing any problems. However, if the platelet count is very high or if there is an increased risk of blood clots, medications may be prescribed to lower the platelet count or prevent blood clots from forming. In severe cases, a procedure called phlebotomy may be performed to remove excess platelets from the blood.

Prostaglandins are a group of hormone-like substances that are produced in the body from fatty acids. They play a variety of roles in the body, including regulating inflammation, blood pressure, and pain. Prostaglandins are synthesized in cells throughout the body, including in the lining of the stomach, the lungs, and the reproductive organs. They are also produced in response to injury or infection, and are thought to play a role in the body's healing process. Prostaglandins are often used as medications to reduce inflammation and pain, and are also used to prevent blood clots and to induce labor in pregnant women.

Thrombopoietin (TPO) is a hormone produced by the liver and kidneys that stimulates the production of platelets, which are essential for blood clotting. TPO binds to receptors on the surface of megakaryocytes, the cells in the bone marrow that produce platelets, and triggers a signaling cascade that leads to the proliferation and differentiation of megakaryocytes into platelets. In the medical field, TPO is used as a diagnostic tool to measure the level of platelets in the blood, which can be an indicator of various medical conditions such as thrombocytopenia (low platelet count) or thrombocytosis (high platelet count). TPO is also used as a treatment for thrombocytopenia, particularly in patients with chronic myeloid leukemia or other blood disorders. In these cases, TPO can stimulate the production of platelets and help increase their count in the blood.

Fibrin is a protein that plays a crucial role in blood clotting, also known as coagulation. It is produced by platelets and certain cells in the blood called endothelial cells, and it forms a mesh-like structure that helps to stabilize a blood clot and prevent further bleeding. Fibrin is a key component of the blood clotting cascade, which is a series of chemical reactions that occur when blood vessels are damaged and bleeding occurs. When a blood vessel is injured, platelets aggregate at the site of the injury and release chemicals that activate the coagulation cascade. This cascade leads to the formation of fibrin, which forms a mesh-like structure around the platelets and other blood cells, creating a stable clot. Fibrin is also important in wound healing, as it helps to form a scab over a wound and prevent infection. In addition, fibrin is involved in the formation of blood clots in the heart and brain, which can be life-threatening if they become dislodged and travel to other parts of the body. Overall, fibrin is a critical protein in the body's ability to prevent and control bleeding, and it plays an important role in wound healing and the prevention of blood clots.

Cyclic GMP (cGMP) is a signaling molecule that plays a crucial role in regulating various physiological processes in the body, including smooth muscle contraction, neurotransmission, and blood pressure regulation. It is synthesized from guanosine triphosphate (GTP) by the enzyme guanylate cyclase and is degraded by the enzyme phosphodiesterase. In the medical field, cGMP is often studied in the context of its role in the regulation of blood vessels and the cardiovascular system. For example, cGMP is involved in the dilation of blood vessels, which helps to lower blood pressure and improve blood flow. It is also involved in the regulation of heart rate and contractility. Abnormal levels of cGMP can lead to a variety of medical conditions, including hypertension, heart failure, and erectile dysfunction. In these cases, medications that either increase or decrease cGMP levels may be used to treat the underlying condition.

Coronary thrombosis is a medical condition in which a blood clot forms in one of the coronary arteries, which supply blood to the heart muscle. This can lead to a blockage of blood flow to the heart, which can cause chest pain (angina), heart attack, or even sudden death. Coronary thrombosis is a serious condition that requires prompt medical attention. It is often caused by the buildup of plaque in the coronary arteries, which can rupture and form a blood clot. Risk factors for coronary thrombosis include high blood pressure, high cholesterol, smoking, diabetes, obesity, and a family history of heart disease. Treatment for coronary thrombosis may include medications to dissolve the clot or surgery to open the blocked artery.

Integrin beta3, also known as CD18, is a protein that plays a crucial role in the immune system and blood clotting. It is a subunit of integrin receptors, which are transmembrane proteins that mediate cell-cell and cell-extracellular matrix interactions. In the context of the immune system, integrin beta3 is expressed on the surface of various immune cells, including neutrophils, monocytes, and platelets. It helps these cells to adhere to the endothelium (inner lining of blood vessels) and migrate through the blood vessel walls to sites of inflammation or infection. In the context of blood clotting, integrin beta3 is expressed on the surface of platelets. It plays a critical role in platelet aggregation, which is the process by which platelets stick together to form a plug at the site of a blood vessel injury. Integrin beta3 also helps to activate platelets and promote the formation of a fibrin clot, which stabilizes the platelet plug and prevents further bleeding. Mutations in the gene encoding integrin beta3 can lead to various bleeding disorders, such as Glanzmann thrombasthenia, a rare inherited bleeding disorder characterized by impaired platelet aggregation.

Snake venoms are complex mixtures of proteins and other molecules that are produced by venom glands in snakes. These venoms are used by snakes as a means of defense against predators or as a tool for capturing prey. The effects of snake venom can vary widely depending on the species of snake and the specific components of the venom. Some snake venoms are primarily hemotoxic, meaning they cause damage to blood vessels and can lead to internal bleeding or organ failure. Other snake venoms are neurotoxic, meaning they affect the nervous system and can cause paralysis or respiratory failure. Still, other snake venoms are myotoxic, meaning they cause damage to muscle tissue. In the medical field, snake venoms are studied for their potential therapeutic uses. Some components of snake venom have been found to have anti-inflammatory, anti-cancer, or anti-viral properties. Additionally, some snake venom components have been used to develop new drugs for the treatment of conditions such as heart disease, stroke, and diabetes. However, it is important to note that snake venom can also be dangerous and can cause serious harm or death if not treated properly.

Ginkgolides are a group of bioactive compounds found in the leaves of the Ginkgo biloba tree. They are known to have various pharmacological effects, including anti-inflammatory, antiplatelet, and neuroprotective properties. Ginkgolides are also used in the treatment of cerebrovascular diseases, such as stroke and dementia, as well as in the management of cardiovascular disorders, such as hypertension and angina. They are typically administered as dietary supplements or as active ingredients in pharmaceutical drugs.

Factor VIII, also known as Antihemophilic Factor VIII or Factor VIII concentrate, is a protein that plays a crucial role in blood clotting. It is one of the eight clotting factors in the blood that work together to stop bleeding when a blood vessel is injured. Factor VIII is produced by the liver and circulates in the bloodstream. It is essential for the formation of blood clots, which help to prevent excessive bleeding. In individuals with hemophilia A, a genetic disorder that affects the blood's ability to clot, the production of Factor VIII is impaired, leading to excessive bleeding and an increased risk of bleeding-related complications. Factor VIII concentrate is a medication used to treat hemophilia A. It is made from human plasma and contains purified Factor VIII. It is administered by injection and can help to reduce the frequency and severity of bleeding episodes in individuals with hemophilia A.

Membrane proteins are proteins that are embedded within the lipid bilayer of a cell membrane. They play a crucial role in regulating the movement of substances across the membrane, as well as in cell signaling and communication. There are several types of membrane proteins, including integral membrane proteins, which span the entire membrane, and peripheral membrane proteins, which are only in contact with one or both sides of the membrane. Membrane proteins can be classified based on their function, such as transporters, receptors, channels, and enzymes. They are important for many physiological processes, including nutrient uptake, waste elimination, and cell growth and division.

Anticoagulants are medications that are used to prevent blood clots from forming. They work by interfering with the normal clotting process in the blood, which helps to prevent the formation of blood clots that can lead to serious medical conditions such as stroke, heart attack, and pulmonary embolism. There are several types of anticoagulants, including: 1. Vitamin K antagonists: These drugs, such as warfarin, work by inhibiting the production of vitamin K-dependent clotting factors in the liver. 2. Direct thrombin inhibitors: These drugs, such as dabigatran, directly inhibit the enzyme thrombin, which is a key factor in the clotting process. 3. Direct factor Xa inhibitors: These drugs, such as rivaroxaban, directly inhibit factor Xa, another key enzyme in the clotting process. Anticoagulants are typically prescribed for patients who are at risk of developing blood clots, such as those who have had a previous blood clot, are undergoing surgery, or have a medical condition that increases their risk of blood clots. They are also used to treat certain medical conditions, such as deep vein thrombosis and pulmonary embolism. However, anticoagulants can also increase the risk of bleeding, so they must be used carefully and monitored by a healthcare provider.

In the medical field, "Cells, Cultured" refers to cells that have been grown and maintained in a controlled environment outside of their natural biological context, typically in a laboratory setting. This process is known as cell culture and involves the isolation of cells from a tissue or organism, followed by their growth and proliferation in a nutrient-rich medium. Cultured cells can be derived from a variety of sources, including human or animal tissues, and can be used for a wide range of applications in medicine and research. For example, cultured cells can be used to study the behavior and function of specific cell types, to develop new drugs and therapies, and to test the safety and efficacy of medical products. Cultured cells can be grown in various types of containers, such as flasks or Petri dishes, and can be maintained at different temperatures and humidity levels to optimize their growth and survival. The medium used to culture cells typically contains a combination of nutrients, growth factors, and other substances that support cell growth and proliferation. Overall, the use of cultured cells has revolutionized medical research and has led to many important discoveries and advancements in the field of medicine.

Salivary proteins and peptides are molecules that are secreted by the salivary glands and are present in saliva. They play important roles in various aspects of oral health and function, including lubrication of the mouth, protection against bacterial and viral infections, and digestion of food. Some of the major classes of salivary proteins and peptides include mucins, amylase, lipase, lysozyme, lactoferrin, and histatins. Mucins are large, complex glycoproteins that help to lubricate and protect the oral mucosa, while amylase and lipase are digestive enzymes that break down carbohydrates and fats in food. Lysozyme is an antimicrobial protein that helps to protect against bacterial infections, while lactoferrin and histatins have antimicrobial and anti-inflammatory properties. Abnormal levels or function of salivary proteins and peptides can be associated with various oral and systemic diseases, such as dry mouth, periodontal disease, and cancer. Therefore, the study of salivary proteins and peptides is an important area of research in the medical field.

Integrin alpha2 is a type of protein that plays a crucial role in the formation and function of the extracellular matrix (ECM) in the human body. It is a member of the integrin family of proteins, which are transmembrane receptors that mediate cell-cell and cell-ECM interactions. Integrin alpha2 is expressed on the surface of many different types of cells, including platelets, leukocytes, and endothelial cells. It is a heterodimeric protein, meaning that it is composed of two different subunits: alpha2 and beta1. The alpha2 subunit is responsible for binding to specific ECM proteins, such as collagen and laminin, while the beta1 subunit is responsible for anchoring the integrin to the cytoskeleton of the cell. Integrin alpha2 plays a critical role in many physiological processes, including cell adhesion, migration, and signaling. It is also involved in the development and progression of many diseases, including cancer, autoimmune disorders, and cardiovascular disease. Therefore, understanding the function and regulation of integrin alpha2 is important for developing new therapeutic strategies for these diseases.

Tyrosine is an amino acid that is essential for the production of certain hormones, neurotransmitters, and other important molecules in the body. It is a non-essential amino acid, which means that it can be synthesized by the body from other amino acids or from dietary sources. In the medical field, tyrosine is often used as a dietary supplement to support the production of certain hormones and neurotransmitters, particularly dopamine and norepinephrine. These hormones play important roles in regulating mood, motivation, and other aspects of brain function. Tyrosine is also used in the treatment of certain medical conditions, such as phenylketonuria (PKU), a genetic disorder that affects the metabolism of phenylalanine, another amino acid. In PKU, tyrosine supplementation can help to prevent the buildup of toxic levels of phenylalanine in the body. In addition, tyrosine has been studied for its potential benefits in the treatment of other conditions, such as depression, anxiety, and fatigue. However, more research is needed to confirm these potential benefits and to determine the optimal dosage and duration of tyrosine supplementation.

Receptors, cell surface are proteins that are located on the surface of cells and are responsible for receiving signals from the environment. These signals can be chemical, electrical, or mechanical in nature and can trigger a variety of cellular responses. There are many different types of cell surface receptors, including ion channels, G-protein coupled receptors, and enzyme-linked receptors. These receptors play a critical role in many physiological processes, including sensation, communication, and regulation of cellular activity. In the medical field, understanding the function and regulation of cell surface receptors is important for developing new treatments for a wide range of diseases and conditions.

Blood viscosity refers to the thickness or stickiness of blood. It is a measure of the resistance of blood to flow through the blood vessels. Blood viscosity is influenced by several factors, including the number of red blood cells, the amount of plasma in the blood, and the concentration of certain proteins and other substances in the blood. In the medical field, blood viscosity is an important parameter for diagnosing and treating various conditions, such as cardiovascular diseases, blood disorders, and kidney diseases. High blood viscosity can increase the risk of blood clots, stroke, and heart attack, while low blood viscosity can lead to anemia and other conditions. Therefore, measuring blood viscosity is often used as a diagnostic tool to identify and monitor these conditions.

Antibodies, also known as immunoglobulins, are proteins produced by the immune system in response to the presence of foreign substances, such as viruses, bacteria, and other pathogens. Antibodies are designed to recognize and bind to specific molecules on the surface of these foreign substances, marking them for destruction by other immune cells. There are five main classes of antibodies: IgG, IgA, IgM, IgD, and IgE. Each class of antibody has a unique structure and function, and they are produced by different types of immune cells in response to different types of pathogens. Antibodies play a critical role in the immune response, helping to protect the body against infection and disease. They can neutralize pathogens by binding to them and preventing them from entering cells, or they can mark them for destruction by other immune cells. In some cases, antibodies can also help to stimulate the immune response by activating immune cells or by recruiting other immune cells to the site of infection. Antibodies are often used in medical treatments, such as in the development of vaccines, where they are used to stimulate the immune system to produce a response to a specific pathogen. They are also used in diagnostic tests to detect the presence of specific pathogens or to monitor the immune response to a particular treatment.

In the medical field, binding sites refer to specific locations on the surface of a protein molecule where a ligand (a molecule that binds to the protein) can attach. These binding sites are often formed by a specific arrangement of amino acids within the protein, and they are critical for the protein's function. Binding sites can be found on a wide range of proteins, including enzymes, receptors, and transporters. When a ligand binds to a protein's binding site, it can cause a conformational change in the protein, which can alter its activity or function. For example, a hormone may bind to a receptor protein, triggering a signaling cascade that leads to a specific cellular response. Understanding the structure and function of binding sites is important in many areas of medicine, including drug discovery and development, as well as the study of diseases caused by mutations in proteins that affect their binding sites. By targeting specific binding sites on proteins, researchers can develop drugs that modulate protein activity and potentially treat a wide range of diseases.

Amyloid is a type of protein that is abnormal and forms deposits in tissues throughout the body. These deposits are made up of fibrils, which are long, twisted strands of protein. Amyloidosis is a disease that occurs when amyloid fibrils build up in tissues, leading to damage and dysfunction. There are many different types of amyloidosis, which can affect different organs and tissues in the body. Some types of amyloidosis are inherited, while others are acquired. Treatment for amyloidosis depends on the specific type and severity of the disease.

Glycoproteins are a type of protein that contains one or more carbohydrate chains covalently attached to the protein molecule. These carbohydrate chains are made up of sugars and are often referred to as glycans. Glycoproteins play important roles in many biological processes, including cell signaling, cell adhesion, and immune response. They are found in many different types of cells and tissues throughout the body, and are often used as markers for various diseases and conditions. In the medical field, glycoproteins are often studied as potential targets for the development of new drugs and therapies.

Cyclooxygenase (COX) inhibitors are a class of drugs that are used to reduce inflammation and pain by blocking the activity of enzymes called cyclooxygenases. These enzymes are responsible for the production of prostaglandins, which are hormone-like substances that play a role in inflammation, pain, and fever. There are two main types of COX enzymes: COX-1 and COX-2. COX-1 is found in many tissues throughout the body and is involved in the production of prostaglandins that help to protect the stomach lining and regulate blood pressure. COX-2 is primarily found in cells that are involved in inflammation and pain. COX inhibitors can be classified as either non-selective or selective. Non-selective COX inhibitors block the activity of both COX-1 and COX-2, which can lead to side effects such as stomach ulcers and increased risk of heart attack and stroke. Selective COX-2 inhibitors, on the other hand, block the activity of only COX-2, which reduces the risk of these side effects but may not be as effective at reducing inflammation and pain. COX inhibitors are commonly used to treat conditions such as arthritis, menstrual cramps, and headaches. They are also sometimes used to reduce the risk of blood clots after surgery or to prevent heart attacks and strokes in people with certain risk factors.

Afibrinogenemia is a rare medical condition characterized by a deficiency or absence of fibrinogen, a protein that plays a crucial role in blood clotting. Fibrinogen is produced in the liver and is essential for the formation of blood clots, which help to stop bleeding after an injury. In afibrinogenemia, the body is unable to produce enough fibrinogen, leading to an increased risk of bleeding and bruising. This can manifest as easy bruising, nosebleeds, bleeding gums, and prolonged bleeding after injury or surgery. In severe cases, afibrinogenemia can lead to life-threatening bleeding episodes, such as intracranial hemorrhage or bleeding into the abdomen. Afibrinogenemia can be caused by genetic mutations that affect fibrinogen production or by other medical conditions that affect the liver's ability to produce fibrinogen. Treatment for afibrinogenemia typically involves replacement therapy with fibrinogen concentrate or cryoprecipitate, which can help to prevent bleeding episodes.

Sulfinpyrazone is a medication that is used to treat gout, a type of arthritis that is caused by the buildup of uric acid crystals in the joints. It works by reducing the amount of uric acid that is produced by the body, which helps to prevent the formation of uric acid crystals and reduce the frequency and severity of gout attacks. It is usually taken in combination with other medications, such as allopurinol, to help lower uric acid levels in the blood.

Integrin alpha2beta1 is a type of cell surface protein that plays a crucial role in cell adhesion and migration. It is a heterodimeric protein composed of two subunits, alpha2 and beta1, which are encoded by separate genes. In the medical field, integrin alpha2beta1 is involved in various physiological processes, including wound healing, tissue repair, and immune cell function. It is also expressed on the surface of many different types of cells, including fibroblasts, endothelial cells, and immune cells. Abnormalities in integrin alpha2beta1 expression or function have been linked to a variety of diseases, including cancer, autoimmune disorders, and cardiovascular disease. For example, integrin alpha2beta1 has been shown to play a role in the development and progression of breast cancer, and its expression has been associated with poor prognosis in patients with the disease. Additionally, integrin alpha2beta1 has been implicated in the pathogenesis of autoimmune disorders such as rheumatoid arthritis and multiple sclerosis.

Dipyridamole is a medication that is used to prevent blood clots from forming in the blood vessels. It is also used to treat angina (chest pain caused by reduced blood flow to the heart) and to prevent blood clots after a heart attack or stroke. Dipyridamole works by increasing the amount of a substance called prostacyclin in the blood vessels, which helps to keep the blood vessels open and improve blood flow. It is usually taken by mouth in the form of a tablet or capsule.

Adenosine monophosphate (AMP) is a nucleotide that plays a crucial role in various cellular processes, including energy metabolism, signal transduction, and gene expression. It is a component of the nucleic acids DNA and RNA and is synthesized from adenosine triphosphate (ATP) by the removal of two phosphate groups. In the medical field, AMP is often used as a biomarker for cellular energy status and is involved in the regulation of various physiological processes. For example, AMP levels are increased in response to cellular energy depletion, which can trigger the activation of AMP-activated protein kinase (AMPK), a key regulator of energy metabolism. Additionally, AMP is involved in the regulation of the sleep-wake cycle and has been shown to play a role in the development of various neurological disorders, including Alzheimer's disease and Parkinson's disease.

In the medical field, the term "cattle" refers to large domesticated animals that are raised for their meat, milk, or other products. Cattle are a common source of food and are also used for labor in agriculture, such as plowing fields or pulling carts. In veterinary medicine, cattle are often referred to as "livestock" and may be treated for a variety of medical conditions, including diseases, injuries, and parasites. Some common medical issues that may affect cattle include respiratory infections, digestive problems, and musculoskeletal disorders. Cattle may also be used in medical research, particularly in the fields of genetics and agriculture. For example, scientists may study the genetics of cattle to develop new breeds with desirable traits, such as increased milk production or resistance to disease.

Prostaglandins D (PGD) are a group of lipid signaling molecules that are synthesized from arachidonic acid by the enzyme prostaglandin D synthase (PGDS). They are involved in a variety of physiological processes, including inflammation, pain, and immune function. PGD2 is a specific subtype of prostaglandin D that is produced by immune cells and plays a role in regulating immune responses. It is also involved in the contraction of smooth muscle cells, which can contribute to the constriction of blood vessels and bronchial tubes. In the medical field, PGD2 and its receptors are being studied for their potential therapeutic applications in the treatment of various conditions, including asthma, allergic reactions, and cancer. For example, drugs that target PGD2 receptors have been shown to have anti-inflammatory and bronchodilatory effects, and may be useful in the management of asthma and other respiratory diseases.

Prostaglandins, Synthetic are synthetic versions of natural hormones called prostaglandins. Prostaglandins are hormone-like substances that are produced in the body and have a variety of functions, including regulating inflammation, blood pressure, and pain. Synthetic prostaglandins are used in medicine to treat a variety of conditions, including menstrual cramps, labor pain, and inflammation. They are typically administered as creams, gels, or tablets.

Thiophenes are a class of organic compounds that contain a five-membered ring with one sulfur atom and two carbon atoms. They are commonly found in a variety of natural and synthetic compounds, including some pharmaceuticals and pesticides. In the medical field, thiophenes are sometimes used as ingredients in drugs to treat a variety of conditions. For example, some thiophene-containing drugs are used to treat high blood pressure, while others are used to treat depression and anxiety. Some thiophenes have also been studied for their potential use in treating cancer. It is important to note that thiophenes can have potential side effects, and their use in medicine is carefully regulated by regulatory agencies such as the U.S. Food and Drug Administration (FDA).

In the medical field, "binding, competitive" refers to a type of interaction between a ligand (a molecule that binds to a receptor) and a receptor. Competitive binding occurs when two or more ligands can bind to the same receptor, but they do so in a way that limits the maximum amount of ligand that can bind to the receptor at any given time. In other words, when a ligand binds to a receptor, it competes with other ligands that may also be trying to bind to the same receptor. The binding of one ligand can prevent or reduce the binding of other ligands, depending on the relative affinities of the ligands for the receptor. Competitive binding is an important concept in pharmacology, as it helps to explain how drugs can interact with receptors in the body and how their effects can be influenced by other drugs or substances that may also be present. It is also important in the study of biological systems, where it can help to explain how molecules interact with each other in complex biological networks.

Prostanoic acids are a class of bioactive lipids that are derived from the omega-6 fatty acid arachidonic acid. They are also known as eicosanoids and are produced by the metabolism of arachidonic acid by enzymes called cyclooxygenases (COX) and lipoxygenases (LOX). Prostanoic acids play a variety of roles in the body, including regulating inflammation, blood pressure, and blood clotting. They are also involved in the regulation of pain, fever, and immune responses. There are several different types of prostanoic acids, including prostaglandins, thromboxanes, and leukotrienes. Each type of prostanoic acid has a specific function and can have both beneficial and harmful effects on the body, depending on the context in which it is produced and released. In the medical field, prostanoic acids are often used as targets for the development of drugs to treat a variety of conditions, including inflammation, pain, and cardiovascular disease. They are also used as diagnostic tools to help identify and monitor certain medical conditions.

Prostaglandins E (PGE) are a group of lipid signaling molecules that are produced in the body from arachidonic acid. They are synthesized by enzymes called cyclooxygenases (COX) and are involved in a wide range of physiological processes, including inflammation, pain, fever, and blood clotting. PGEs are produced in response to various stimuli, such as injury, infection, or stress, and act as messengers to regulate cellular responses. They can also act as vasodilators, increasing blood flow to tissues, and as bronchodilators, relaxing smooth muscle in the airways. In the medical field, PGEs are used as drugs to treat a variety of conditions, including pain, inflammation, and asthma. They are also used in research to study the mechanisms of these processes and to develop new treatments.

Cell adhesion molecules (CAMs) are proteins that mediate the attachment of cells to each other or to the extracellular matrix. They play a crucial role in various physiological processes, including tissue development, wound healing, immune response, and cancer progression. There are several types of CAMs, including cadherins, integrins, selectins, and immunoglobulin superfamily members. Each type of CAM has a unique structure and function, and they can interact with other molecules to form complex networks that regulate cell behavior. In the medical field, CAMs are often studied as potential targets for therapeutic interventions. For example, drugs that block specific CAMs have been developed to treat cancer, autoimmune diseases, and cardiovascular disorders. Additionally, CAMs are used as diagnostic markers to identify and monitor various diseases, including cancer, inflammation, and neurodegenerative disorders.

Type C phospholipases are a family of enzymes that hydrolyze phospholipids, which are important components of cell membranes. These enzymes are characterized by the presence of a catalytic cysteine residue in their active site, which is involved in the hydrolysis of the phospholipid substrate. Type C phospholipases are involved in a variety of cellular processes, including signal transduction, membrane trafficking, and cell growth and differentiation. They are also involved in the pathogenesis of several diseases, including cancer, neurodegenerative disorders, and inflammatory diseases. There are several subtypes of type C phospholipases, including phospholipase C (PLC), which hydrolyzes phosphatidylinositol 4,5-bisphosphate (PIP2) to produce inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG), and phospholipase D (PLD), which hydrolyzes phosphatidylcholine (PC) to produce phosphatidic acid (PA) and choline.

Iloprost is a medication used to treat a variety of medical conditions related to blood vessels, including pulmonary hypertension (high blood pressure in the arteries of the lungs), Raynaud's phenomenon (a condition that causes the fingers and toes to turn white or blue when exposed to cold), and chronic thromboembolic pulmonary hypertension (high blood pressure in the arteries of the lungs caused by blood clots). It works by relaxing and widening blood vessels, which can improve blood flow and reduce blood pressure. Iloprost is usually administered as a gas through a nebulizer or as a solution that is injected into a vein. It can cause side effects such as headache, nausea, and flushing.

The cytoskeleton is a complex network of protein filaments that extends throughout the cytoplasm of a cell. It plays a crucial role in maintaining the shape and structure of the cell, as well as facilitating various cellular processes such as cell division, movement, and intracellular transport. The cytoskeleton is composed of three main types of protein filaments: microfilaments, intermediate filaments, and microtubules. Microfilaments are the thinnest filaments and are involved in cell movement and muscle contraction. Intermediate filaments are slightly thicker than microfilaments and provide mechanical strength to the cell. Microtubules are the thickest filaments and serve as tracks for intracellular transport and as the structural framework for the cell. In addition to these three types of filaments, the cytoskeleton also includes various associated proteins and motor proteins that help to regulate and control the movement of the filaments. Overall, the cytoskeleton is a dynamic and essential component of the cell that plays a critical role in maintaining cellular structure and function.

Fibrinopeptide A is a small peptide that is generated during the process of blood clotting. It is a fragment of the larger protein fibrinogen, which is a key component of the blood clotting cascade. Fibrinopeptide A is released when fibrinogen is cleaved by the enzyme thrombin, which is activated during the clotting process. Once released, fibrinopeptide A helps to stabilize the fibrin clot and promote its formation. It is also involved in the regulation of blood vessel tone and the inflammatory response. In the medical field, fibrinopeptide A is often measured as a marker of blood clotting activity and can be used to diagnose and monitor various clotting disorders.

Alpha-Synuclein is a protein that is found in nerve cells in the brain and spinal cord. It is involved in the normal functioning of these cells, and it is also a key component of Lewy bodies, which are abnormal protein aggregates that are found in the brains of people with Parkinson's disease and other neurodegenerative disorders. Alpha-Synuclein is thought to play a role in the development of these disorders by disrupting the normal functioning of nerve cells and leading to the formation of Lewy bodies.

Microfilament proteins are a type of cytoskeletal protein that make up the thinest filaments in the cytoskeleton of cells. They are composed of actin, a globular protein that polymerizes to form long, thin filaments. Microfilaments are involved in a variety of cellular processes, including cell shape maintenance, cell movement, and muscle contraction. They also play a role in the formation of cellular structures such as the contractile ring during cell division. In the medical field, microfilament proteins are important for understanding the function and behavior of cells, as well as for developing treatments for diseases that involve disruptions in the cytoskeleton.

In the medical field, "Disease Models, Animal" refers to the use of animals to study and understand human diseases. These models are created by introducing a disease or condition into an animal, either naturally or through experimental manipulation, in order to study its progression, symptoms, and potential treatments. Animal models are used in medical research because they allow scientists to study diseases in a controlled environment and to test potential treatments before they are tested in humans. They can also provide insights into the underlying mechanisms of a disease and help to identify new therapeutic targets. There are many different types of animal models used in medical research, including mice, rats, rabbits, dogs, and monkeys. Each type of animal has its own advantages and disadvantages, and the choice of model depends on the specific disease being studied and the research question being addressed.

Protein kinase C (PKC) is a family of enzymes that play a crucial role in various cellular processes, including cell growth, differentiation, and apoptosis. In the medical field, PKC is often studied in relation to its involvement in various diseases, including cancer, cardiovascular disease, and neurodegenerative disorders. PKC enzymes are activated by the binding of diacylglycerol (DAG) and calcium ions, which leads to the phosphorylation of target proteins. This phosphorylation can alter the activity, localization, or stability of the target proteins, leading to changes in cellular signaling pathways. PKC enzymes are divided into several subfamilies based on their structure and activation mechanisms. The different subfamilies have distinct roles in cellular signaling and are involved in different diseases. For example, some PKC subfamilies are associated with cancer progression, while others are involved in the regulation of the immune system. Overall, PKC enzymes are an important area of research in the medical field, as they have the potential to be targeted for the development of new therapeutic strategies for various diseases.

In the medical field, macromolecular substances refer to large molecules that are composed of repeating units, such as proteins, carbohydrates, lipids, and nucleic acids. These molecules are essential for many biological processes, including cell signaling, metabolism, and structural support. Macromolecular substances are typically composed of thousands or even millions of atoms, and they can range in size from a few nanometers to several micrometers. They are often found in the form of fibers, sheets, or other complex structures, and they can be found in a variety of biological tissues and fluids. Examples of macromolecular substances in the medical field include: - Proteins: These are large molecules composed of amino acids that are involved in a wide range of biological functions, including enzyme catalysis, structural support, and immune response. - Carbohydrates: These are molecules composed of carbon, hydrogen, and oxygen atoms that are involved in energy storage, cell signaling, and structural support. - Lipids: These are molecules composed of fatty acids and glycerol that are involved in energy storage, cell membrane structure, and signaling. - Nucleic acids: These are molecules composed of nucleotides that are involved in genetic information storage and transfer. Macromolecular substances are important for many medical applications, including drug delivery, tissue engineering, and gene therapy. Understanding the structure and function of these molecules is essential for developing new treatments and therapies for a wide range of diseases and conditions.

Phosphatidic acids are a type of phospholipid, which are important components of cell membranes. They are composed of a glycerol backbone, two fatty acid chains, and a phosphate group. Phosphatidic acids play a number of important roles in the body, including serving as a source of energy, regulating metabolism, and participating in signaling pathways. In the medical field, phosphatidic acids are sometimes used as a diagnostic tool to help identify certain diseases or conditions, such as liver disease or cancer. They may also be used as a therapeutic agent to treat certain conditions, such as metabolic disorders or inflammation.

Phospholipids are a type of lipid molecule that are essential components of cell membranes in living organisms. They are composed of a hydrophilic (water-loving) head and two hydrophobic (water-fearing) tails, which together form a bilayer structure that separates the interior of the cell from the external environment. Phospholipids are important for maintaining the integrity and fluidity of cell membranes, and they also play a role in cell signaling and the transport of molecules across the membrane. They are found in all types of cells, including animal, plant, and bacterial cells, and are also present in many types of lipoproteins, which are particles that transport lipids in the bloodstream. In the medical field, phospholipids are used in a variety of applications, including as components of artificial cell membranes for research purposes, as components of liposomes (small vesicles that can deliver drugs to specific cells), and as ingredients in dietary supplements and other health products. They are also the subject of ongoing research in the fields of nutrition, metabolism, and disease prevention.

Quinacrine is an antimalarial drug that was first synthesized in the early 20th century. It is a synthetic antimalarial agent that is effective against both chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum, the parasite that causes the most severe form of malaria. Quinacrine is a yellow-orange crystalline powder that is insoluble in water but soluble in organic solvents. It is usually administered orally as a tablet or as a suspension in water. Quinacrine works by inhibiting the growth and reproduction of the Plasmodium parasite in the red blood cells of the host. It does this by interfering with the parasite's ability to synthesize heme, a vital component of hemoglobin, which is necessary for the survival of the parasite. Quinacrine has also been used to treat other parasitic infections, such as leishmaniasis and schistosomiasis. However, its use has been limited due to its side effects, which include nausea, vomiting, diarrhea, and skin rashes. Additionally, quinacrine has been associated with an increased risk of liver damage and has been banned in some countries due to its potential carcinogenic effects.

Integrins are a family of transmembrane proteins that play a crucial role in cell adhesion and signaling. They are composed of two subunits, alpha and beta, which form a heterodimer that spans the cell membrane. Integrins bind to various extracellular matrix proteins, such as fibronectin, laminin, and collagen, and transmit signals across the cell membrane to the cytoplasm. This process is essential for cell migration, tissue development, and immune function. In the medical field, integrins are important targets for the development of drugs to treat various diseases, including cancer, autoimmune disorders, and cardiovascular diseases.

Adenosine is a naturally occurring nucleoside that plays a crucial role in various physiological processes in the human body. It is a component of the nucleic acids DNA and RNA and is also found in high concentrations in the cells of the heart, brain, and other organs. In the medical field, adenosine is often used as a medication to treat certain heart conditions, such as supraventricular tachycardia (SVT) and atrial fibrillation (AFib). Adenosine works by blocking the electrical signals that cause the heart to beat too fast or irregularly. It is typically administered as an intravenous injection and has a short duration of action, lasting only a few minutes. Adenosine is also used in research to study the function of various cells and tissues in the body, including the nervous system, immune system, and cardiovascular system. It has been shown to have a wide range of effects on cellular signaling pathways, including the regulation of gene expression, cell proliferation, and apoptosis (cell death).

GTP-binding protein alpha subunits, Gi-Go, are a family of proteins that play a crucial role in signal transduction pathways in cells. They are also known as G proteins or heterotrimeric G proteins because they consist of three subunits: an alpha subunit, a beta subunit, and a gamma subunit. The alpha subunit of Gi-Go proteins is responsible for binding to guanosine triphosphate (GTP), a small molecule that is involved in regulating many cellular processes. When GTP binds to the alpha subunit, it causes a conformational change in the protein, which in turn activates or inhibits downstream signaling pathways. Gi-Go proteins are involved in a wide range of cellular processes, including cell growth and differentiation, metabolism, and immune function. They are also involved in the regulation of neurotransmitter release in the nervous system and the contraction of smooth muscle cells in the cardiovascular system. Dysfunction of Gi-Go proteins has been implicated in a number of diseases, including cancer, diabetes, and neurological disorders. Therefore, understanding the role of these proteins in cellular signaling pathways is an important area of research in the medical field.

Aurintricarboxylic acid (ATA) is a synthetic compound that has been studied for its potential therapeutic effects in various medical conditions. It is a tricarboxylic acid with a gold complex attached to it, and it has been shown to have anti-inflammatory, anti-oxidant, and anti-cancer properties. In the medical field, ATA has been investigated for its potential use in treating a variety of conditions, including cancer, inflammatory diseases, and neurodegenerative disorders. Some studies have suggested that ATA may have anti-tumor effects by inhibiting the growth and proliferation of cancer cells, as well as by inducing apoptosis (cell death) in cancer cells. ATA has also been shown to have anti-inflammatory effects by reducing the production of pro-inflammatory cytokines and by inhibiting the activation of immune cells. Additionally, ATA has been found to have anti-oxidant properties by scavenging free radicals and reducing oxidative stress. While ATA has shown promise in preclinical studies, more research is needed to fully understand its potential therapeutic effects and to determine the optimal dosing and administration for various medical conditions.

S-Nitrosothiols (RSNOs) are a class of compounds that contain a nitric oxide (NO) moiety bound to a sulfur atom of a cysteine residue in a protein or a small molecule. They are formed by the reaction of NO with thiols, such as cysteine, and are involved in various physiological and pathophysiological processes in the body. In the medical field, S-Nitrosothiols have been studied for their potential therapeutic effects in a variety of diseases, including cardiovascular disease, neurodegenerative disorders, and cancer. They have been shown to have anti-inflammatory, anti-apoptotic, and anti-oxidant properties, and may play a role in regulating blood flow, neurotransmission, and immune function. However, the biological activity of S-Nitrosothiols is complex and can be influenced by a variety of factors, including their chemical structure, stability, and cellular localization. As such, further research is needed to fully understand their mechanisms of action and potential therapeutic applications.

Receptors, IgG are a type of immune system receptor that recognizes and binds to the Fc region of immunoglobulin G (IgG) antibodies. These receptors are found on the surface of various immune cells, including macrophages, neutrophils, and dendritic cells. When an IgG antibody binds to its specific antigen, it can activate these immune cells through the interaction with their IgG receptors. This activation can lead to the destruction of the antigen-antibody complex, as well as the recruitment of additional immune cells to the site of infection or inflammation. Receptors, IgG play an important role in the immune response to infections and other diseases, and their dysfunction can contribute to various immune disorders.

L-amino acid oxidase (LAAO) is an enzyme that catalyzes the oxidative deamination of L-amino acids, which are the building blocks of proteins. This enzyme is found in various tissues throughout the body, including the liver, kidney, and brain. In the medical field, LAAO has been studied for its potential therapeutic applications. For example, LAAO has been shown to have anti-inflammatory and anti-cancer effects, and it may be useful in the treatment of various diseases, including cancer, neurodegenerative disorders, and inflammatory disorders. LAAO is also involved in the metabolism of certain drugs, and it has been shown to interact with a number of medications, including antidepressants, antipsychotics, and antihypertensives. As a result, the activity of LAAO may need to be taken into account when prescribing these drugs to patients. Overall, LAAO is an important enzyme that plays a role in various physiological processes, and it has potential therapeutic applications in the treatment of a range of diseases.

Methysergide is a medication that belongs to a class of drugs called ergot alkaloids. It is primarily used to treat migraines and cluster headaches, as well as to prevent nausea and vomiting caused by chemotherapy or surgery. Methysergide works by constricting blood vessels in the brain and reducing inflammation, which can help to alleviate the symptoms of migraines and cluster headaches. It can also help to prevent nausea and vomiting by blocking the action of certain chemicals in the brain that trigger these symptoms. Methysergide is available in both oral and injectable forms, and is typically taken on an as-needed basis for the treatment of migraines and cluster headaches. However, it is important to note that methysergide can have side effects, including nausea, dizziness, and chest pain, and should only be used under the supervision of a healthcare professional.

Phosphatidylinositols (PtdIns) are a class of lipids that are important signaling molecules in the cell membrane. They are composed of a glycerol backbone, two fatty acid chains, and a phosphate group attached to the third carbon of the glycerol molecule. There are several different types of PtdIns, each with a unique structure and function. In the medical field, PtdIns play a crucial role in various cellular processes, including cell growth, differentiation, and apoptosis (programmed cell death). They are also involved in the regulation of the immune system, insulin signaling, and the development of cancer. PtdIns are often used as markers for various diseases, including cancer, cardiovascular disease, and neurological disorders. They are also used as targets for drug development, as they play a key role in many cellular signaling pathways. Overall, PtdIns are an important class of lipids that play a critical role in many cellular processes and are the subject of ongoing research in the medical field.

Prostaglandin-endoperoxide synthases, also known as cyclooxygenases (COXs), are enzymes that play a crucial role in the production of prostaglandins and thromboxanes, which are hormone-like substances that regulate various physiological processes in the body. There are two main isoforms of COX: COX-1 and COX-2. COX-1 is constitutively expressed in most tissues and is involved in the maintenance of normal physiological functions, such as platelet aggregation, gastric mucosal protection, and renal blood flow regulation. In contrast, COX-2 is induced in response to various stimuli, such as inflammation, injury, and stress, and is primarily involved in the production of prostaglandins that mediate inflammatory and pain responses. Prostaglandins and thromboxanes are synthesized from arachidonic acid, a polyunsaturated fatty acid that is released from membrane phospholipids in response to various stimuli. COXs catalyze the conversion of arachidonic acid to prostaglandin H2 (PGH2), which is then further metabolized to various prostaglandins and thromboxanes by other enzymes. In the medical field, COX inhibitors are commonly used as anti-inflammatory and analgesic drugs. Nonsteroidal anti-inflammatory drugs (NSAIDs) such as aspirin, ibuprofen, and naproxen are examples of COX inhibitors that are widely used to treat pain, inflammation, and fever. However, long-term use of NSAIDs can have adverse effects on the gastrointestinal tract and cardiovascular system, which has led to the development of newer COX-2 selective inhibitors, such as celecoxib and rofecoxib, that are thought to have fewer gastrointestinal side effects.

Thromboplastin is a protein complex that plays a crucial role in the blood clotting process, also known as coagulation. It is produced by the liver and stored in the blood as an inactive form called prothrombin. When the body experiences an injury or damage to a blood vessel, thromboplastin is activated, which triggers a series of chemical reactions that ultimately lead to the formation of a blood clot. This clot helps to stop bleeding and prevent further damage to the blood vessel. Thromboplastin is also used in medical tests to assess the function of the blood clotting system. Abnormal levels of thromboplastin can indicate a variety of medical conditions, including liver disease, vitamin K deficiency, and certain blood disorders.

Chromatography, Gel is a technique used in the medical field to separate and analyze different components of a mixture. It involves passing a sample through a gel matrix, which allows different components to move through the gel at different rates based on their size, charge, or other properties. This separation is then detected and analyzed using various techniques, such as UV absorbance or fluorescence. Gel chromatography is commonly used in the purification of proteins, nucleic acids, and other biomolecules, as well as in the analysis of complex mixtures in environmental and forensic science.

In the medical field, "Antigens, CD" refers to a group of proteins found on the surface of certain cells in the immune system. These proteins, known as CD antigens, are recognized by other immune cells and play a crucial role in the immune response to infections and diseases. CD antigens are classified into different families based on their structure and function. Some CD antigens are expressed on the surface of immune cells themselves, while others are found on the surface of cells that are targeted by the immune system, such as cancer cells or cells infected with viruses. The identification and characterization of CD antigens has been important for the development of new diagnostic tests and therapies for a variety of diseases, including cancer, autoimmune disorders, and infectious diseases. For example, monoclonal antibodies that target specific CD antigens have been used in cancer immunotherapy to help the immune system recognize and attack cancer cells.

Blood preservation refers to the process of maintaining the quality and viability of blood or blood components for extended periods of time. This is typically done to ensure that blood products are available for transfusion when needed, and to prevent wastage of blood that has been collected. There are several methods used for blood preservation, including refrigeration, freezing, and chemical preservation. Refrigeration is the most common method used for short-term storage of blood, typically for up to 21 days. Freezing is used for longer-term storage of blood, typically for up to 10 years. Chemical preservation involves the use of preservatives to prevent the growth of bacteria and other microorganisms in the blood. Blood preservation is an important aspect of blood banking and transfusion medicine, as it allows for the efficient and safe distribution of blood products to patients in need. However, it is important to note that blood preservation can affect the quality and functionality of the blood, and careful handling and storage are necessary to ensure that blood products remain safe and effective for transfusion.

High-pressure liquid chromatography (HPLC) is a technique used in the medical field to separate and analyze complex mixtures of compounds. It involves the use of a liquid mobile phase that is forced through a column packed with a stationary phase under high pressure. The compounds in the mixture interact with the stationary phase to different extents, causing them to separate as they pass through the column. The separated compounds are then detected and quantified using a detector, such as a UV detector or a mass spectrometer. HPLC is commonly used in the analysis of drugs, biological samples, and other complex mixtures in the medical field.

Thiazoles are a class of heterocyclic compounds that contain a five-membered ring with one nitrogen atom and two sulfur atoms. They are commonly used in the medical field as pharmaceuticals, particularly as diuretics, antihistamines, and anti-inflammatory agents. Some examples of thiazole-based drugs include hydrochlorothiazide (a diuretic), loratadine (an antihistamine), and celecoxib (a nonsteroidal anti-inflammatory drug). Thiazoles are also used as intermediates in the synthesis of other drugs and as corrosion inhibitors in various industrial applications.

Beta-globulins are a group of proteins that are found in the blood plasma. They are also known as albumins and are one of the major components of blood plasma. Beta-globulins are synthesized in the liver and play a number of important roles in the body, including transporting hormones, fatty acids, and other molecules throughout the bloodstream, as well as helping to maintain the osmotic pressure of the blood and protecting against infection. There are several different types of beta-globulins, including albumin, alpha-1 globulin, alpha-2 globulin, and gamma globulin. Abnormal levels of beta-globulins can be an indication of certain medical conditions, such as liver disease, kidney disease, or certain types of cancer.

Azepines are a class of organic compounds that contain a seven-membered ring with four nitrogen atoms and three carbon atoms. They are often used as a building block for the synthesis of other drugs and are also used as anticonvulsants, anxiolytics, and sedatives in the medical field. Some common examples of azepines include triazolam (a benzodiazepine used to treat anxiety and insomnia), alprazolam (another benzodiazepine used to treat anxiety and panic disorder), and meprobamate (an antianxiety medication).

In the medical field, "Crotalus" refers to a genus of venomous snakes that are commonly known as rattlesnakes. There are several species of rattlesnakes, including the eastern diamondback rattlesnake, the western diamondback rattlesnake, and the Mojave rattlesnake, among others. These snakes are found in various parts of the world, including North and South America, and are known for their distinctive rattle at the end of their tails. Rattlesnakes are venomous and can cause serious harm or death if their venom is injected into a person or animal. Treatment for rattlesnake bites typically involves antivenom, which is designed to neutralize the venom and prevent its harmful effects.

Chlorpromazine is a medication that belongs to a class of drugs called antipsychotics. It is primarily used to treat schizophrenia, but it can also be used to treat other mental health conditions such as bipolar disorder, anxiety disorders, and Huntington's disease. Chlorpromazine works by blocking the action of dopamine in the brain, which helps to reduce symptoms of psychosis such as hallucinations and delusions. It is usually taken orally in tablet form, but it can also be given intravenously or intramuscularly in certain situations. Chlorpromazine can cause side effects such as drowsiness, dizziness, dry mouth, blurred vision, and constipation. It can also cause more serious side effects such as tardive dyskinesia, a movement disorder that causes involuntary movements of the face, tongue, and limbs.

Phospholipase C gamma (PLCγ) is an enzyme that plays a crucial role in signal transduction pathways in cells. It is a member of the phospholipase C family of enzymes, which hydrolyze phosphatidylinositol 4,5-bisphosphate (PIP2) to produce inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). In the medical field, PLCγ is involved in various cellular processes, including cell proliferation, differentiation, migration, and survival. It is also implicated in the regulation of immune responses, as well as in the development and progression of various diseases, including cancer, cardiovascular disease, and neurological disorders. PLCγ is activated by a variety of extracellular signals, including growth factors, cytokines, and hormones, through the binding of their receptors to specific intracellular signaling molecules. Once activated, PLCγ cleaves PIP2, leading to the production of IP3 and DAG, which in turn activate downstream signaling pathways that regulate cellular responses. In summary, PLCγ is a key enzyme in cellular signaling pathways that plays a critical role in various physiological and pathological processes.

Nitroglycerin is a powerful vasodilator medication that is used to treat angina pectoris (chest pain caused by reduced blood flow to the heart muscle) and to prevent heart attacks. It works by relaxing the smooth muscles in the blood vessels, particularly those that supply blood to the heart, which increases blood flow and reduces the workload on the heart. Nitroglycerin is usually administered as a sublingual tablet or spray, which is placed under the tongue or sprayed into the mouth. It is absorbed quickly into the bloodstream and begins to work within a few minutes. The effects of nitroglycerin are short-lived, lasting only a few minutes to an hour, and the medication must be taken as needed to relieve symptoms. While nitroglycerin is a highly effective medication for treating angina, it can cause side effects such as headache, dizziness, and low blood pressure. It is also contraindicated in patients with certain medical conditions, such as uncontrolled high blood pressure or severe heart failure.

Isosorbide is a type of organic compound that is used in the medical field as a medication. It is a type of sugar alcohol that is similar in structure to sorbitol, but with a different chemical formula. Isosorbide is used to treat a variety of medical conditions, including chest pain (angina), high blood pressure, and heart failure. It works by relaxing the blood vessels and improving blood flow to the heart. Isosorbide is available in both oral and intravenous forms, and is typically prescribed by a healthcare provider.

Dideoxyadenosine (ddA) is a nucleoside analog that is used in the treatment of certain viral infections, particularly HIV and hepatitis B. It works by inhibiting the activity of the viral reverse transcriptase enzyme, which is essential for the replication of these viruses. ddA is typically administered as a part of combination therapy with other antiretroviral drugs. It is also being studied for its potential use in the treatment of other viral infections and cancer.

Prothrombin is a protein that plays a crucial role in the blood clotting process. It is produced in the liver and is converted into thrombin by the enzyme thrombinase, which is activated by the tissue factor (TF) protein. Thrombin then catalyzes the conversion of fibrinogen, a soluble plasma protein, into insoluble fibrin strands, which form the basis of a blood clot. Prothrombin is also known as factor II, and it is one of the factors in the coagulation cascade, a series of reactions that ultimately leads to the formation of a blood clot. Deficiencies or mutations in the prothrombin gene can lead to bleeding disorders such as hemophilia A or B. On the other hand, excessive production of prothrombin can increase the risk of blood clots, which can lead to serious health problems such as stroke or heart attack.

In the medical field, a cell line refers to a group of cells that have been derived from a single parent cell and have the ability to divide and grow indefinitely in culture. These cells are typically grown in a laboratory setting and are used for research purposes, such as studying the effects of drugs or investigating the underlying mechanisms of diseases. Cell lines are often derived from cancerous cells, as these cells tend to divide and grow more rapidly than normal cells. However, they can also be derived from normal cells, such as fibroblasts or epithelial cells. Cell lines are characterized by their unique genetic makeup, which can be used to identify them and compare them to other cell lines. Because cell lines can be grown in large quantities and are relatively easy to maintain, they are a valuable tool in medical research. They allow researchers to study the effects of drugs and other treatments on specific cell types, and to investigate the underlying mechanisms of diseases at the cellular level.

Receptors, Thrombopoietin (TPO) are proteins found on the surface of certain cells in the bone marrow that are responsible for the production of platelets, also known as thrombocytes. Thrombopoietin is a hormone that stimulates the production and maturation of platelets in the bone marrow. The TPO receptors on the surface of the cells in the bone marrow bind to TPO, which triggers a signaling cascade that leads to the production and release of platelets into the bloodstream. TPO receptors are also found on other cells, such as endothelial cells and megakaryocytes, which are involved in the production of platelets. Abnormalities in TPO receptors or the production of TPO can lead to disorders of platelet production, such as thrombocytopenia or thrombocytosis.

Fibrinolysin is a type of enzyme that breaks down fibrin, a protein that forms blood clots. It is produced by various types of white blood cells, including neutrophils and macrophages, and is also found in some bacteria and fungi. In the medical field, fibrinolysin is used to treat a variety of conditions that involve abnormal blood clotting, such as deep vein thrombosis, pulmonary embolism, and stroke. It works by breaking down the fibrin in the blood clot, allowing the clot to be dissolved and removed from the body. Fibrinolysin is available as a medication, usually in the form of a solution that is injected into a vein. It is typically used in combination with other medications, such as anticoagulants, to prevent the formation of new blood clots. However, fibrinolysin can also have side effects, including bleeding, allergic reactions, and damage to surrounding tissues. Therefore, it is typically used only in cases where the benefits of treatment outweigh the risks.

Cyclooxygenase 1 (COX-1) is an enzyme that plays a crucial role in the production of prostaglandins, which are hormone-like substances that regulate various physiological processes in the body, including inflammation, pain, and blood clotting. COX-1 is found in most tissues throughout the body, including the stomach, blood vessels, and kidneys. In the medical field, COX-1 is often targeted for the treatment of various conditions, including pain, inflammation, and gastrointestinal disorders. Nonsteroidal anti-inflammatory drugs (NSAIDs) such as aspirin and ibuprofen are commonly used to inhibit COX-1 activity, which can help reduce pain and inflammation. However, long-term use of high doses of NSAIDs can also lead to side effects such as stomach ulcers and increased risk of cardiovascular events. COX-1 is also involved in the production of thromboxanes, which are potent vasoconstrictors that can contribute to the formation of blood clots. As a result, COX-1 inhibitors have been developed for the treatment of conditions such as hypertension and cardiovascular disease. However, these drugs can also increase the risk of bleeding, particularly in patients taking anticoagulant medications.

Blotting, Western is a laboratory technique used to detect specific proteins in a sample by transferring proteins from a gel to a membrane and then incubating the membrane with a specific antibody that binds to the protein of interest. The antibody is then detected using an enzyme or fluorescent label, which produces a visible signal that can be quantified. This technique is commonly used in molecular biology and biochemistry to study protein expression, localization, and function. It is also used in medical research to diagnose diseases and monitor treatment responses.

Yohimbine is a chemical compound that is derived from the bark of the yohimbe tree (Pausinystalia johimbe). It has been used in traditional medicine for centuries to treat various conditions, including erectile dysfunction, depression, and weight loss. In the medical field, yohimbine is primarily used as a medication to treat erectile dysfunction. It works by blocking the action of an enzyme called alpha-2 adrenergic receptors, which can cause blood vessels to constrict and reduce blood flow to the penis. By blocking these receptors, yohimbine can help to increase blood flow to the penis and improve erectile function. Yohimbine is available as a prescription medication and is typically taken orally. It can cause side effects, including headache, nausea, dizziness, and increased heart rate. It is important to note that yohimbine can interact with other medications, including antidepressants and blood pressure medications, so it should only be taken under the supervision of a healthcare provider.

In the medical field, nitroso compounds are a class of chemical compounds that contain a nitroso group (-NO) attached to a carbon atom. These compounds are commonly found in the environment and in certain foods, such as bacon and processed meats. There are two main types of nitroso compounds: primary nitroso compounds and secondary nitroso compounds. Primary nitroso compounds are formed when a nitrite ion (NO2-) reacts with an amine (NH2-) to form a nitrosamine. Secondary nitroso compounds are formed when a nitrite ion reacts with an aldehyde or ketone to form a nitrosylamine. Nitroso compounds can be toxic to humans and have been linked to various health problems, including cancer. Some nitroso compounds can also react with certain enzymes in the body to form reactive nitrogen species, which can damage cells and DNA. As a result, the consumption of nitroso compounds in certain foods has been linked to an increased risk of certain types of cancer, such as stomach cancer.

Antithrombin III (AT-III) is a protein that plays a crucial role in the regulation of blood clotting. It is produced in the liver and circulates in the bloodstream, where it acts as an inhibitor of several clotting factors, including thrombin, factor Xa, and factor IXa. AT-III binds to these clotting factors and prevents them from catalyzing the conversion of fibrinogen to fibrin, which is a key step in the formation of blood clots. By inhibiting these clotting factors, AT-III helps to maintain a balance between clotting and bleeding in the body. AT-III deficiency, also known as antithrombin deficiency, is a rare genetic disorder that can increase the risk of blood clots and thrombosis. In this condition, the body produces less AT-III than normal, which can lead to an imbalance between clotting and bleeding and increase the risk of blood clots forming in the veins or arteries. Treatment for AT-III deficiency typically involves replacement therapy with AT-III concentrate or other clotting inhibitors.

Calpain is a family of calcium-dependent proteases that play a crucial role in various cellular processes, including cell signaling, protein turnover, and cell death. In the medical field, calpain is often studied in relation to various diseases and conditions, including neurodegenerative disorders, cardiovascular disease, and cancer. Calpain enzymes are activated by the binding of calcium ions, which triggers a conformational change in the enzyme that allows it to cleave specific peptide bonds in target proteins. This cleavage can lead to the activation or inactivation of signaling pathways, changes in protein function, and ultimately, cell death. In the context of neurodegenerative disorders, calpain has been implicated in the degradation of proteins that are important for maintaining the structure and function of neurons. In cardiovascular disease, calpain has been shown to contribute to the development of heart failure by promoting the degradation of contractile proteins in cardiac muscle cells. In cancer, calpain has been shown to play a role in the regulation of cell proliferation and survival. Overall, calpain is a complex and multifaceted enzyme that plays a critical role in many cellular processes, and its dysregulation has been implicated in a wide range of diseases and conditions.

Phosphoproteins are proteins that have been modified by the addition of a phosphate group to one or more of their amino acid residues. This modification is known as phosphorylation, and it is a common post-translational modification that plays a critical role in regulating many cellular processes, including signal transduction, metabolism, and gene expression. Phosphoproteins are involved in a wide range of biological functions, including cell growth and division, cell migration and differentiation, and the regulation of gene expression. They are also involved in many diseases, including cancer, diabetes, and cardiovascular disease. Phosphoproteins can be detected and studied using a variety of techniques, including mass spectrometry, Western blotting, and immunoprecipitation. These techniques allow researchers to identify and quantify the phosphorylation status of specific proteins in cells and tissues, and to study the effects of changes in phosphorylation on protein function and cellular processes.

Cricetinae is a subfamily of rodents that includes hamsters, voles, and lemmings. These animals are typically small to medium-sized and have a broad, flat head and a short, thick body. They are found in a variety of habitats around the world, including grasslands, forests, and deserts. In the medical field, Cricetinae are often used as laboratory animals for research purposes, as they are easy to care for and breed, and have a relatively short lifespan. They are also used in studies of genetics, physiology, and behavior.

Cathepsin G is a protease enzyme that is produced by various immune cells, including neutrophils and macrophages. It is a member of the cysteine protease family and plays a role in the degradation of extracellular matrix proteins, as well as the activation of other immune cells. In the context of the immune response, cathepsin G is involved in the destruction of invading pathogens, such as bacteria and viruses. It is also involved in the process of inflammation, where it helps to break down tissue barriers and facilitate the migration of immune cells to the site of infection or injury. Cathepsin G has been implicated in a number of diseases, including inflammatory bowel disease, rheumatoid arthritis, and certain types of cancer. It is also being studied as a potential therapeutic target for the treatment of these conditions.

Phospholipases A are a group of enzymes that hydrolyze the sn-2 ester bond of phospholipids, releasing fatty acids and lysophospholipids. There are several types of phospholipases A, including phospholipase A1, phospholipase A2, and phospholipase A3, each with different substrate specificities and functions. In the medical field, phospholipases A play important roles in various physiological and pathological processes. For example, they are involved in the metabolism of cellular membranes, the regulation of inflammation, and the activation of signaling pathways. Phospholipases A are also involved in the pathogenesis of various diseases, including cardiovascular disease, cancer, and neurodegenerative disorders. Pharmacological agents that target phospholipases A have been developed for the treatment of various diseases, including cancer, inflammation, and cardiovascular disease. For example, some phospholipase A inhibitors have been shown to have anti-inflammatory and anti-cancer effects, while some phospholipase A activators have been shown to have beneficial effects in cardiovascular disease.

CD36 is a protein that is expressed on the surface of many different types of cells in the body, including macrophages, monocytes, and endothelial cells. It is a member of the class B scavenger receptor family and is involved in the uptake and metabolism of a variety of molecules, including fatty acids, heme, and oxidized low-density lipoprotein (LDL). In the context of the immune system, CD36 is an antigen-presenting molecule that plays a role in the presentation of antigens to T cells. It is also involved in the regulation of immune responses, particularly those involving T cells and monocytes. CD36 has been implicated in a number of different diseases, including atherosclerosis, diabetes, and inflammatory disorders.

Coronary disease, also known as coronary artery disease (CAD), is a condition in which the blood vessels that supply blood to the heart muscle become narrowed or blocked due to the buildup of plaque. This can lead to reduced blood flow to the heart, which can cause chest pain (angina), shortness of breath, and other symptoms. In severe cases, coronary disease can lead to a heart attack, which occurs when the blood flow to a part of the heart is completely blocked, causing damage to the heart muscle. Coronary disease is a common condition that affects many people, particularly those who are middle-aged or older, and is often associated with other risk factors such as high blood pressure, high cholesterol, smoking, and diabetes. Treatment for coronary disease may include lifestyle changes, medications, and in some cases, procedures such as angioplasty or coronary artery bypass surgery.

Ketanserin is a medication that belongs to a class of drugs called serotonin receptor antagonists. It is primarily used to treat high blood pressure and Raynaud's phenomenon, a condition characterized by cold, white fingers and toes. Ketanserin works by blocking the action of serotonin, a neurotransmitter that plays a role in regulating blood pressure and blood vessel constriction. It is available in both oral and intravenous forms.

Proteins are complex biomolecules made up of amino acids that play a crucial role in many biological processes in the human body. In the medical field, proteins are studied extensively as they are involved in a wide range of functions, including: 1. Enzymes: Proteins that catalyze chemical reactions in the body, such as digestion, metabolism, and energy production. 2. Hormones: Proteins that regulate various bodily functions, such as growth, development, and reproduction. 3. Antibodies: Proteins that help the immune system recognize and neutralize foreign substances, such as viruses and bacteria. 4. Transport proteins: Proteins that facilitate the movement of molecules across cell membranes, such as oxygen and nutrients. 5. Structural proteins: Proteins that provide support and shape to cells and tissues, such as collagen and elastin. Protein abnormalities can lead to various medical conditions, such as genetic disorders, autoimmune diseases, and cancer. Therefore, understanding the structure and function of proteins is essential for developing effective treatments and therapies for these conditions.

Phospholipases A2 (PLA2s) are a family of enzymes that hydrolyze the sn-2 ester bond of phospholipids, releasing fatty acids and lysophospholipids. There are several types of PLA2s, including secreted PLA2s (sPLA2s), cytosolic PLA2s (cPLA2s), and calcium-independent PLA2s (iPLA2s), each with distinct properties and functions. In the medical field, PLA2s have been implicated in various diseases and conditions, including inflammation, cancer, and neurodegenerative disorders. For example, sPLA2s are involved in the production of arachidonic acid, a precursor of pro-inflammatory eicosanoids, and have been shown to play a role in the pathogenesis of inflammatory diseases such as rheumatoid arthritis and asthma. cPLA2s are involved in the regulation of cell signaling and have been implicated in the development of cancer. iPLA2s have been shown to play a role in the regulation of membrane fluidity and have been implicated in the pathogenesis of neurodegenerative disorders such as Alzheimer's disease. Overall, PLA2s are important enzymes that play a role in various physiological and pathological processes, and their study has led to the development of potential therapeutic targets for a range of diseases.

Cytochalasin D is a fungal metabolite that is used in the medical field as a research tool to study cell biology and cell motility. It is a potent inhibitor of actin polymerization, which is a key process in cell movement and shape change. Cytochalasin D is often used to study the dynamics of actin filaments and their role in cell migration, endocytosis, and cytokinesis. It is also used to study the effects of actin polymerization on the structure and function of other cellular components, such as microtubules and intermediate filaments. In addition, Cytochalasin D has been used in the treatment of certain types of cancer, as it can inhibit the growth and spread of cancer cells by disrupting their actin cytoskeleton.

"Fibrinogens, Abnormal" refers to a group of medical conditions characterized by the presence of abnormal fibrinogens in the blood. Fibrinogens are proteins that play a crucial role in the blood clotting process. Abnormal fibrinogens can lead to bleeding disorders or an increased risk of blood clots, depending on the specific type of abnormality. There are several types of abnormal fibrinogens, including: 1. Fibrinogen deficiency: This is a rare condition in which the body produces too little fibrinogen, leading to an increased risk of bleeding. 2. Fibrinogen abnormality: This is a broad term that encompasses a variety of conditions in which the structure or function of fibrinogen is abnormal, leading to an increased risk of blood clots. 3. Fibrinogen excess: This is a condition in which the body produces too much fibrinogen, leading to an increased risk of blood clots. Abnormal fibrinogens can be caused by genetic mutations, certain medical conditions, or the use of certain medications. Diagnosis typically involves blood tests to measure fibrinogen levels and to assess the structure and function of the protein. Treatment depends on the specific type and severity of the abnormality and may include medications to manage bleeding or prevent blood clots, as well as lifestyle changes and other therapies.

CHO cells are a type of Chinese hamster ovary (CHO) cell line that is commonly used in the biotechnology industry for the production of recombinant proteins. These cells are derived from the ovaries of Chinese hamsters and have been genetically modified to produce large amounts of a specific protein or protein complex. CHO cells are often used as a host cell for the production of therapeutic proteins, such as monoclonal antibodies, growth factors, and enzymes. They are also used in research to study the structure and function of proteins, as well as to test the safety and efficacy of new drugs. One of the advantages of using CHO cells is that they are relatively easy to culture and can be grown in large quantities. They are also able to produce high levels of recombinant proteins, making them a popular choice for the production of biopharmaceuticals. However, like all cell lines, CHO cells can also have limitations and may not be suitable for all types of protein production.

Receptors, Epoprostenol are a type of cell surface receptors that are activated by the prostacyclin hormone, also known as prostaglandin I2 (PGI2). These receptors are found in various tissues throughout the body, including the cardiovascular system, respiratory system, and central nervous system. Epoprostenol receptors, also known as prostacyclin receptors, are classified into two types: IP receptors and EP receptors. The IP receptors are responsible for the vasodilatory and antiplatelet effects of PGI2, while the EP receptors are involved in a variety of physiological processes, including bronchodilation, vasodilation, and inhibition of platelet aggregation. In the medical field, the activation of Epoprostenol receptors is often used as a therapeutic strategy to treat a variety of conditions, including pulmonary hypertension, heart failure, and ischemic stroke. Drugs that mimic the effects of PGI2, such as iloprost and treprostinil, are used to activate these receptors and improve blood flow and oxygenation in the affected tissues.

Antithrombins are a group of proteins that play a crucial role in preventing blood clotting (coagulation). They are naturally occurring substances in the blood that help to regulate the coagulation cascade, which is a series of chemical reactions that ultimately leads to the formation of a blood clot. There are several types of antithrombins, including antithrombin III (AT-III), antithrombin IV (AT-IV), and antithrombin V (AT-V). Antithrombin III is the most abundant and important of these, and it is produced in the liver. Antithrombins work by inhibiting the activity of enzymes that are involved in the coagulation cascade, such as thrombin and factor Xa. By inhibiting these enzymes, antithrombins help to prevent the formation of blood clots, which can be dangerous if they occur in the wrong place in the body, such as in the veins or arteries. Antithrombins are often used as a treatment for conditions that involve excessive blood clotting, such as deep vein thrombosis (DVT), pulmonary embolism (PE), and stroke. They may also be used to prevent blood clots in people who are at high risk, such as those who have had a previous blood clot or who are undergoing surgery.

Cytosol is the fluid inside the cytoplasm of a cell, which is the gel-like substance that fills the cell membrane. It is also known as the cytoplasmic matrix or cytosolic matrix. The cytosol is a complex mixture of water, ions, organic molecules, and various enzymes and other proteins that play important roles in cellular metabolism, signaling, and transport. It is the site of many cellular processes, including protein synthesis, energy production, and waste removal. The cytosol is also the site of many cellular organelles, such as the mitochondria, ribosomes, and endoplasmic reticulum, which are responsible for carrying out specific cellular functions.

Disseminated Intravascular Coagulation (DIC) is a complex and potentially life-threatening disorder characterized by widespread activation of the coagulation system in the blood vessels. This leads to the formation of blood clots throughout the body, which can obstruct blood flow and cause tissue damage. DIC can occur as a complication of various medical conditions, including infections, cancer, and obstetric complications, and can also be triggered by certain medications or toxins. The hallmark of DIC is an imbalance between clotting and fibrinolysis, leading to an accumulation of fibrin clots in the blood vessels and a deficiency of clotting factors. This can result in a range of symptoms, including bleeding, bruising, and organ dysfunction. Treatment of DIC typically involves supportive care, such as fluid replacement and blood transfusions, as well as measures to manage the underlying cause of the disorder.

Amyloid beta (Aβ) peptides are a group of proteins that are produced as a normal byproduct of metabolism in the brain. They are formed from the cleavage of a larger protein called amyloid precursor protein (APP) by enzymes called beta-secretase and gamma-secretase. In healthy individuals, Aβ peptides are cleared from the brain by a process called phagocytosis, in which immune cells called microglia engulf and degrade the peptides. However, in individuals with Alzheimer's disease (AD), the clearance of Aβ peptides is impaired, leading to the accumulation of these peptides in the brain. The accumulation of Aβ peptides in the brain is thought to play a key role in the development of AD. The peptides can form insoluble aggregates called amyloid plaques, which are a hallmark of AD. These plaques can disrupt the normal functioning of neurons and contribute to the cognitive decline associated with the disease. In addition to their role in AD, Aβ peptides have also been implicated in other neurological disorders, such as Parkinson's disease and frontotemporal dementia.

Immunoglobulin G (IgG) is a type of protein that is produced by the immune system in response to the presence of foreign substances, such as bacteria, viruses, and toxins. It is the most abundant type of immunoglobulin in the blood and is responsible for the majority of the body's defense against infections. IgG is produced by B cells, which are a type of white blood cell that plays a key role in the immune response. When a B cell encounters a foreign substance, it produces IgG antibodies that can recognize and bind to the substance, marking it for destruction by other immune cells. IgG antibodies can also be transferred from mother to child through the placenta during pregnancy, providing the baby with some protection against infections during the first few months of life. In addition, some vaccines contain IgG antibodies to help stimulate the immune system and provide protection against specific diseases. Overall, IgG is an important component of the immune system and plays a critical role in protecting the body against infections and diseases.

Lathyrism is a condition caused by the consumption of certain legumes, particularly the seeds of the grass pea (Lathyrus sativus), which contain a toxic amino acid called beta-oxalyl-L-arginine (BOAA). BOAA is converted to another toxic compound called beta-aminopropionitrile (BAPN) in the body, which can damage the nervous system and cause a range of symptoms. The symptoms of lathyrism can vary depending on the severity and duration of exposure to BOAA. In acute cases, symptoms may include muscle weakness, numbness, tingling, and difficulty walking. In chronic cases, symptoms may include progressive paralysis, muscle wasting, and cognitive impairment. Lathyrism is most commonly found in regions where the grass pea is a staple food, such as parts of India, Africa, and South America. Prevention of lathyrism involves avoiding the consumption of contaminated legumes and providing alternative sources of protein in the diet. Treatment for lathyrism is supportive and may include physical therapy, pain management, and nutritional support.

Cross-over studies are a type of clinical trial design in which a single subject serves as their own control. In other words, the subject is exposed to two or more treatments or interventions, and the effects of each treatment are compared within the same individual. The main advantage of cross-over studies is that they can reduce the number of subjects needed to obtain reliable results, as each subject serves as their own control. This can be particularly useful in situations where it is difficult or unethical to recruit a large number of subjects, or where the study requires a long duration of treatment. However, cross-over studies can also have limitations, such as carryover effects, where the effects of one treatment may persist after the subject has been switched to a different treatment. Additionally, the order in which treatments are administered can affect the results, and statistical methods must be used to account for this. Cross-over studies are commonly used in the medical field to evaluate the effectiveness and safety of new drugs, medical devices, and other interventions. They can also be used to compare different dosages or formulations of a treatment, or to evaluate the effectiveness of a treatment in different patient populations.

Protein-tyrosine kinases (PTKs) are a family of enzymes that play a crucial role in various cellular processes, including cell growth, differentiation, metabolism, and signal transduction. These enzymes catalyze the transfer of a phosphate group from ATP to the hydroxyl group of tyrosine residues on specific target proteins, thereby modifying their activity, localization, or interactions with other molecules. PTKs are involved in many diseases, including cancer, cardiovascular disease, and neurological disorders. They are also targets for many drugs, including those used to treat cancer and other diseases. In the medical field, PTKs are studied to understand their role in disease pathogenesis and to develop new therapeutic strategies.

Piperazines are a class of organic compounds that contain a six-membered ring with two nitrogen atoms. They are commonly used in the medical field as drugs and are known for their anticholinergic, antispasmodic, and sedative properties. Some examples of piperazine-based drugs include antihistamines, antipsychotics, and antidiarrheals. Piperazines can also be used as intermediates in the synthesis of other drugs.

Biphenyl compounds are a class of organic compounds that consist of two benzene rings joined together by a single carbon-carbon bond. They are commonly used as industrial solvents, plasticizers, and flame retardants. In the medical field, biphenyl compounds have been studied for their potential therapeutic effects, including anti-inflammatory, anti-cancer, and anti-viral properties. Some biphenyl compounds have also been used as diagnostic agents in medical imaging. However, some biphenyl compounds have been associated with adverse health effects, including endocrine disruption, neurotoxicity, and carcinogenicity, and their use is regulated in many countries.

In the medical field, cell size refers to the dimensions of a cell, which is the basic unit of life. The size of a cell can vary widely depending on the type of cell and its function. For example, red blood cells, which are responsible for carrying oxygen throughout the body, are much smaller than white blood cells, which are involved in the immune response. Similarly, nerve cells, which transmit signals throughout the body, are much longer than most other types of cells. The size of a cell can also be influenced by various factors such as the availability of nutrients, hormones, and other signaling molecules. Changes in cell size can be an indicator of various medical conditions, such as cancer or certain genetic disorders. Therefore, measuring cell size can be an important diagnostic tool in the medical field.

Molecular chaperones are a class of proteins that assist in the folding, assembly, and transport of other proteins within cells. They play a crucial role in maintaining cellular homeostasis and preventing the accumulation of misfolded or aggregated proteins, which can lead to various diseases such as neurodegenerative disorders, cancer, and certain types of infections. Molecular chaperones function by binding to nascent or partially folded proteins, preventing them from aggregating and promoting their proper folding. They also assist in the assembly of multi-subunit proteins, such as enzymes and ion channels, by ensuring that the individual subunits are correctly folded and assembled into a functional complex. There are several types of molecular chaperones, including heat shock proteins (HSPs), chaperonins, and small heat shock proteins (sHSPs). HSPs are induced in response to cellular stress, such as heat shock or oxidative stress, and are involved in the refolding of misfolded proteins. Chaperonins, on the other hand, are found in the cytosol and the endoplasmic reticulum and are involved in the folding of large, complex proteins. sHSPs are found in the cytosol and are involved in the stabilization of unfolded proteins and preventing their aggregation. Overall, molecular chaperones play a critical role in maintaining protein homeostasis within cells and are an important target for the development of new therapeutic strategies for various diseases.

In the medical field, a suspension is a type of medication that is administered as a liquid or powder that is suspended in a liquid. Suspensions are typically used when a medication needs to be given in a form that is not available as a tablet, capsule, or other solid form. Suspensions can be made from a variety of ingredients, including active pharmaceutical ingredients (APIs), excipients, and stabilizers. APIs are the active ingredients that provide the therapeutic effect of the medication, while excipients are substances that help to improve the stability, texture, or taste of the suspension. Stabilizers are added to prevent the API from settling out of the suspension and to ensure that the suspension remains homogeneous. Suspensions are commonly used to deliver medications to children, as well as to patients who have difficulty swallowing solid forms of medication. They can also be used to deliver medications that are not available in solid form, such as certain vaccines or antiviral medications. It is important to note that suspensions can be more prone to contamination and degradation than solid forms of medication, so they must be stored and handled properly to maintain their effectiveness and safety.

Circular Dichroism (CD) is a spectroscopic technique used to study the three-dimensional structure of biomolecules such as proteins, nucleic acids, and lipids. In the medical field, CD is used to study the structure and function of biomolecules involved in various diseases, such as cancer, neurodegenerative disorders, and infectious diseases. CD measures the difference in the absorption of left- and right-handed circularly polarized light by a sample. This difference is related to the molecular structure of the sample, particularly the secondary and tertiary structure of proteins and nucleic acids. By analyzing the CD spectrum of a biomolecule, researchers can gain insights into its structure, stability, and dynamics, which can help to understand its biological function and potential therapeutic targets. CD is a non-destructive technique that can be used in solution or in the solid state, and it can be applied to a wide range of biomolecules, including small molecules, peptides, and large proteins. In the medical field, CD is used in drug discovery and development, as well as in the study of protein-protein interactions, enzyme kinetics, and the mechanism of action of therapeutic agents.

Thienopyridines are a class of drugs that are used to prevent blood clots in patients with cardiovascular diseases. They work by inhibiting the enzyme called platelet cyclooxygenase-1 (COX-1), which is involved in the formation of blood clots. Thienopyridines are commonly used in the treatment of conditions such as coronary artery disease, peripheral artery disease, and stroke. The most commonly used thienopyridines are aspirin, clopidogrel, and ticlopidine. These drugs are usually taken in combination with other medications to reduce the risk of blood clots and prevent further cardiovascular events.

CD31 is a protein that is expressed on the surface of certain cells in the immune system, including platelets and certain types of white blood cells. It is also known as platelet endothelial cell adhesion molecule-1 (PECAM-1) or cluster of differentiation 31 (CD31). In the medical field, CD31 is often used as a marker to identify and study certain types of cells, particularly those involved in the immune response. It is also used as a diagnostic tool to help diagnose and monitor certain medical conditions, such as cancer and cardiovascular disease. CD31 is also used in research to study the function of immune cells and to develop new treatments for various diseases. For example, it has been shown to play a role in the formation of new blood vessels, which is important for wound healing and tissue repair. It is also involved in the regulation of the immune response and the development of certain types of cancer.

Thrombotic Thrombocytopenic Purpura (TTP) is a rare and life-threatening blood disorder characterized by the formation of blood clots in small blood vessels throughout the body, leading to widespread damage to organs and tissues. The condition is also associated with a low platelet count, which can lead to easy bruising and bleeding. TTP is caused by a deficiency in an enzyme called ADAMTS13, which is responsible for breaking down von Willebrand factor (vWF), a protein that helps platelets stick together and form blood clots. Without sufficient ADAMTS13 activity, vWF can accumulate and form large clots that block small blood vessels, leading to tissue damage and organ failure. Symptoms of TTP can include fever, abdominal pain, headache, confusion, seizures, and vision problems. Treatment typically involves plasma exchange, which involves removing and replacing abnormal blood plasma with healthy plasma, as well as medications to prevent blood clots and manage symptoms. Early diagnosis and treatment are critical for improving outcomes in patients with TTP.

Indium is a chemical element with the symbol In and atomic number 49. It is a soft, silvery-white metal that is not commonly used in the medical field. However, indium compounds have been studied for their potential medical applications. One potential use of indium compounds in medicine is as imaging agents for diagnostic imaging. Indium-111, a radioactive isotope of indium, has been used in nuclear medicine to image tumors, infections, and other abnormalities in the body. It is often used in conjunction with a radiolabeled antibody or other targeting molecule to specifically target and image certain cells or tissues. Indium compounds have also been studied for their potential use in treating cancer. For example, indium-111-labeled monoclonal antibodies have been used in clinical trials to treat certain types of cancer, such as non-Hodgkin's lymphoma and breast cancer. In addition, indium compounds have been studied for their potential use in treating other medical conditions, such as Alzheimer's disease and diabetes. However, more research is needed to fully understand the potential benefits and risks of using indium compounds in medicine.

Eicosapentaenoic acid (EPA) is an omega-3 fatty acid that is found in fish oil and other sources. It is a polyunsaturated fatty acid, which means that it has multiple double bonds in its carbon chain. EPA is a type of long-chain fatty acid that is essential for human health, meaning that it cannot be synthesized by the body and must be obtained through the diet. In the medical field, EPA is often used as a dietary supplement to help reduce inflammation and lower triglyceride levels in the blood. It has also been studied for its potential benefits in treating a variety of conditions, including cardiovascular disease, depression, and certain types of cancer. Some research suggests that EPA may have anti-inflammatory and anti-thrombotic effects, which may help to reduce the risk of heart disease. However, more research is needed to confirm these potential benefits and to determine the optimal dosage and duration of treatment.

Theophylline is a medication that is used to treat a variety of respiratory conditions, including asthma, chronic obstructive pulmonary disease (COPD), and bronchitis. It works by relaxing the muscles in the airways, making it easier to breathe. Theophylline is available in both oral and inhaled forms, and it is usually taken on a regular basis to prevent symptoms from occurring. It is important to note that theophylline can have side effects, including nausea, vomiting, and an irregular heartbeat, and it should only be taken under the supervision of a healthcare provider.

Chymotrypsin is a digestive enzyme that is produced by the pancreas and secreted into the small intestine. It is a protease enzyme that breaks down proteins into smaller peptides and amino acids. Chymotrypsin is particularly effective at breaking down proteins that contain aromatic amino acids such as tryptophan, tyrosine, and phenylalanine. In the medical field, chymotrypsin is used to treat a variety of conditions, including: 1. Pancreatitis: Chymotrypsin is used to help break down the excess enzymes in the pancreas that can cause inflammation and damage to the pancreas. 2. Gallstones: Chymotrypsin is used to dissolve gallstones that are composed of cholesterol. 3. Inflammatory bowel disease: Chymotrypsin is used to help reduce inflammation in the digestive tract. 4. Cancer: Chymotrypsin is being studied as a potential treatment for certain types of cancer, including breast cancer and prostate cancer. Chymotrypsin is usually administered as a medication in the form of a tablet or injection. It is important to note that chymotrypsin can have side effects, including nausea, vomiting, and diarrhea, and should only be used under the guidance of a healthcare professional.

Fibrin Fibrinogen Degradation Products (FDPs) are a group of proteins that are produced when fibrinogen, a protein in the blood, is broken down into smaller pieces. FDPs are typically measured in the blood as a way to assess the extent of blood clotting and fibrinolysis (the breakdown of blood clots). Fibrinogen is a key component of the blood clotting process, and it is converted into fibrin when the body needs to form a clot. Fibrin acts as a scaffold for platelets and other clotting factors to form a stable clot. When a clot is no longer needed, it is broken down by enzymes called fibrinolytic enzymes, which degrade the fibrin into smaller pieces. FDPs are produced when fibrin is broken down by these enzymes. They can be measured in the blood using a laboratory test called the FDP assay. Elevated levels of FDPs in the blood can indicate that there is either excessive fibrinolysis (too much breakdown of blood clots) or inadequate fibrinolysis (not enough breakdown of blood clots). This can be caused by a variety of medical conditions, including disseminated intravascular coagulation (DIC), deep vein thrombosis (DVT), and stroke.

Malondialdehyde (MDA) is a toxic compound that is produced as a byproduct of lipid peroxidation, a process that occurs when lipids (fats) in cells are damaged by free radicals or other reactive molecules. MDA is a highly reactive molecule that can bind to proteins, DNA, and other cellular components, causing damage and potentially leading to cell death. In the medical field, MDA is often used as a biomarker of oxidative stress and inflammation. Oxidative stress occurs when there is an imbalance between the production of reactive oxygen species (ROS) and the body's ability to neutralize them. Inflammation is a normal response to injury or infection, but chronic inflammation can contribute to the development of a wide range of diseases, including cancer, cardiovascular disease, and neurodegenerative disorders. MDA levels can be measured in blood, urine, or other body fluids, and elevated levels of MDA have been associated with a variety of health problems, including aging, diabetes, and certain types of cancer. Therefore, MDA is an important biomarker for monitoring the health status of individuals and for identifying potential risk factors for disease.

In the medical field, "Drugs, Chinese Herbal" refers to a category of medications that are derived from plants, animals, and minerals found in China and other parts of East Asia. These medications are used to treat a wide range of conditions, including digestive disorders, respiratory problems, and pain. Chinese herbal medicine has a long history dating back thousands of years and is based on the principles of traditional Chinese medicine. It involves the use of various herbs, roots, and other natural substances that are combined to create a formula that is tailored to the individual patient's needs. Chinese herbal medicine is often used in conjunction with other forms of treatment, such as acupuncture and massage, to provide a holistic approach to healthcare. However, it is important to note that the use of Chinese herbal medicine can have potential side effects and interactions with other medications, so it is important to consult with a qualified healthcare provider before using these medications.

The ristocetin-induced platelet aggregation (RIPA) is an ex vivo assay for live platelet function. It measures platelet ... it causes agglutination of fixed platelets or initiates the initial agglutination phase of aggregation of live platelets.[ ... Ristocetin cofactor assay uses the patient's platelet poor plasma (with vWF but no platelets) and adds ristocetin and exogenous ... The results of the ristocetin-induced platelet aggregation in some characteristic diseases are the following: Type 1 vWD: ...
"Why Perform Platelet Aggregation?". Helena Biosciences. 2015 William B. Coleman; Gregory J. Tsongalis (2009). Molecular ... Therefore, the following examples include: Platelet alpha-granules Gray platelet syndrome Quebec platelet disorder Dense ... such as platelet alpha-granules[citation needed] one of three types of platelet secretory granule Platelet α-granules are ... The diagnosis of this condition can be done via the following: Flow cytometry Bleeding time analysis Platelet aggregation ...
"Pamicogrel inhibits platelet aggregation". Inpharma Weekly. 1272 (1): 11. January 2001. doi:10.2165/00128413-200112720-00021. ... Pamicogrel is a cyclooxygenase inhibitor that was under development for its anti-platelet-aggregation effects. Light P ( ...
A suspicion of congenital afibrinogenemia may appear on a platelet aggregation function test. The most common treatment is ... "Why Perform Platelet Aggregation?". Helena Biosciences. 2015 "Congenital afibrinogenemia". www.pennmedicine.org. Retrieved 2015 ...
Aggregation of platelets begins minutes after their activation, and occurs as a result of turning on the GPIIb/IIIa receptor, ... Platelets also secrete platelet-derived growth factor (PDGF). Platelets modulate neutrophils by forming platelet-leukocyte ... Platelets secrete thromboxane A2, which acts on the platelet's own thromboxane receptors on the platelet surface (hence the so- ... A disorder of platelet function is called a thrombocytopathy or a platelet function disorder. Normal platelets can respond to ...
Platelet aggregation studies are optional. Serum protein electrophoresis results indicate evidence of a monoclonal spike but ... A low white blood cell count, and low platelet count in the blood may be observed. A low level of neutrophils (a specific type ... According to the model, factors predicting reduced survival are: Age > 65 years Hemoglobin ≤ 11.5 g/dL Platelet count ≤ 100×109 ... However, CXCR4 mutation is not associated with splenomegaly, high platelet counts, or different response to therapy, ...
Platelet aggregation studies were normal.[citation needed] The abnormal platelet reaction following EDTA exposure is thought to ... Pseudo-gray platelet syndrome differs from gray platelet syndrome (GPS), one of the giant platelet syndromes. GPS is ... Platelets from the mother, sisters, and a daughter were normal in number and appearance under the light microscope. Platelets ... "Pseudo grey platelet syndrome--grey platelets due to degranulation in blood collected into EDTA". Eur. J. Haematol. 41 (4): 326 ...
The platelet plug, also known as the hemostatic plug or platelet thrombus, is an aggregation of platelets formed during early ... Platelet aggregation is mainly mediated by β3 (αIIbβ3) integrin and its ligands, such as vWF and fibrinogen. While platelet ... Thrombin also causes platelet aggregation. As such, more often than not, platelet adhesion and activation occur in overlapping ... ADP can then catalyze the aggregation of platelets, allowing for fibrinogen to link two platelets together.[citation needed] As ...
... is a platelet aggregation inhibitor. It acts as a reversible cyclooxygenase inhibitor. The Merck Index (12th ed.). p ...
This promotes platelet adhesion and aggregation. Moreover, only once disruption of the plaque surface has occurred are these ...
... is a platelet aggregation inhibitor. It works as a thromboxane synthase inhibitor and a thromboxane receptor ...
... is a platelet aggregation inhibitor. Orefice G, Grasso A, Fazio N, Del Vecchio G, Volpe G, Coppola M, D'Alessio A, ...
In addition, PGE2 inhibits platelet aggregation. PGE2 also suppresses T cell receptor signaling and proliferation, and may play ...
... the result is inhibition of platelet aggregation. Plant synthesis of vitamin B6 contributes to protection from sunlight. ...
It blocks thromboxane induced platelet aggregation and vasoconstriction. Waksman R, Gurbel P, Gaglia M (2014). Antiplatelet ...
10R,17S-diHDHA and to slightly lesser degrees 10R,17S-diHDHA and PDX inhibit the human platelet aggregation response to ... These E,Z,E PUFA are 20- to 100-fold stronger in inhibiting human platelet aggregation than two mono-hydroxyl-containing ... Croset M, Lagarde M (1983). "Stereospecific inhibition of PGH2-induced platelet aggregation by lipoxygenase products of ... potently inhibit blood platelet aggregation". FASEB Journal. 25 (1): 382-8. doi:10.1096/fj.10-161836. PMID 20833872. S2CID ...
... inhibits glucose transport and platelet aggregation. It blocks adenosine-induced apoptotic body formation ...
Platelet aggregation is another possible mechanism of injury. Blisters and spasm of blood vessels (vasospasm) can develop after ...
... a new class of anti-platelet drug. It functions by inhibiting thrombin-related platelet aggregation. This mechanism works by a ... Unlike many other medication, vorapaxar does not affect ADP-mediated platelet aggregation, coagulation parameters, or bleeding ... Vorapaxar is a new anti-platelet drug that is part of the PAR-1 antagonist family, ... different pathway than other anti-platelet medications such as aspirin and P2Y12 inhibitors. ...
Antiplatelets are drugs that interfere with platelet aggregation. These drugs are prescribed in certain medical conditions/ ... At the time of extraction a platelet rich fibrin (PRF) membrane containing bone growth enhancing elements is placed in the ... Peck MT, Marnewick J, Stephen L (2011). "Alveolar ridge preservation using leukocyte and platelet-rich fibrin: a report of a ... Khiste SV, Naik Tari R (2013). "Platelet-Rich Fibrin as a Biofuel for Tissue Regeneration". ISRN Biomaterials. 2013: 1-6. doi: ...
"Acute microvascular platelet aggregation after subarachnoid hemorrhage (SAH)." J Neurosurg 2005. 102(6) 1094- 1100. PMID ...
Uraemia can lead to alteration of platelet aggregation. This situation, combined with the use of heparin and other ... Aspirin is characterized by an anti-platelet activity and thus its use should be avoided in uremic patients. The challenge in ...
PDE3 is an important player in platelet aggregation. It has been reported that higher concentration of cGMP causes inhibition ... Interplay between those two functions seems to mediate an opposing regulation of cAMP in platelets. PDE2 regulates cardiac L- ... PDE2 is expressed in various tissues, for example: adrenal medulla, brain, heart, platelet, macrophages and endothelial cells. ... that PDE2 might play an important role in the regulation of elevated intracellular concentrations of cAMP and cGMP in platelets ...
... signaling may contribute to platelet activation and aggregation. A PKA/PKG phosphorylation site has been identified in ... Zimman A, Titz B, Komisopoulou E, Biswas S, Graeber TG, Podrez EA (2014). "Phosphoproteomic analysis of platelets activated by ... Significantly increased phosphorylation on S249 of CASS4, also in the unstructured domain, after platelet stimulation with the ... which may implicate CASS4 mediated signaling in platelet hyperreactivity. There are currently no therapeutic approaches ...
Furthermore, it is known that nicergoline inhibits platelet aggregation. Studies have shown that nicergoline also increases ... Migraines of vascular origin Coadjutant therapy in clinical situations accompanied by platelet hyper-aggregability, arterial ...
Tuchin DA, Erve PR, Schumer W (1976). "Prevention of endotoxin--induced irreversible platelet aggregation in vitro". Surgical ...
It works by reducing platelet aggregation and thrombus formation. Gastrointestinal disturbances were reported as a potential ...
... the latter may modify platelet aggregation and blood viscosity. Stroke, particularly intracerebral hemorrhage, is the most ...
This would utilize platelet aggregation studies and flow cytometry. Giant platelet disorders can be further categorized: caused ... Platelet Disorders Overview of Platelet Disorders at eMedicine Mhawech, Paulette (2000). "Inherited Giant Platelet Disorders". ... Giant platelet disorder occurs for inherited diseases like Bernard-Soulier syndrome, gray platelet syndrome and May-Hegglin ... "Giant platelet syndrome". MedicineNet. Archived from the original on 2018-08-15. Retrieved 2016-04-14. "Giant platelet syndrome ...
... it does not inhibit platelet aggregation at approved doses. People with prior history of ulcer disease or GI bleeding require ... Celecoxib does not usually affect prothrombin time, partial thromboplastin time or platelet counts; ... a platelet activator. COX-1 is traditionally defined as a constitutively expressed "housekeeping" enzyme and plays a role in ... the protection of the gastrointestinal mucosa, kidney hemodynamics, and platelet thrombogenesis. COX-2, on the contrary, is ...
The platelet aggregation blood test checks how well platelets, a part of blood, clump together and cause blood to clot. ... The platelet aggregation blood test checks how well platelets, a part of blood, clump together and cause blood to clot. ... Your provider may order this test if you have signs of a bleeding disorder or a low platelet count. It may also be ordered if a ... When platelets clump together, the blood sample is clearer. A machine measures the changes in cloudiness and prints a record of ...
... it is widely held that platelet shape change is a prerequisite for platelet aggregation. We conducted this study to determine ... We conclude that platelet aggregation occurs independently of shape change and that shape change is not necessarily followed by ... These results indicate that platelet shape change is not a prerequisite for aggregation and that the signal widely believed to ... aggregation. These observations suggest an alternative role for platelet shape change of single platelets. ...
... was found constitutively expressed on human platelets. Biochemical analysis revealed that platelet CD69 appears on sodium ... CD69 is expressed on platelets and mediates platelet activation and aggregation J Exp Med. 1990 Sep 1;172(3):701-7. doi: ... CD69 stimulation by anti-Leu-23 monoclonal antibodies induced platelet aggregation in a dose-dependent fashion. This effect was ... was found constitutively expressed on human platelets. Biochemical analysis revealed that platelet CD69 appears on sodium ...
Antibodies for proteins involved in platelet aggregation pathways, according to their Panther/Gene Ontology Classification ... Antibodies for proteins involved in platelet aggregation pathways; according to their Panther/Gene Ontology Classification. ...
Substances that reduce platelet aggregation include tocotrienols, shark liver oil, curcumin, gingko biloba, grape seed extract ... Platelet Aggregation Risk. Substances that reduce platelet aggregation include tocotrienols, shark liver oil, curcumin, gingko ... Excessive platelet aggregation has been linked with the development of atherosclerosis and other cardiovascular conditions. ... The prolapsing mitral valve is known to damage platelets and increase their aggregation. This work has been confirmed in ...
... of adiponectin and sCD40L levels with platelet aggregation in the MS and the effects of adiponectin on platelet aggregation and ... since it inhibits platelet aggregation and platelet activation.. CITATION Am J Physiol Endocrinol Metab. 2010 May;298(5):E1072- ... Adiponectin diminishes platelet aggregation and sCD40L release. Potential role in the metabolic syndrome.. Mar 2, 2010 , ... ADP- and epinephrine platelet aggregation was measured after preincubation with adiponectin. sCD40L and P-selectin secretion ...
The effect of Iloprost (ZK 36 374), a chemically stable carboprostacyclin derivative, on ADP-induced platelet aggregation was ... Effect of Iloprost (ZK 36 374), a Novel Prostacyclin Analogue, on ADP-induced Platelet Aggregation. Acta Haematol (1985) 73 (4 ...
We present a microfluidic device that is able to trigger initial recruitment and subsequent aggregation of discoid platelets by ... A Platform to Study Platelet Aggregation and Thrombus Growth Based on Dynamic Stress. Poster Published: August 11, 2010 ... We present a microfluidic device that is able to trigger initial recruitment and subsequent aggregation of discoid platelets by ...
The platelets arise from the fragmentation of the cytoplasm of megakaryocytes in the bone marrow and circulate in blood as disc ... The hemostatic system consists of platelets, coagulation factors, and the endothelial cells lining the blood vessels. ... The platelet GP IIb/IIIa complex mediates platelet-to-platelet interactions (platelet aggregation). On resting platelets, GP ... Platelet adhesion to vWF via platelet GP Ib platelet activation. *Platelet aggregation mediated by the interaction of GP IIb/ ...
The platelets arise from the fragmentation of the cytoplasm of megakaryocytes in the bone marrow and circulate in blood as disc ... The hemostatic system consists of platelets, coagulation factors, and the endothelial cells lining the blood vessels. ... The platelet GP IIb/IIIa complex mediates platelet-to-platelet interactions (platelet aggregation). On resting platelets, GP ... Platelet adhesion to vWF via platelet GP Ib platelet activation. *Platelet aggregation mediated by the interaction of GP IIb/ ...
Platelet Aggregation Studies. Category. Haematology ,, Specialised Coagulation Services Test background. Platelet aggregation ... Platelet aggregation is rarely performed in isolation and is never used solely in the diagnosis of a bleeding disorder, rather ... Please note: - Platelet aggregation requests must be approved by the haematology clinical team and booked with the lab prior to ... Investigation of bleeding phenotype consistent with a possible platelet function disorder. Confirmation of previously diagnosed ...
The reference range is a normal biphasic pattern of aggregation in response to specific platelet activators (see image below).{ ... Platelet aggregation studies test the clumping response of platelets to various platelet activators (eg, ADP, collagen, ... encoded search term (Platelet Aggregation) and Platelet Aggregation What to Read Next on Medscape ... Platelet secretion defects can provide greater diagnostic sensitivity than platelet aggregation testing alone. [1, 2, 3] ...
The reference range is a normal biphasic pattern of aggregation in response to specific platelet activators (see image below).{ ... Platelet aggregation studies test the clumping response of platelets to various platelet activators (eg, ADP, collagen, ... encoded search term (Platelet Aggregation) and Platelet Aggregation What to Read Next on Medscape ... Platelet secretion defects can provide greater diagnostic sensitivity than platelet aggregation testing alone. [1, 2, 3] ...
Aims: Therefore this study aims to determine if platelet aggregation is a true measure of global platelet responsiveness; or ... What defines Platelet Responsiveness? "Aggregation and secretion are independently regulated". E. Alfatani ... For example, the maximal extent of platelet aggregation varies in response to TRAP from a minimum 31.50% to maximum 120%). ... However, there is no correlation between platelet secretion and aggregation responses.. Conclusion(s): Substantial inter- ...
Platelet Aggregation (Clotting). ...the condition "...tocotrienols, shark liver oil, curcumin, gingko biloba, grape seed ... "Taurine reduces platelet aggregation, which is how most natural products work in stroke prevention." ...
RA was active at concentrations as low as 10(-7) M and required 20 min prior incubation with platelet suspension in order t ... Retinoic acid (RA) was found to inhibit ADP induced but not collagen induced aggregation of human platelets and the ... Differential effect of retinoic acid on ADP and collagen induced platelet aggregation. G MUKHERJEE, G C CHATTERJEE, D BANERJEE ... RA when used as an agent for differentiation induction of cell progenitor is likely to affect the platelet aggregation and ...
Ikeda Y, Murata M, Goto S. Von Willebrand factor-dependent shear-induced platelet aggregation: Basic mechanisms and clinical ... Ikeda, Y, Murata, M & Goto, S 1997, Von Willebrand factor-dependent shear-induced platelet aggregation: Basic mechanisms and ... Von Willebrand factor-dependent shear-induced platelet aggregation : Basic mechanisms and clinical implications. In: Annals of ... Ikeda, Y., Murata, M., & Goto, S. (1997). Von Willebrand factor-dependent shear-induced platelet aggregation: Basic mechanisms ...
... or aggregation of platelets and are frequently associated with excessive bleeding, often following trauma or surgery. These ... Platelet Aggregation Testing. Further testing for a functional platelet disorder involves platelet aggregation testing. Light ... Functional Platelet Disorders Functional platelet disorders affect the adhesion, activation, or aggregation of platelets and ... Platelet Aggregation Studies. Platelet Dense Granule Analysis. Platelet Flow Cytometry. Bernard-Soulier syndrome. Decreased ...
Platelet aggregation test. Platelet aggregation test. The platelet aggregation blood test checks how well platelets, a part of ... Anagrelide to lower platelet counts.. *Ruxolitinib (Jakafi) to reduce the number of red blood cells and reduce an enlarged ... The numbers of white blood cells and platelets may also be higher than normal. ...
... are defined by specific alterations in hemostasis and platelet function. ... Platelet Dysfunction An inhibitor of platelet aggregation has been observed in the plasma of patients with severe LF and ... Release of platelet granule contents is necessary for the second wave of platelet activation that sustains aggregation. The ... Cummins D, Fisher-Hoch SP, Walshe KJ, Mackie IJ, McCormick JB, Bennett D, et al. A plasma inhibitor of platelet aggregation in ...
Synthesis of Novel 12-Substituted11,13,15-Triazasteroidal Compounds and Their Inhibitory Activity on Platelet Aggregation. (共著) ... Synthesis of Novel 12-Substituted11,13,15-Triazasteroidal Compounds and Their Inhibitory Activity on Platelet Aggregation. (共著) ... Synthesis of Novel 12-Substituted11,13,15-Triazasteroidal Compounds and Their Inhibitory Activity on Platelet Aggregation. (共著 ... T1 - Synthesis of Novel 12-Substituted11,13,15-Triazasteroidal Compounds and Their Inhibitory Activity on Platelet Aggregation ...
NZ-1 neutralized platelet aggregation by LN319. These results suggest that podoplanin is a main reason for platelet aggregation ... NZ-1 neutralized platelet aggregation by LN319. These results suggest that podoplanin is a main reason for platelet aggregation ... NZ-1 neutralized platelet aggregation by LN319. These results suggest that podoplanin is a main reason for platelet aggregation ... NZ-1 neutralized platelet aggregation by LN319. These results suggest that podoplanin is a main reason for platelet aggregation ...
... and the platelet aggregation test (aggregation of cuvettes in a four-channel platelet aggregometer) were also conducted. The ... The study aimed to determine the effect of coffee intake on AGEs formation and platelet aggregation in diabetic Wistar rats. ... Coffee intake (Coffea arabica L. ) reduces advanced glycation end product (AGEs) formation and platelet aggregation in diabetic ... Coffea arabica L., Diabetes Mellitus, End Products of Advanced Glycation, Aminoguanidine, Platelet Aggregation ...
Plasma Phospholipid Transfer Protein Promotes Platelet Aggregation. Zhao XM, et al. Thromb Haemost, 2018 Dec. PMID 30419596, ...
This process involves vasoconstriction and platelet aggregation. Platelets also act as a source of growth factors and ... Platelet-activating factor derived from mast cells induces platelet degranulation and releases many factors, such as TGF-β, ... Moulin, V.; Lawny, F.; Barritault, D.; Caruelle, J.P. Platelet releasate treatment improves skin healing in diabetic rats ... TGF-β1 derived from epidermal keratinocytes, platelets, macrophages, and fibroblasts promotes the secretion of ED-A fibronectin ...
An antiplatelet is a medication that decreases platelet aggregation and inhibits thrombus formation. They are effective in the ... Antiplatelet drugs limit the migration or aggregation of platelets; Anticoagulants limit the ability of the blood to clot; ...
Platelet aggregation studies - only aggregation with ristocetin would be informative. *Von Willebrand factor activity = looks ... It is the thing that locates the platelets to the correct spot = affects platelet adhesion process. ... Usually helps in the clotting process by binding to the surface of the wall and then making platelets bind to the surface of ... Once they bind, it brings other platelets to clump on the surface=blood stops flowing and a clot is formed. ...
Naproxen may decrease platelet aggregation and prolong bleeding time. This effect should be kept in mind when bleeding times ... NSAIDs inhibit platelet aggregation and have been shown to prolong bleeding time in some patients. Unlike aspirin, their effect ... Patients receiving Naproxen Tablets, USP who may be adversely affected by alterations in platelet function, such as those with ... The free fraction of warfarin may increase substantially in some subjects and naproxen interferes with platelet function. ...
  • CD69, a surface dimer so far considered an early activation antigen restricted to lymphocytes, was found constitutively expressed on human platelets. (nih.gov)
  • Retinoic acid (RA) was found to inhibit ADP induced but not collagen induced aggregation of human platelets and the differential action is related to intraplatelet Ca2+ reflux. (caluniv.ac.in)
  • Platelet aggregation studies offer a qualitative assessment of platelet function in response to various agonists that stimulate platelet activation pathways. (nwlpathology.nhs.uk)
  • Platelet disorders and von Willebrand disease. (medlineplus.gov)
  • Platelets play a primary role in this process, interacting with subendothelium-bound von Willebrand factor (vWf) via the membrane glycoprotein (GP) Ib complex. (medscape.com)
  • Ikeda, Y, Murata, M & Goto, S 1997, ' Von Willebrand factor-dependent shear-induced platelet aggregation: Basic mechanisms and clinical implications ', Annals of the New York Academy of Sciences , vol. 811, pp. 325-336. (elsevierpure.com)
  • The workup of a patient with a platelet-type bleeding pattern typically includes correlation with platelet count ( thrombocytopenia ), evaluation of platelet morphology on peripheral smear, exclusion of acquired causes of platelet dysfunction, and testing for von Willebrand disease (VWD) . (arupconsult.com)
  • CD69 stimulation by anti-Leu-23 monoclonal antibodies induced platelet aggregation in a dose-dependent fashion. (nih.gov)
  • Since then, the initial decrease in light transmission detected in aggregometry is used as a measure for the extent of platelet shape change. (nature.com)
  • Clopidogrel , prasugrel , and ticagrelor all can markedly reduce platelet function and increase bleeding. (msdmanuals.com)
  • Novel evidence is provided demonstrating that adiponectin has anti-thrombotic properties, since it inhibits platelet aggregation and platelet activation. (cun.es)
  • First, we established a highly reactive anti-podoplanin antibody, NZ-1, which inhibits podoplanin-induced platelet aggregation completely. (elsevierpure.com)
  • An antiplatelet is a medication that decreases platelet aggregation and inhibits thrombus formation. (cdc.gov)
  • The hemostatic system consists of platelets, coagulation factors, and the endothelial cells lining the blood vessels. (medscape.com)
  • Under physiological circumstances, the resistance of the endothelial cell lining to interactions with platelets and coagulation factors prevents thrombosis. (medscape.com)
  • Platelet disorders lead to defects in primary hemostasis and produce signs and symptoms different from coagulation factor deficiencies (disorders of secondary hemostasis). (medscape.com)
  • 70%. Severe cases exhibit abnormal coagulation, endothelial barrier disruption, and dysfunctional platelet aggregation but the underlying mechanisms remain poorly understood. (cdc.gov)
  • In Sierra Leone during 2015-2018, we assessed LF patients' day-of-admission plasma samples for levels of proteins necessary for coagulation, fibrinolysis, and platelet function. (cdc.gov)
  • Acquired platelet dysfunction is suspected and diagnosed when unusual or prolonged bleeding is observed and other possible diagnoses (eg, thrombocytopenia, coagulation abnormalities) have been eliminated. (msdmanuals.com)
  • Platelet aggregometry is a standard clinical technique that measures the in vitro aggregability of platelets in response to agonists by using the amount of light transmitted through platelet-rich plasma (PRP) ( Holmsen, 1987 ). (nature.com)
  • Severe abnormalities in platelet function, such as Bernard-Soulier syndrome, Glanzmann's thrombasthenia, or platelet storage-pool deficiency, are characterized by the inability of platelets to aggregate in response to certain agonists. (nature.com)
  • This initial interaction (platelet adhesion) sets the stage for other adhesive reactions that allow the platelets to interact with other agonists in the vicinity of vessel injury, such as adenosine 5'-diphosphate (ADP), subendothelial collagen, and thrombin. (medscape.com)
  • Specifically, we examined the dose-response nature of each individual's responsiveness to platelet agonists in parallel assays of platelet aggregation (assessed by light transmission in PRP) and platelet ATP secretion (assessed by luminometry). (isth.org)
  • The results show significant inter-individual differences in aggregation and secretion responses to all 3 agonists in the donor population. (isth.org)
  • There is a strong positive correlation between responses to all 3 agonists in the aggregation assays and, separately, in the secretion assays. (isth.org)
  • Conditions associated with decreased platelet aggregation include suspected hereditary and acquired disorders of platelet function. (medscape.com)
  • Functional platelet disorders affect the adhesion, activation, or aggregation of platelets and are frequently associated with excessive bleeding, often following trauma or surgery. (arupconsult.com)
  • How do functional platelet disorders manifest clinically? (arupconsult.com)
  • The clinical features of functional platelet disorders vary. (arupconsult.com)
  • rarely, it may be observed in functional platelet disorders). (arupconsult.com)
  • Functional platelet disorders are generally associated with immediate bleeding in response to surgery or trauma, whereas factor deficiencies are associated with delayed bleeding. (arupconsult.com)
  • What are some causes of acquired functional platelet disorders? (arupconsult.com)
  • Which functional platelet disorders are inherited? (arupconsult.com)
  • Bernard-Soulier syndrome (an adhesion disorder) and Glanzmann thrombasthenia (an aggregation disorder) are among the most well-recognized inherited disorders of platelet function and are severe clinical conditions. (arupconsult.com)
  • Refer to the table, Laboratory Findings in Selected Inherited Functional Platelet Disorders , for additional information and a more comprehensive list of inherited functional platelet disorders. (arupconsult.com)
  • Laboratory testing for functional platelet disorders is appropriate in individuals with bleeding manifestations that suggest a functional platelet disorder (eg, easy bruising, prolonged bleeding following dental work or surgery, menorrhagia), particularly those with a family history of a bleeding disorder and in whom VWD has been previously excluded. (arupconsult.com)
  • Thrombocytopenia is a common feature of hemorrhagic fevers and vascular permeability disorders ( 8 ), but the decrease in platelet counts in acute LF is not low enough to cause spontaneous hemorrhage. (cdc.gov)
  • Acquired platelet dysfunction, which is common, may result from aspirin , other nonsteroidal anti-inflammatory drugs (NSAIDs), or systemic disorders. (msdmanuals.com)
  • Overview of Platelet Disorders Platelets are circulating cell fragments that function in the clotting system. (msdmanuals.com)
  • It may also be ordered if a member of your family is known to have a bleeding disorder due to platelet dysfunction. (medlineplus.gov)
  • The impaired homeostasis and platelet dysfunction implicate alterations in the protein C pathway, which might contribute to the loss of endothelial barrier function in fatal infections. (cdc.gov)
  • The platelet GP IIb/IIIa complex mediates platelet-to-platelet interactions (platelet aggregation). (medscape.com)
  • Platelet aggregation studies test the clumping response of platelets to various platelet activators (eg, ADP, collagen, arachidonic acid, thrombin, epinephrine, ristocetin) as continuously recorded by a light transmission aggregometer. (medscape.com)
  • AGEs quantification (spectrofluorometric method ) and the platelet aggregation test (aggregation of cuvettes in a four-channel platelet aggregometer) were also conducted. (bvsalud.org)
  • Magnesium is a powerful antagonist of platelet adhesion. (digitalnaturopath.com)
  • The body's reaction to vessel wall injury is rapid adhesion of platelets to the subendothelium. (medscape.com)
  • It is the thing that locates the platelets to the correct spot = affects platelet adhesion process. (wikibooks.org)
  • Platelet activation allows binding of these proteins, which bridges adjacent platelets. (medscape.com)
  • The alpha granules contain hemostatic proteins such as fibrinogen, vWf, and growth factors (eg, platelet-derived growth factor and transforming growth factors). (medscape.com)
  • Microaggregation appeared to be distinct from full aggregation, as it was not inhibited by the addition of CD61, an antibody to the β 3 integrin. (nature.com)
  • Seven tubes are required for full aggregation and secretion testing. (medscape.com)
  • With some aggregometers, the secretion of platelet granules, another indicator of platelet function, may also be evaluated simultaneously by measuring the release of ATP by the aggregating platelets. (medscape.com)
  • Platelet secretion defects can provide greater diagnostic sensitivity than platelet aggregation testing alone. (medscape.com)
  • Similarly, the maximal extent of ATP secreted in response to TRAP from minimum 0.11 to maximum 4.67 pmoles / 106 platelets, demonstrating a 40 to 50 fold range in secretion-capacity for this dense-granule component. (isth.org)
  • However, there is no correlation between platelet secretion and aggregation responses. (isth.org)
  • Aggregation and secretion are independently regulated, suggesting that more studies are merited to investigate if ATP secretion might provide better insights into clinical risks in patient populations. (isth.org)
  • This was also seen when preactivated platelets, which cannot undergo further morphological changes, were used, and when platelets were activated in the presence of shape-change inhibitors such as cytochalasin D and vincristine. (nature.com)
  • Biochemical analysis revealed that platelet CD69 appears on sodium dodecyl sulfate-polyacrylamide gel electrophoresis as a broad 55-65-kD band, in which three 55-, 60-, and 65-kD components were detectable when nonreduced, and as two 28- and 32-kD bands when reduced, corresponding to the two disulfide-linked chains of the dimer. (nih.gov)
  • All the steps in ADP induced but not collagen induced platelet activation, viz. (caluniv.ac.in)
  • Your provider may order this test if you have signs of a bleeding disorder or a low platelet count . (medlineplus.gov)
  • Platelet aggregation is rarely performed in isolation and is never used solely in the diagnosis of a bleeding disorder, rather it is interpreted in conjunction with other investigations such as Lumi Aggregation, PFA-100 testing and the clinical bleeding score. (nwlpathology.nhs.uk)
  • As blood circulates through a pump oxygenator during cardiopulmonary bypass, platelets may become dysfunctional, prolonging bleeding. (msdmanuals.com)
  • Regardless of platelet count, patients who bleed excessively after cardiopulmonary bypass are often transfused with platelets. (msdmanuals.com)
  • Platelets were activated with ADP, thrombin, or the thrombin receptor agonist peptide SFLLRN (TRAP 1-6 ). (nature.com)
  • The platelet aggregation blood test checks how well platelets, a part of blood, clump together and cause blood to clot. (medlineplus.gov)
  • When platelets clump together, the blood sample is clearer. (medlineplus.gov)
  • The normal time it takes for platelets to clump depends on temperature, and may vary from laboratory to laboratory. (medlineplus.gov)
  • Once they bind, it brings other platelets to clump on the surface=blood stops flowing and a clot is formed. (wikibooks.org)
  • Once activated, platelets have two major mechanisms to recruit additional platelets to the growing hemostatic plug. (medscape.com)
  • Excessive platelet aggregation has been linked with the development of atherosclerosis and other cardiovascular conditions. (digitalnaturopath.com)
  • The test can help diagnose problems with platelet function. (medlineplus.gov)
  • These results suggest that CD69 may function as an activating molecule on platelets, as on lymphocytes, and point toward a more general role of this surface dimer in signal transduction. (nih.gov)
  • We hypothesized that adiponectin modulates platelet function. (cun.es)
  • Recovery time of platelet function after aspirin withdrawal. (medscape.com)
  • aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs) are common causes of abnormal platelet function, and platelet function testing may need to be deferred if patients have been taking these medications. (arupconsult.com)
  • Results showed that coffee reduced AGE formation and platelet aggregation in our animal model , not altering the animals ' renal function. (bvsalud.org)
  • It can interfere with the fetus's platelet function, making it more prone to bleeding. (medicalnewstoday.com)
  • Acquired abnormalities of platelet function are very common. (msdmanuals.com)
  • can impair platelet function. (msdmanuals.com)
  • Giving an antifibrinolytic agent during bypass may preserve platelet function and reduce the need for transfusion. (msdmanuals.com)
  • Drugs that affect platelet function. (msdmanuals.com)
  • On resting platelets, GP IIb/IIIa is unable to bind fibrinogen or vWf. (medscape.com)
  • Please note: - Platelet aggregation requests must be approved by the haematology clinical team and booked with the lab prior to testing. (nwlpathology.nhs.uk)
  • Fibrinogen is an essential blood-clotting factor and is involved in a range of other functions, including platelet aggregation and smooth muscle proliferation. (cdc.gov)
  • Also, in vitro studies were performed in platelet-rich plasma from 9 healthy volunteers. (cun.es)
  • The mucin-type sialoglycoprotein, podoplanin (aggrus), is a platelet-aggregating factor on cancer cells. (elsevierpure.com)
  • The platelets arise from the fragmentation of the cytoplasm of megakaryocytes in the bone marrow and circulate in blood as disc-shaped anucleate particles for 7-10 days. (medscape.com)
  • Thrombopoietin helps control the number of circulating platelets by stimulating the bone marrow to produce megakaryocytes. (msdmanuals.com)
  • Overview of Myeloproliferative Neoplasms Myeloproliferative neoplasms are clonal proliferations of bone marrow stem cells, which can manifest as an increased number of platelets, red blood cells (RBCs), or white blood cells (WBCs). (msdmanuals.com)
  • Taurine reduces platelet aggregation, which is how most natural products work in stroke prevention. (diagnose-me.com)
  • Platelets contain two unique types of granules: alpha granules and dense granules. (medscape.com)
  • Platelet activation plays an important role in arterial thrombosis in coronary heart disease, stroke, and peripheral arterial disease. (isth.org)
  • Platelet inhibitory effect of clopidogrel in patients treated with omeprazole, pantoprazole, and famotidine: a prospective, randomized, crossover study. (medscape.com)
  • ADP- and epinephrine platelet aggregation was measured after preincubation with adiponectin. (cun.es)
  • Higher platelet aggregation was found in the MS. Adiponectin inversely correlated with P-selectin (R:-0.35, p:0.009), sCD40L (R:-0.24, p:0.05) and epinephrine and collageninduced aggregation (r=-0.80, p=0.005 and r=-0.70, p=0.011). (cun.es)
  • These results indicate that platelet shape change is not a prerequisite for aggregation and that the signal widely believed to represent shape change reflects platelet microaggregation instead. (nature.com)
  • These results suggest that podoplanin is a main reason for platelet aggregation induced by LN319. (elsevierpure.com)
  • Aggregation leads to a substantial increase in light transmission because of the formation of large particles and the concomitant clearing of the sample. (nature.com)
  • We conclude that platelet aggregation occurs independently of shape change and that shape change is not necessarily followed by aggregation. (nature.com)
  • Transmission electron microscopy was used to support the interpretation that the initial decrease in light transmission was caused by platelet shape change ( Born et al, 1978 ). (nature.com)
  • The reference range is a normal biphasic pattern of aggregation in response to specific platelet activators (see image below). (medscape.com)
  • The initial hemostatic plug, composed primarily of platelets, is stabilized further by a fibrin mesh generated in secondary hemostasis. (medscape.com)
  • What is the general diagnostic testing approach to a patient with a platelet-type bleeding pattern? (arupconsult.com)
  • The laboratory specialist will look at how the platelets spread out in the liquid part of the blood (plasma) and whether they form clumps after a certain chemical or drug is added. (medlineplus.gov)
  • We present a microfluidic device that is able to trigger initial recruitment and subsequent aggregation of discoid platelets by mimicking the effects of pathological changes in blood vessel geometry. (technologynetworks.com)
  • The numbers of white blood cells and platelets may also be higher than normal. (limamemorial.org)
  • Usually helps in the clotting process by binding to the surface of the wall and then making platelets bind to the surface of the blood vessel wall. (wikibooks.org)
  • It was suggested that this optical effect was caused by the morphological change of platelets from discs to spherical cells with pseudopodia ( Latimer et al, 1977 ). (nature.com)
  • Morphologically, the platelets change dramatically from discs to spiny spheres in a process called shape change. (medscape.com)
  • Because the initial decrease in light transmission in platelet aggregometry is attributed to platelet shape change, it is widely held that platelet shape change is a prerequisite for platelet aggregation. (nature.com)
  • RA when used as an agent for differentiation induction of cell progenitor is likely to affect the platelet aggregation and thereby the haemostatic process. (caluniv.ac.in)
  • These observations suggest an alternative role for platelet shape change of single platelets. (nature.com)